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Cells achieve a balance between the daily production of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) through a number of 
efficient cellular antioxidant systems, including the major thiol redox systems: 
the thioredoxin (Trx) and glutathione (GSH) systems. Transient or permanent 
oxidative stress resulting from excessive ROS/RNS produces thiol oxidative 
modifications in cellular proteins. Such modifications lead to alterations in the 
proteins’ biological functions. Apparently, the varying severity of oxidative 
stress can lead to different patterns of oxidative modifications, which result in 
differential cellular consequences. This thesis is focused on the investigation 
of the redox sensitivities of two cysteine-containing proteins, the apoptosis 
inducing factor (AIF) and Kelch-like ECH-associated protein 1 (Keap1). 
Following the preliminary finding of a novel interaction between AIF and 
Trx1, it was found that the catalytic and non-catalytic cysteine residues in 
Trx1 were essential for Trx1’s interaction with AIF. Conversely, the cysteines 
in AIF were found non-essential for this interaction. Under strong oxidative 
stress conditions brought about by cytotoxic concentrations of oxidants H2O2 
and diamide, the AIF-Trx1 interaction was abolished and was re-established 
during oxidative stress recovery (upon removal of oxidative stress stimuli) or 
by concurrent treatment of N-acetylcysteine. Experiments carried out to 
elucidate the functional significance of the Trx1-AIF interaction in regulating 
apoptosis involving AIF had arrived at the following conclusions: under 
physiological conditions, cytosolic Trx1 in its reduced form was involved in 
antagonizing the nuclear translocation of AIF; when localized in the nucleus, 
nuclear Trx1 in its reduced form could attenuate AIF’s DNA damaging 
effects.  
Investigation of the susceptibilities of AIF and Keap1 to oxidative 
modifications revealed that both proteins were oxidized to disulfide forms 
with differing sensitivities. AIF, which contains three cysteines, was 
comparatively more resistant than Keap1 to oxidative modifications. Under 
constitutive conditions, oxidized AIF formed through intramolecular disulfide 
 viii 
 
formation between Cys255 and Cys440 (numbering in mouse AIF) was 
absent, while Keap1 was found to be partially oxidized to intra-, as well as 
inter-molecular disulfide forms. Furthermore, relatively lower doses of 
oxidants, including non-cytotoxic concentrations, were able to cause Keap1 
oxidation, whereas higher levels of oxidants usually in the cytotoxic range 
caused AIF oxidation. The high redox sensitivity of Keap1 had aligned with 
the role of Keap1 as a sensor protein responsive to stress induced by a broad 
spectrum of mild to moderate doses of electrophilic compounds and oxidants. 
It was therefore deduced that oxidative modifications rendered to the Keap1 
protein led to alterations in Keap1’s function, which resulted in the 
upregulation of NF-E2-related factor 2 (Nrf2) and antioxidant response 
element (ARE)-dependent transcriptional activation of phase II detoxifying 
and antioxidant enzymes. The thiol redox states of both AIF and Keap1 were 
found to be at least partly regulated by the Trx and GSH systems, where these 
thiol redox systems provided reducing equivalents to oppose or reduce the 
formation of oxidized AIF and Keap1. 
In conclusion, this study had explored the redox sensitivities of AIF and 
Keap1 and their regulation by thiol redox systems. The difference in their 
sensitivities to oxidative stress, as well as their oxidation profiles would 
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1.1 General introduction 
Redox-dependent cell signaling is known to have a plethora of biological 
functions that are important for embryogenesis, tissue homeostasis and 
remodeling through regulation of cell survival, proliferation and apoptotic cell 
death (Powis et al., 1995, Ufer et al., 2010, Burhans and Heintz, 2009, Giles, 
2006). These signaling are mediated by reactive oxygen species (ROS), 
reactive nitrogen species (RNS) and reactive electrophile species (RES). At 
physiological levels, these redox active species acts as “redox messengers” 
and regulate several biological processes (Antelmann, 2011). Although 
important for the normal functioning of cells, the abnormally increased redox 
active entities during exaggerated or defective metabolic activities or exposure 
to xenobiotics can cause oxidative stress to the cell, which may lead to 
development of pathophysiological conditions. Indeed, increasing evidence 
has suggested that apoptosis caused by oxidative stress is involved in the 
etiology of several diseases such as Alzheimer’s disease (Markesbery, 1999), 
Parkinson’s disease (Jenner and Olanow, 1996), diabetes mellitus 
(Kuyvenhoven and Meinders, 1999) and AIDS (Gil et al., 2003b). On the 
other hand, abnormal levels of ROS have been implicated in cancer 
development through causing potential DNA damage and mutations (Marnett, 
1999, Ma and He, 2012). To combat against the excessive amount of oxidative 
and electrophilic insults, aerobic cells contains various antioxidants and 
antioxidant defense systems that maintain the cellular redox equilibrium 
(Valko et al., 2006). Under redox equilibrium state, the redox regulation of 
biological processes such as gene expression, apoptosis, immune and 
inflammatory responses helps to maintain normal cellular functioning (Hirota 
et al., 1997, Hayes and McMahon, 2001, Trachootham et al., 2008).   
Cellular proteins containing redox-sensitive cysteines that are crucial for the 
proteins’ biological functions are sensitive to oxidative and electrophilic 
stress. It is therefore important to study the redox sensitivity of such proteins 





1.2 Redox biochemistry 
Reduction-oxidation (redox) reactions are fundamental chemical reactions in 
biological systems. Aerobic organisms have developed a classic way of energy 
production; during the process of oxidative phosphorylation, energy is 
released from the oxidation of organic or inorganic molecules using oxidizing 
equivalents of molecular oxygen (O2). However, during this process of energy 
production, the single electron reduction of O2 leads to the formation of 
superoxide (O2∙−) radical as a by-product (Boveris et al., 1972). Superoxide 
(O2∙−) radicals are further converted to other types of ROS by enzymatic or 
non-enzymatic reactions.     
 
Figure 1.1 A part of oxidative phosphorylation pathway presenting the sites of 
superoxide radical (O2∙−) generation. During the process of oxidative 
phosphorylation, electrons flow through the four complexes of the electron transport 
chain (І to ІV). The leakage of electrons from complex І and ІІІ lead to superoxide 
radical (O2∙−) generation. (IMS = intermembrane space, IMM = inner mitochondrial 
membrane, Q = coenzyme Q/ubiquinone, Cyt C = cytochrome C).  
 
1.2.1 ROS and RNS 
Mitochondria are major organelles involved in the production of ROS in 
aerobic cells (Boveris et al., 1972). As mentioned above, during respiratory 
cycles, O2∙− radicals are continuously produced from complex І and ІІІ of the 
electron transport chain (ETC) located at the inner mitochondria membrane. In 
addition, depending on the activity of the respiratory chain, matrix pH, and the 
NADH pool within the mitochondrial matrix, O2∙− radicals can also be 




intermembrane space and outer membrane of the mitochondria (Korshunov et 
al., 1997, Lambert and Brand, 2004). ROS generated from mitochondria 
accounts for about 90% of total cellular ROS production (Balaban et al., 
2005). There are other mechanisms by which ROS are generated from various 
enzymatic reactions in the form of either O2∙− radical or hydrogen peroxide 
(H2O2). These reactions include those catalyzed by α-ketoglutarate 
dehydrogenase (on outer membrane of mitochondria), NADPH-cytochrome 
P450 reductase (in mitochondrial matrix), NADPH-cytochrome b5 reductase 
(in microsomal ETC), NADPH oxidases, xanthine oxidases, xanthine 
dehydrogenase, lipooxygenase and cyclooxygenase (Dupuy et al., 1991, 
Granger, 1988, Andreyev et al., 2005, Starkov et al., 2004, Tretter and Adam-
Vizi, 2004, Migliaccio et al., 2006, Korshunov et al., 1997, Lambert and 
Brand, 2004).  
The weak diffusivity of O2∙− restricts this radical within the mitochondrial 
matrix, where it gets reacted to other types of ROS. O2∙− is metabolized to 
H2O2 by the enzymatic reaction catalyzed by superoxide dismutases (SODs) 
(Zelko et al., 2002). O2∙− can also react with nitric oxide (NO) to form 
peroxynitrite (ONOO−), which is widely known to cause lipid peroxidation of 
membrane lipids (Radi et al., 1991). Unlike O2∙−, H2O2 penetrates across the 
membrane of organelles and cell likely through aquaporins (Bienert et al., 
2006). H2O2 itself is not a highly reactive radical. However, it gets converted 
to a highly reactive hydroxyl radical (OH∙) by reacting with transition metals 
such as Fe2+ in a Fenton-type reaction (Fenton, 1894). Hydroxyl radicals can 
also be formed by Haber-Weiss reaction between O2∙− and H2O2 (Haber, 
1934). A reaction between hydroxyl radicals with polyunsaturated fatty acids 
forms lipid hydroperoxides, which is also a type of ROS (Radi et al., 1991).  
Besides, H2O2 is reduced by various antioxidant enzymes such as catalase, 
glutathione peroxidase (GPx) and peroxiredoxin (Prx) (Kang et al., 2005, 
George, 1947, Kang et al., 1998, Gaetani et al., 1989). 
ROS (O2∙−, OH∙, ONOO−, NO and H2O2) is endogenously generated through 
metabolic processes. Some form of ROS (H2O2, HOCl, organic 




sources such as through inhalation, ingestion and injection. In addition, toxic 
chemicals or ionizing radiations are reported to induce in vivo generation of 
ROS (Sanlioglu et al., 2001, Yamamori et al., 2012). RNS is basically 
generated endogenously through enzymatic reactions or by metabolic 
processes mediated by ROS. NO and ONOO− can also be classified as RNS. 
NO, mainly produced by constitutive or inducible oxide synthetase (eNOS or 
iNOS respectively) is the most common RNS (Bredt et al., 1991). ONOO− is a 
highly reactive form of RNS (Beckman et al., 1990, Koppenol et al., 1992). 
RNS can also be taken up into the cells through exogenous sources such as 
NO donors. On the other hand, RES such as quinones, aldehydes and epoxides 
are also mainly of exogenous sources such as foods or drug intake. RES 
usually possesses low, moderate to high reactivity towards nucleophilic groups 
present in proteins, lipids and nucleic acids (Liebler, 2008).   
1.2.3 Oxidative modifications in macromolecules 
Cellular macromolecules including lipids, proteins and nucleic acids are 
susceptible to oxidative modifications (Valko et al., 2006). Polyunsaturated 
fatty acids in membranes undergo lipid peroxidation with ROS such as OH∙ 
and ONOO− (Radi et al., 1991). The formed lipid hydroperoxides are another 
form of ROS that can cause oxidation of other macromolecules (Wang et al., 
1996). Highly reactive hydroxyl radicals, peroxynitrite radicals, and lipid 
hydroperoxides are known to cause oxidative damages to nucleic acids by 
altering the purine and pyrimidine bases, as well as the deoxyribose sugar or 
by cleaving the phosphodiester backbone, which eventually lead to mutations, 
deletions or double strand breaks (DSB) in DNA (Breen and Murphy, 1995). 
Proteins are most susceptible to oxidative modifications in times of oxidative 
stress. The functional groups on the side chain of amino acids undergo various 
types of oxidative changes. For instance, sulfur-containing amino acids, 
namely methionine and cysteine are susceptible (Dean et al., 1985). 
Methionine undergoes reversible oxidation to methionine sulfoxide (Shechter, 
1986), whereas cysteine undergoes reversible oxidative modifications such as 
S-sulfenation, S-glutathionylation, S-nitrosylation and disulfide bond 




reversible oxidation to sulfinic (-SOOH) or irreversible sulfonic acids (-
SOOOH). Sulfiredoxin catalyzes reduction of sulfinic acid to free thiols in 2-
Cys peroxiredoxins (Woo et al., 2005). Other irreversible oxidative 
modifications in proteins include carbonylation of side chain of lysine, 
histidine and cysteine amino acids (Esterbauer et al., 1991) and tyrosine 
nitration (Radi, 2004). The reactivity of cysteines towards oxidative stress and 
the details of various forms of thiol oxidative modifications are presented in 
the following Section 1.2.3.1. 
1.2.3.1 Thiol modifications by ROS, RNS and RES 
Among the amino acids, cysteine is most susceptible to oxidative 
modifications caused by ROS, RNS and RES. However, not all cysteines are 
susceptible to such oxidative modifications. At basic pH, the sulfhydryl group 
in cysteine gets deprotonated to a thiolate anion (S−) that is a reactive 
nucleophile.  Given that the pKa of cysteine is around 8.5, at physiological 
pH, cysteine is not completely ionized (Sevier and Kaiser, 2006). This makes 
it a weak nucleophile for oxidative attack. However, reactivity of thiol groups 
of cysteines within a protein can vary depending on the pH of the 
environment, the types of amino acids adjacent to the cysteines and the extent 
of hydrogen bonding within the structure of a protein (Rietsch and Beckwith, 
1998). Presence of basic amino acids such as histidine, lysine or arginine 
adjacent to or within the spatial vicinity of the cysteine residue helps to lower 
the pKa of the cysteine. As a result, the more nucleophilic thiolate anion 
predominates at physiological pH and therefore increases the reactivity of the 
cysteines. For example, at physiological pH, Cys151 in Keap1 has a depressed 
pKa value because of the surrounding basic amino acids, which renders it the 
most reactive cysteine among the 27 cysteines in Keap1 (McMahon et al., 
2010).  
The sulfhydryl groups (with lower pKa values) in cysteines can be reversibly 
or irreversibly oxidized by pro-oxidative entities. This includes S-sulfenation 
(−S-OH) and disulfide formation (−S−S−), S-nitrosylation (−S−NO) and S-
alkylation (−S−R) mediated by ROS, RNS and RES respectively (Lee et al., 




oxidized by reacting with glutathione (GSH). Fig. 1.2 depicts the various 
oxidative reactions that the sulfhydryl group in cysteine can participate. The 
thiolate anion reacts with ROS and RNS to become oxidized to sulfenic acid. 
Being unstable and reactive, sulfenic acid further reacts with ROS and RNS to 
form irreversible sulfinic and sulfonic acids. Sulfenic acid also reacts with 
GSH to form a S-glutathionylated compound, which can be reversibly 
deglutathionylated. Similarly, sulfenic acid can also react with the reactive 
thiol groups within the same protein or in other proteins to form 
intramolecular or intermolecular disulfide linkages respectively. These 
intramolecular or intermolecular disulfide bonds can be reduced by 
glutaredoxin or thioredoxin. In addition, through an intramolecular reaction, 
the sulfenic acid can give rise the formation of sulfenamide. RNS such as NO 
reacts with the reactive thiol group to form the S-nitrosothiol, which in turn 
gets reduced to free thiols by the S-denitrosylation process. Lastly, the 
sulfhydryl group can be alkylated by RES. Such S-alkylation reaction can be 
reversible or irreversible, depending on the nature of the attacking 
electrophiles. These oxidative thiol modifications conferred to proteins lead to 
chemical or conformational changes in them, which eventually regulates 
several redox-dependent cellular processes [reviewed by (Biswas et al., 2006a, 
Poole and Nelson, 2008)].      
 
Figure 1.2 Scheme of the oxidative fate of the thiol group in a cysteine residue. 




1.2.4 Cellular effects of oxidative modifications in macromolecules  
Oxidative modifications in macromolecules are reported to influence many 
cellular activities (Vaughan, 1997). Oxidative modifications in lipids and 
DNA usually lead to deleterious effects that may cause permanent cell damage 
(Beckman and Ames, 1997, Mylonas and Kouretas, 1999). While extensive 
peroxidation of lipids have been observed to cause severe damage to 
membranes of the cell and organelles that lead to cell death, there have been a 
few studies reporting that moderate oxidative modifications of lipids mediate 
cell signaling (Keller and Mattson, 1998). Similarly, oxidative post-
translational changes in various redox-sensitive proteins are reported to be 
either useful or harmful for normal cellular functioning. ROS produced at low 
to moderate doses can acts as second-messenger through producing reversible 
oxidative modifications in cellular proteins, which leads to activation or 
inhibition of cellular signaling (Berlett and Stadtman, 1997). These redox-
dependent cell signaling pathways are involved in the regulation of 
physiological processes such as embryogenesis, tissue homeostasis and 
remodeling. Conversely, overproduction and accumulation of ROS as result of 
uncontrolled metabolic processes or xenobiotic insults, coupled with 
insufficient scavenging capacities of cellular redox systems, culminates in 
oxidative stress that activates pro-apoptotic or pathophysiological processes 
(Powis et al., 1995).   
Generally, the redox equilibrium of a cell determines the extent of oxidative 
thiol modifications brought upon cellular proteins. The redox equilibrium of 
the cell is maintained by antioxidant defense systems working both at the 
proteomic or the transcriptional levels. At the proteomic level, enzymatic and 
non-enzymatic systems participate in redox homeostasis by directly 
scavenging ROS, RNS and RES and/or reversing the oxidative modifications 
made to cellular proteins. At the transcriptional level, components of redox 
defense systems are replenished by inducing the expression of antioxidant and 
detoxifying enzymes through redox-dependent activation of transcription 




antioxidant defense systems involved in maintenance of the redox equilibrium 
of cell.   
1.2.5 Antioxidant defense systems 
In the cell, there are two main types of antioxidants to achieve redox 
homeostasis. The non-enzymatic antioxidants are low molecular weight 
organic molecules of either endogenous or exogenous origin. On the other 
hand, enzymatic antioxidants are proteins of endogenously produced by the 
cells.  
1.2.5.1 Non-enzymatic antioxidants         
Non-enzymatic antioxidants contribute to the major fraction of total cellular 
antioxidants and are usually the first line of antioxidant defense against the 
redox active species generated endogenously and/or acquired from exogenous 
sources. The non-enzymatic antioxidants are further classified into water 
soluble and lipid soluble antioxidants.    
A) Water soluble antioxidants:  
Water soluble non-enzymatic antioxidants together with water soluble 
enzymatic antioxidants form the major antioxidant cellular defense 
systems. The water soluble non-enzymatic antioxidants include GSH, 
ascorbate (vitamin C), polyphenols and uric acid, etc. GSH is the most 
abundant redox buffer that plays an important role in scavenging redox 
active species and reversing the oxidative modifications found in 
proteins and lipids (Masella et al., 2005). The role of glutathione shall 
be discussed in detail in Section 1.2.5.1. Ascorbate is another 
important water soluble antioxidant that is available from exogenous 
sources such as from fruits and vegetables. It is regarded as one of the 
most effective water soluble antioxidant because of its potent free 
radical scavenging activity. The daily intake of ascorbate is known to 
attenuate oxidative stress-induced pathological conditions such as 
oncogenesis, neurological disorders and cardiac disorders (Bunker, 
1992, Mezzetti et al., 1996). Polyphenolic flavonoids (e.g. quercetin) 




antioxidants of plant origins; they exert their antioxidant effects 
through chelating to transition metals, which in turn prevent metal 
cation-induced ROS generation. In addition, flavonoids can also 
scavenge ROS by directly reacting with the radicals (Pandey and 
Rizvi, 2009, Fraga, 2007). Uric acid, a product of purine metabolism, 
is another water soluble antioxidant present in plasma. Uric acid 
scavenges free radicals because of its ability to accept a single electron 
(Ames et al., 1981).  
 
B) Lipid soluble antioxidants: 
Lipid soluble antioxidants are important for scavenging ROS produced 
in hydrophobic lipid bilayer located in membranes enveloping cells 
and organelles. Lipid soluble antioxidants include vitamin A 
(carotenoids), vitamin E (α-tocopherol), α-lipoic acid, ubiquinol, etc. 
Carotenoids, the orange-red pigment present in plants are the precursor 
for retinoic acid that is known for its essential role in cell growth and 
development. Carotenoids and retinoic acids are also known for their 
antioxidant properties (El-Agamey et al., 2004). α-tocopherol is the 
most active form of vitamin E and plays an important antioxidant role 
in the membranes of cell and organelles. Because of the high lipid 
solubility of α-tocopherol, it acts as a potent membrane-bound 
antioxidant in the hydrophobic environment. It stabilizes reactive free 
radicals by donating an unpaired electron. As a result, it becomes 
converted into a stable tocopheroxyl radical. The tocopheroxyl radical 
further gets reduced by other cellular antioxidants (Kamal-Eldin and 
Appelqvist, 1996). α-lipoic acid and ubiquinol are endogenous lipid 
soluble antioxidants. α-lipoic acid is synthesized in the mitochondria 
and is an important cofactor of pyruvate dehydrogenase and α-
ketoglutarate dehydrogenase multienzyme complex. Both oxidized (α-
lipoic acid) and reduced (dihydrolipoic acid) forms possess antioxidant 
activity (Biewenga et al., 1997). Ubiquinol/ubiquinone redox pair is 
known for its role in shuttling a pair of electron in between complex ІІ 
and ІІІ of the ETC during oxidative phosphorylation. In addition, it can 




semiquinone, of which possesses free radical scavenging capacity 
(Cabrini et al., 1986).   
1.2.5.2 Enzymatic antioxidants 
Enzymatic antioxidant, as the name itself implies, are antioxidant enzymes 
that brings about redox homeostasis by catalyzing processes that results in the 
removal of excessive ROS and/or reversing oxidatively modified cellular 
entities. Examples of enzymatic antioxidants include superoxide dismutase 
(SOD), catalase, glutathione peroxidase (GPx), glutathione transferase (GST), 
heme oxygenase-1 (HO-1), peroxiredoxin (Prx), glutaredoxin (Grx), and Trx.  
A) Superoxide dismutase (SOD): 
SOD is regarded as a primary antioxidant enzyme, as it is involved in 
scavenging the superoxide radicals, which are the primary ROS 
produced during respiratory cycles. SOD catalyzes the dismutation of 
superoxide radical to form H2O2. There are different forms of SODs, 
among which MnSOD and Cu/ZnSOD are most common in 
mammalian cells. MnSOD is a mitochondrial form of homotetrameric 
enzyme, while Cu/ZnSOD is homodimeric and is localized in the 
cytosol. The extracellular (EC-SOD) is found to be a type of 
homotetrameric Cu/ZnSOD (Kinnula and Crapo, 2003, Kinnula, 2005, 
Zelko et al., 2002).   
    
B) Catalase 
Catalase is a homotetrameric enzyme that contains a heme group at the 
site of action of in each monomer; it catalyzes the reduction of H2O2 to 
water. Catalases are predominantly present in the mitochondria and 
cytosol, and are also present in other cell organelles (Kirkman et al., 
1999). 
   
C) Glutathione peroxidase (GPx) 
GPx is one of the most abundant antioxidant enzymes in mammalian 
cells. This homotetrameric enzyme catalyzes the reduction of H2O2 and 




respectively (Flohé, 1988). It is a selenoprotein, where selenocysteine 
is present at its active site. In the reaction with hydroperoxides, GPx 
gets oxidized to selenenic acid (-SeOH), which is reduced back to 
selenothiol (-SeH) through GSH system comprising GSH, glutathione 
reductase (GR) and NADPH. Different GPx isoforms have been 
described to be present at different sub-cellular locations (Arthur, 
2000, Chu et al., 1993, Comhair et al., 2001).   
 
D) Glutathione transferase (GST): 
There are number of known GST isoforms and their role is to detoxify 
xenobiotics by conjugating a GSH molecule to their reactive group. 
The more water soluble glutathione-conjugated xenobiotics are then 
excreted from the body. Similarly, lipid peroxides can also be 
detoxified by GSTs (Ladner et al., 2004, Robinson et al., 2004, Hayes 
and Pulford, 1995). 
  
E) Peroxiredoxin (Prx) 
Prx is another important antioxidant enzyme that catalyzes the 
reduction of H2O2, organic hydroperoxides and peroxynitrite. Various 
isoforms of Prxs are identified to be present in human cells. They vary 
in their sub-cellular distribution and/or substrate for reduction (Kinnula 
et al., 2002). The reduction of peroxides by Prx leads to formation of 
water or alcohols. At one of the active site thiol group in Prx, an 
intermediate sulfenic acid is formed, which is recycled back to free 
thiol by different mechanisms, mostly through reacting with other 
conserved reactive cysteine thiol to form intramolecular disulfide 
bond. This intramolecular disulfide next gets reduced by Trx using 
thioredoxin reductase (TrxR), and NADPH as reducing equivalent 
(Dubuisson et al., 2004, Holmgren, 2000).   
 
F) Glutaredoxin (Grx) 
 
Grx is not directly involved in free radical scavenging, but is involved 




thiols (P-SH). In this reaction, Grx itself becomes glutathionylated, 
which in turn reduced back to free thiols via the GSH redox system. 
On the other hand, it also catalyzes the glutathionylation of some 
proteins (Holmgren, 2000).   
   
G) Thioredoxin (Trx) 
 
Trx is a small redox protein that is a component of the Trx system 
(Holmgren, 1985). Trx is mainly involved in reversing the thiol 
oxidative modifications in proteins such as the reduction of disulfides 
and the denitrosylation of S-nitrosylated proteins (Holmgren and 
Bjornstedt, 1995, Benhar et al., 2008). Through its role in reducing 
oxidized Prx after Prx reacted with hydroperoxides, Trx is also 
involved in the indirect scavenging of ROS (Kang et al., 2005).       
1.2.6 Thiol antioxidant defense systems 
As described earlier, the thiol groups in cysteine residues undergo reversible 
or irreversible oxidative modifications that can modulate the signaling many 
essential or pathophysiological pathways. If the damage is not extensive, these 
thiol oxidative modifications in proteins can be reversed by cellular thiol 
antioxidant defense systems. The GSH and Trx systems are the two main 
cellular thiol antioxidant defense systems.  
1.2.6.1 GSH system 
The GSH system comprises of GSH, GR and reducing equivalent NADPH. In 
this redox system, GR catalyzes the reduction of oxidized glutathione (GSSG) 
to GSH using reducing equivalents from NADPH (Meister and Anderson, 
1983, Kosower and Kosower, 1978).  
A) Glutathione (GSH): 
GSH is the most abundant non-enzymatic, water soluble antioxidant 
available in eukaryotic and prokaryotic organisms except in gram-
positive bacteria. It is a tripeptide made up of L-cysteine, L-glutamate 




limiting step is a formation of γ-glutamylcysteine catalyzed by γ-
glutamylcysteine ligase (γ-GCL). In the second step, glycine is added 
to γ-glutamylcysteine by glutathione synthetase (Meister and 
Anderson, 1983). Inhibition of enzyme γ-GCL by L-buthionine-(SR)-
sulfoximine (BSO) blocks GSH biosynthesis and leads to a drastic 
reduction in intracellular GSH levels (Meister, 1988). In mammalian 
cells, they are present in the cytosol, mitochondria, nucleus, 
endoplasmic reticulum and other organelles. A large fraction of 
approximately 90% of the total GSH pool is present in the cytosol, 
followed by in the mitochondria, endoplasmic reticulum and nucleus. 
The intracellular concentration of glutathione lies between 0.5 to 10 
mM (Kosower and Kosower, 1978). The ratio of GSH/GSSG is an 
indicator of the redox status in the cell; under physiological condition, 
it remains around 100:1 (Hwang et al., 1992). GSH performs a wide 
range of antioxidant roles in cells. The direct free radical scavenging 
activity of GSH includes neutralization of H2O2 and lipid peroxides via 
the enzymatic activity of GPx. It is also important in maintaining the 
reduced pool of vitamin C and E (Winkler et al., 1994).  GSH also 
participates in redox homeostasis and xenobiotic detoxification 
through GST-catalyzed conjugation to electrophilic xenobiotics and 
lipid hydroperoxides (Sharma et al., 1991, Hayes et al., 2005).  
 
B) Glutathione reductase (GR): 
GR is a homodimeric NADPH-dependent flavoenzyme possessing 
disulfide oxidoreductase activity that catalyzes the reduction of GSSG 
to GSH (Mannervik, 1987, Meister, 1988).   
 
C) NADPH: 
NADPH is a reduced form of phosphorylated derivative of pyridine 
nucleotide called nicotinamide adenine dinucleotide (NAD). NADPH 
acts as cofactor in various enzymatic and metabolic reactions, For 
example, it is a cofactor required for the oxidoreductase activity of 
TrxR, and GR, and indirectly for ribonucleotide reductase (RR) 




equivalents by donating two electrons and gets oxidized to NADP+. 
The oxidized NADP+ is recycled back to NADPH by accepting two 
electrons mainly through the oxidative cycle of the pentose phosphate 
pathway.           
1.2.6.2 Thioredoxin (Trx) system 
The Trx system is another major thiol antioxidant defense system that 
comprises of Trx, TrxR and NADPH, where oxidized Trx gets reduced to 
reduced Trx by NADPH-dependent TrxR (Holmgren, 1989).    
A) Thioredoxin (Trx): 
Trxs are small redox active protein (~12 kDa) that is ubiquitiously 
found in eukaryotic and prokaryotic cells. In mammalian cells, there 
are two main isoforms of Trx: Trx1 exists in the cytosol and nucleus, 
whereas Trx2 exists in the mitochondria. Trx contains a conserved 
dithiol/disulfide (CXXC) catalytic site, which catalyzes the reduction 
of intra- and inter-molecular disulfides in oxidized proteins (Holmgren, 
1985). The low pKa value of the thiol group in one of the catalytic 
cysteine residues in Trx, for example Cys32 in human Trx1 (hTrx1), 
makes it ionized to thiolate anion under physiological pH (Forman-
Kay et al., 1992). This thiolate anion reacts with the disulfide bond in 
the oxidized protein, forming an intermediate mixed disulfide (Trx-S-
S-protein). The disulfide bond in the mixed disulfide intermediate is 
next attacked by the second cysteine residue at the catalytic site of Trx 
(Cys35 in hTrx1), finally resulting in the reduction of disulfides in 
oxidized proteins. During this process, the Trx is oxidized with an 
intramolecular disulfide bond formed between Cys32 and Cys35. 
Oxidized Trx is reduced by a flavoprotein TrxR using NADPH as the 
reducing equivalent. According to recent report, GSH and Grx are 
proposed to play back up role to TrxR in reduction of disulfide bond in 
oxidized Trx (Du et al., 2012). A summary of the oxidoreductase 





Figure 1.3 Scheme of oxidoreductase activity of the Trx system. Reactive 
thiolate anion of catalytic cysteine residue in reduced Trx attacks the 
disulfide bond in oxidized proteins and catalyzes reduction of the disulfide to 
free thiols, leaving behind a disulfide bond in oxidized Trx. The disulfide in 
oxidized Trx gets reduced by TrxR using reducing equivalents from NADPH. 
Modified from (Kumar et al., 2004). 
 
The cytosolic Trx1 in mammalian cells contains three non-catalytic 
cysteine residues, which are absent in mitochondrial Trx2 and in 
prokaryotic Trx (for example, E.coli Trx). In hTrx1, the non-catalytic 
cysteines are present at positions 62, 69 and 73. In recent years, the 
non-catalytic cysteines are also reported to undergo oxidative 
modifications such as S-nitrosylation, S-glutathionylation, as well as 
intra- and/or inter-molecular disulfide bond formations. The S-
nitrosylation of Cys69 in hTrx1 is reported to inhibit apoptosis 
induction (Haendeler et al., 2002). Dimerization of Trx1 through 
intermolecular disulfide bond formation between in each Trx1 
monomer, as well as the formation of intramolecular disulfide bond 
between Cys62 and Cys69 of hTrx1, have been reported to regulate the 
catalytic activity of Trx1 (Hashemy and Holmgren, 2008). On the other 
hand, Cys62 in Trx1 has been reported to be involved in the redox 
regulation of actin (Wang et al., 2010). In addition, the S-
glutathionylation at Cys73 of hTrx1 is proposed to inhibit activity of 
hTrx1 (Casagrande et al., 2002). The absence of non-catalytic cysteine 
residues in mitochondrial Trx2 is suggested to render it in its direct 




absence of any possible inhibition of enzyme activities that can occur 
through oxidative modifications of non-catalytic cysteines. 
 
Trx does not possess direct free radical scavenging capacities. It 
neutralizes ROS such as H2O2 through the actions of Prx. Prx is 
oxidized as a result of reducing H2O2 and Trx is involved in recycling 
oxidized Prx to its reduced form (Kang et al., 2005). Another more 
major way in which Trx executes its redox regulator role is its ability 
to reverse oxidative modifications (disulfide formation and S-
nitrosylation) in cellular proteins (Holmgren, 1985). Thirdly, through 
its interaction with cellular proteins, reduced Trx exerts redox control 
over signaling pathway, which results in modulation of activities of 
transcription factors such as AP-1, NF-κB, and p53 (Hirota et al., 1997, 
Hirota et al., 1999, Ueno et al., 1999) and regulation of apoptotic 
processes through for example, Trx’s inhibitory interaction with 
apoptosis signal-regulating kinase 1 (ASK1) (Saitoh et al., 1998b). In 
addition, Trx is reported to play a role in promoting cell proliferation 
by reducing ribonucleotide reductase so that the enzyme can convert 
ribonucleotides to deoxyribonucleotides, which are the building blocks 
of DNA (Holmgren, 1985, Holmgren and Sengupta, 2010).  
                 
B) Thioredoxin reductase (TrxR) 
TrxR is a class of flavoenzyme oxidoreductase. Using NADPH as 
reducing equivalents, TrxR catalyses the reduction of oxidized Trx 
(Holmgren and Bjornstedt, 1995). Apparently, TrxR in prokaryotes is 
different from mammalian TrxR; prokaryotic TrxR such as E.coli TrxR 
only has a N-terminal dithiol/disulfide catalytic site containing two 
reactive cysteines separated by two amino acids (CXXC), while 
mammalian TrxR contains 2 active sites. Mammalian TrxR, including 
hTrxR, has a N-terminal dithiol/disulfide active site containing two 
reactive cysteines separated by four amino acids (CXXXXC), and a 
second C-terminal active site containing a penultimate selenocysteine 
(SeCys) residue (Gromer et al., 2004, Papp et al., 2007). Mammalian 




mitochondrial TrxR2 that are specific for reduction of oxidized Trx1 
and Trx2 respectively (Sun et al., 1999). In addition, another isoform 
of TrxR, thioredoxin glutathione reductase (TGR) is reported to be 
present in testes (Sun et al., 2001). Since TrxR is an essential cellular 
enzyme that reduces oxidized Trx under constitutive conditions, the 
cellular functions of Trx are dependent on the availability and catalytic 
activity of TrxRs. On the basis that Trx is known to be involved in cell 
proliferation and the progression of tumor growth, TrxR inhibitors are 
suggested to be potential candidates for cancer treatment, as TrxR 
inhibition leads to Trx oxidation and therefore Trx inhibition is 
indirectly achieved (Urig and Becker, 2006). In the last few years, 
several TrxR inhibitors of natural origins have been identified. These 
include curcumin from curcuma longa (turmeric powder) (Fang et al., 
2005), cinnamaldehyde (CA) from cinnamomum genus (cinnamon 
bark) and its analogue such as 2-benzoyloxy cinnamaldehyde (BCA) 
(Chew et al., 2010). Being electrophilic in nature, TrxR inhibitors are 
able to induce apoptosis in cancer cells through multiple mechanisms, 
including the induction of oxidative stress caused by oxidation that 
triggers apoptotic pathways regulated by Trx (Urig and Becker, 2006).   
1.2.7 Indirect antioxidant defense systems 
Mechanisms against oxidative stress include direct free radical scavenging 
activities, as well as indirect antioxidant activities by modulation of the 
pathway(s) involved in expression of cytoprotective enzymes and molecules. 
The inducible Keap1-Nrf2-ARE pathway is one important modulator to 
coordinate expression of phase ІІ detoxifying and antioxidant enzymes such as 
GSTs, γ-GCL, GPx2, HO-1, NAD(P)H:quinone oxidoreductase (NQO1), 
TrxRs, UDP glucuronosyltransferase (UGT), etc (Hayes and McMahon, 2001, 
Itoh et al., 1997). The induced expression of phase ІІ enzymes boosts the 
antioxidant defense systems and restores redox homeostasis. Of note, low to 
moderate oxidative insult is able to trigger such redox defense systems. For 
instance, a moderate oxidative stress induced by inhibition of TrxR1 is 




al., 2009). Conversely, under strong pro-apoptotic oxidative stress, the 
expression of antioxidant enzymes and proteins get hampered and the redox 
homeostasis fails to be restored, eventually leading to apoptotic or necrotic 
cell death. The detailed mechanism of Keap1-Nrf2-ARE cell signaling is 
discussed under Section 1.4.1. 
1.2.8 Redox regulation of biological processes 
ROS regulates various biological processes such as apoptosis pathways, 
antioxidant signalings, immune and inflammatory responses, enzymes 
activation/deactivation, gene regulation as well as many other metabolic 
pathways e.g. cGMP activation, etc (Powis et al., 1995). To be specific to the 
objective of this thesis, we focused on the thiol-mediated redox regulation of 

















1.3.1 Overview of apoptosis 
Apoptosis is a normal physiological process by which old, damaged and 
infected cells undergo programmed cell death. It is recognized as a cellular 
event in various physiological processes such as tissues homeostasis, 
tissue/organ development, maintenance of immunity and ageing (Kerr et al., 
1972, Hockenbery, 1995). Triggered by both endogenous and exogenous 
stimuli, apoptosis is a highly regulated process that is characterized by distinct 
physiochemical (increased Ca2+ uptake, loss of mitochondrial membrane 
potential, etc), biochemical (activation of caspases, activation of 
apoptotic/pro-apoptotic proteins and DNA fragmentation) and morphological 
(shrinkage, blebbing, nuclear condensation and fragmentation) changes 
(Elmore, 2007, Hacker, 2000, Saraste and Pulkki, 2000, Hengartner, 2000). 
Under pathophysiological conditions, the deregulated apoptosis process can 
lead to oncogenesis, ischemic heart diseases, and neurodegenerative disorders 
such as Alzheimer’s or Parkinson’s disease  (Zhang and Herman, 2002, 
Pollack and Leeuwenburgh, 2001). There are various pathways of apoptotic 
cell death induction that are briefly summarized in following sections.    
1.3.2 Apoptosis signaling 
Apoptosis is classified mainly into two types: caspase-dependent and caspase-
independent apoptosis.  
1.3.2.1 Caspase-dependent apoptosis cascades 
Apoptosis induction occurs through activation of caspases, a family of 
cysteine-dependent proteases that cleaves their substances at aspartic acid 
residues. Caspases are expressed as inactive zymogens. Upon application of an 
apoptotic stimulus, the procaspases are activated by proteolytic cleavage.  
(Alnemri et al., Hengartner, 2000). This leads to the release of an 
endonuclease caspase-activated DNase (CAD), then cleavage of a DNA repair 
enzyme poly(ADP-ribose) polymerase (PARP) and ultimately nuclear 




2000). There are various ways in which caspases are activated, which further 
categorizes the apoptotic pathways into the intrinsic and extrinsic pathway 
(MacFarlane and Williams, 2004, Riedl and Shi, 2004).    
A) Intrinsic pathway: 
The intrinsic cell death pathway, also known as the mitochondrial cell 
death pathway, involves various mitochondrial proteins. Upon 
application of an appropriate apoptotic stimulus, the mitochondrial 
permeability transition pore opens and releases cytochrome C into the 
cytosol to complex with apoptotic protease activating factor 1 (Apaf-1) 
(Garrido et al., 2006, Goldstein et al., 2000, Chinnaiyan, 1999). This 
leads to Apaf-1 oligomerization and the subsequent recruitment of 
procaspases-9 to form the apoptosome (Cain et al., 1999). Caspase 9 is 
activated and released from the apoptosome, which in turn activates 
effector caspases procaspase-3 and -7 to caspase-3 and caspase-7. 
Finally, the activated caspase-3 cleaves inhibitor of CAD (ICAD) to 
release CAD, as well as PARP to inactive cleaved PARP. DNA 
fragmentation and cell death then ensues (Lazebnik et al., 1994, Susin 
et al., 2000). The released procaspase-9 is restricted from forming an 
apoptosome by the action of anti-apoptotic protein called the inhibitor 
of apoptosis (IAP). On the other hand, pro-apoptotic Smac/DIABLO 
and Omi/HtrA2 that are released from the mitochondria promote 
activation of procaspase-9 by inhibiting IAP (Du et al., 2000). In 
addition, the regulation of the intrinsic pathway is found to be under 
the control of B-cell lymphoma 2 (Bcl-2) types of proteins. Briefly, 
they are classified into anti-apoptotic or pro-apoptotic proteins and the 
balance between them is critical in the regulation of apoptosis (Gross 
et al., 1999, Li et al., 1998). 
 
B) Extrinsic pathway:  
The extrinsic cell death pathway involves cell surface death receptors 
(DRs), a class of receptors belong to the tissues necrosis factor receptor 
(TNFR) superfamily, being triggered as an initiation of the apoptotic 




tissues necrosis factor α (TNF-α), FasL (CD95L) and TNF-α related 
apoptosis inducing ligand (TRAIL), to the DRs assembly of the 
receptors cytoplasmic death domain (DD) and death effector domain 
(DED) occurs, followed by binding of the assembled receptor death 
domains to adaptor molecule Fas receptor-associated domain (FADD) . 
FADD then recruits procaspase-8 to form the death-inducing signaling 
complex (DISC) (Schulze-Osthoff et al., 1998, Wang and El-Deiry, 
2003). Initiator caspase procaspase-8 and -10 is activated, which next 
takes different caspase activation cascades. In type І (SKW and H9) 
cells, caspase-8 activates procaspase-3 to caspase-3. In type ІІ (Jurkat 
and CEM) cells, caspase-8 cleaves pro-apoptotic protein Bid to 
truncated Bid (tBid), which interacts with Bak/Bax and stimulates 
cytochrome C release from mitochondria to initiate the intrinsic cell 
death pathway (Scaffidi et al., 1999, Chou et al., 1999). On the other 
hand, the assembled DD and DED of DRs interact with TNF receptor-
associated DD (TRADD), receptor-linked kinase (RIP) and caspase-
recruitment domain (CARD) to form a complex that is involved in 
activation of the caspase cascade, as well as the NF-κB and JNK 
signaling pathways (Shim et al., 2005, Hsu et al., 1995). This complex 
recruits and activates initiator procaspase-2 to active caspase-2.  
Similar to the FasL-activated type ІІ caspase activation cascade, 
caspase-2 is involved in cleavage of Bid to tBid and ultimately leads to 
activation of the intrinsic cell death pathway (Chou et al., 1999). In 
addition, recruitment of TNF receptor-associated factor 2 (TRAF2) 
activates NF-κB and JNK signaling through phosphorylation and 
activation of inhibitor of κB kinase (IKK) complex and ASK1, a 
mitogen-activated protein kinase kinase kinase (MAPKKK) 
respectively (Chang et al., 2006, Pantano et al., 2003). Activation of 
JNK signaling expresses pro-apoptotic proteins (e.g. Bax, TNF-α, 
FasL) and promotes apoptosis induction (Micheau and Tschopp, 2003, 
Deng et al., 2002, LeBlanc et al., 2002, Falschlehner et al., 2007). In 
contrast, IKK-mediated activation of NF-κB protects apoptosis 
induction by inducing expression of anti-apoptotic and antioxidant 




NF-κB and JNK signaling is dependent on the ROS levels. At 
physiologically low levels of ROS, NF-κB signaling get activated and 
promote cell survival, whereas at higher concentration of ROS, i.e. 
under pro-apoptotic oxidative stress, JNK signaling is activated leading 
to apoptosis induction (Falschlehner et al., 2007).      
Role of Bcl-2 family proteins in apoptosis induction 
As described above, the disturbed outer mitochondrial membrane permeability 
leads to release of cytochrome C and other apoptotic proteins from the 
mitochondria, which is a key step in the process of intrinsic cell death 
pathway. Bcl-2 family proteins are known to play important role in the 
maintenance of mitochondrial outer membrane permeability and are regarded 
as key players in apoptosis regulation (Kelekar and Thompson, 1998). They 
share four different types of Bcl-2 homology (BH) domains BH1, BH2, BH3 
and BH4 and depending on the types of BH domains they possesses, they are 
classified into anti-apoptotic and pro-apoptotic proteins. The Bcl-2 proteins 
containing all four types of BH domains are anti-apoptotic and they include 
Bcl-2, Bcl-XL, Mcl-1, Bcl-w, and A1, while those containing BH1, BH2 and 
BH3 domains (BAX, BAK, BOK) and BH3-only domain (Bid, Bim, Bik, Bad, 
Bmf, Hrk, NOXA and PUMA) are pro-apoptotic proteins (Gross et al., 1999, 
Kuwana and Newmeyer, 2003). Anti-apoptotic Bcl-2 and Bcl-XL hamper the 
formation of mitochondrial apoptosis-induced channel (MAC) or the 
permeability transition pore and hence inhibit cytochrome C release (Dejean et 
al., 2006b). Cells overexpressing Bcl-2 and Bcl-XL are found to be resistant to 
apoptosis induction (Fontana et al., 1998). In contrast, the pro-apoptotic 
proteins BAX, BAK and BOK localized on the mitochondrial outer membrane 
are reported to undergo polymerization upon application of an apoptosis 
stimulus, which help in the formation of MAC that results in the release of 
cytochrome C (Dejean et al., 2006b). Other BH3-only pro-apoptotic proteins 
are important in regulating core Bcl-2 family proteins to promote apoptosis. 
The activated tBid translocates into the mitochondria and activates BAX and 
BAK, leading to release of cytochrome C into the cytosol (Chou et al., 1999). 




proteins are dependent on the pathophysiological conditions in the cell, in an 
intricate relationship, they work together to regulate apoptosis. 
1.3.2.2 Caspase-independent apoptosis 
Although the classical way of caspase-dependent apoptosis remains the major 
apoptotic pathway, some caspase-independent apoptotic pathways have been 
reported. Release of apoptotic proteins endonuclease G (EndoG), Omi/HtrA2 
and AIF from the mitochondria have been found to mediate cell death in a 
caspase-independent manner. The endonuclease activity of EndoG leads to 
fragmentation of nuclear DNA in the absence of caspases (Li et al., 2001, Lee 
et al., 2005). Omi/HtrA2 is also found to promote cell death through its 
protease activity without involvement of caspases (van Loo et al., 2002). On 
the other hand, AIF, which does not possess any protease or endonuclease 
activity, is also involved in inducing apoptosis in a caspase-independent 
manner (Susin et al., 1999, Cande et al., 2002). In addition, autophagy and 
proteasome-dependent degradation of proteins are also reported to induce 
apoptosis in the absence of caspase activation (Su et al., 2013, Wojcik, 2002). 
A summary of the events involved in the caspase-dependent and caspase-
independent apoptosis pathways is presented in Fig. 1.4.   
 
 





Figure 1.4 Caspase-dependent (extrinsic and intrinsic) and caspase-independent 
apoptosis pathways. In the extrinsic cell death pathway, the binding of death 
receptor ligands such as TNF-α, FasL and TRAIL to their specific DRs initiates 
assembly of DD and DED, which leads to downstream caspase activation cascades. 
In the intrinsic cell death pathway, apoptotic stimulus such as increased ROS causes 
Bax/Bak-mediated release of cytochrome C, Smac/DIABLO, Omi/HrtA2, EndoG and 
AIF. Assembly of Apaf-1, cytochrome C and procaspase-9 forms the apoptosome, 
which initiates the caspase activation cascade. Activated caspase-8 (in extrinsic 
pathway) and caspase-9 (in intrinsic pathway) activate procaspase-3 to effector 
caspase-3, leading to apoptosis. Smac/DIABLO and Omi/HrtA2 inhibit IAPs and 
promote caspase-3 activation. Release of EndoG and AIF from the mitochondrial 
inter-membrane space initiates caspase-independent apoptosis. TNF-α-mediated 
assembly of TRADD, TRAF2 and Rip1 activates NF-κB and JNK signaling through 
TRAF2-mediated activation of NF-κB and JNK respectively. Activated JNK 
signaling leads to apoptosis, whereas activated NF-κB signaling expresses anti-
apoptotic proteins and antioxidant enzymes such as MnSOD and attenuates ROS-
mediated JNK activation. Adapted from (Circu and Aw, 2010). 
 
1.3.2.3 Apoptosis inducing factor (AIF) 
AIF is a phylogenetically conserved mitochondrial flavoprotein that is 
originally discovered as a factor released from the mitochondria into the 
cytosol upon application of apoptotic stimuli; it possesses apoptosis inducing 
potential and is capable of mediating DNA fragmentation in isolated nuclei of 
healthy cells (Susin et al., 1996, Susin et al., 1997b, Zamzami et al., 1996). 
Soon later, it is found that upon its release from the mitochondria into the 
cytosol, AIF translocates into the nucleus to induce chromatin condensation 




al., 1997a, Susin et al., 1999). The full-length AIF protein, a 67 kDa precursor 
protein, is encoded by the AIF gene also known as AIFM1 or PCDC8 
(programmed cell death 8). The precursor AIF protein (613 amino acids in 
human AIF) possesses a N-terminal mitochondrial localization sequence 
(MLS) (aa 1 to 54), two nuclear localization sequences (NLSs) (aa 277 to 301 
and aa 445 to 451), two FAD binding domains (aa 128 to 262 and aa 400 to 
480), a NADH binding domain (aa 262 to 400) and a C-terminal region (aa 
480 to 608). The precursor AIF protein is imported into the mitochondria 
owing to its MLS and it is only imported in its non-native form (i.e. the 
unfolded structure of precursor AIF is imported into the mitochondria). In the 
mitochondria, the MLS in precursor AIF is cleaved to form mitochondrial 
mature AIF (aa 55 to 613) (reviewed by (Sevrioukova, 2011)).  
The mature AIF binds to the outer membrane of the inter-mitochondrial space 
(IMS) and is proposed to be involved in the regulation of mitochondrial 
morphology and maintenance of complex proteins in the ETC. Existing as a 
homodimer with NADH bound to the NADH binding domain, AIF 
demonstrates NADH oxidase and free radical scavenging activities; these 
mitochondrial oxidoreductase functions have been proposed that besides the 
known apoptosis inducing activity, AIF plays additional role in relation to cell 
survival. In a study, it has been found that Harlequin mice deficient in AIF are 
vulnerable to neurodegeneration and blindness due to retinal degeneration 
(Klein et al., 2002). The AIF deficiency is associated with decreased levels of 
complex І and ІІІ proteins of the ETC, although mRNA levels have remained 
unaffected. In addition, reduction of AIF levels is found to increase ROS 
generation (Klein et al., 2002). In another study, it is observed that deficiency 
in AIF has resulted in a defective complex І, which leads to increased ROS 
generation and enhanced susceptibity to apoptotic stimuli (Modjtahedi et al., 
2006). Notably, AIF is also found to be involved in the maintenance of the 
intracellular reduced GSH pool, which implies that it is indirectly involved in 
the inhibition of stress granules formation (Cande et al., 2004b). All in all, 
although it remains to be fully elucidated, current information obtained from 
published studies appears to suggest a pro-survival function of AIF when it is 




Once AIF is released from the mitochondria into the cytosol following the 
application of an apoptotic stimulus including oxidative stress, it translocates 
into the nucleus and induces chromatin condensation and large scale DNA 
fragmentation, a hallmark of apoptotic cell death. Apparently, the 
oxidoreductase function of AIF is independent from its apoptosis inducing 
activity, as the deletion mutant of AIF lacking the oxidoreductase domain does 
not affect its apoptogenic potential (Ohiro et al., 2002, Wu et al., 2002). 
Before its release from the mitochondria, AIF gets cleaved to truncated AIF 
(aa 101 to 613) by calpain-mediated proteolysis; the truncated AIF is the form 
that is released into the cytosol. The calpain-mediated proteolysis and release 
of truncated AIF from the mitochondria is reported to be dependent on an 
increase in intracellular Ca2+ (Polster et al., 2005, Norberg et al., 2008). 
However, to date this finding remains controversial and remains to be verified. 
In addition, increase in intracellular Ca2+ usually coupled with an increase in 
ROS, which is reported to cause oxidative modifications in AIF that would 
promote AIF’s proteolysis and its release from the mitochondria (Norberg et 
al., 2010). Recently, inhibition of TrxR1 is reported to induce nuclear 
translocation of AIF, which further suggest the role of oxidative stress in 
inducing AIF-mediated apoptosis (Poerschke and Moos, 2011). Furthermore, 
the release of AIF from the mitochondria is proposed to be dependent on 
Bax/Bak-mediated permeabilization of the mitochondrial outer membrane 
(Cabon et al., 2012). On the contrary, induction of AIF-mediated apoptosis by 
eleostearic acid has been found to be independent of Bax, Bcl-2 activation and 
cytochrome C release into the cytosol (Kondo et al., 2010).  
In the cytosol, heat shock protein 70 (HSP70) interacts with AIF and restrict 
its nuclear translocation. In doing so, HSP70 is able to inhibit AIF-mediated 
cell death (Gurbuxani et al., 2003, Julian Chun-Kin and Siu-Kai, 2007). 
However, this effect is observed in cells overexpressing HSP70. Hence, 
HSP70’s regulatory role under physiological and apoptotic condition is not 
fully elucidated as yet. Recently, CHIP Ubiquitin E3 ligase and USP2 
deubiquitinase have been found to control AIF-mediated cell death by 
regulating proteasome-dependent degradation of truncated AIF (Oh et al., 




vitro findings have revealed that AIF is able to interact with DNA through 
electrostatic interactions, but displays little or no effect on DNA fragmentation 
(Vahsen et al., 2005). Such observations have therefore raised the plausibility 
that some other cytosolic or nuclear protein(s) is/are to be present to facilitate 
AIF-mediated DNA fragmentation. Notably, truncated AIF is found to 
colocalize with cyclophilin A (CypA) both in the cytosol and nucleus; CypA is 
observed to facilitate AIF-mediated DNA fragmentation possibly by rendering 
its endonuclease activity to AIF (Cande et al., 2004a). Moreover, a study by 
Artus et al., (2010) had reported that an AIF-H2AX interaction was a 
prerequisite for DNA fragmentation. Furthermore, induction of H2AX 
phosphorylation at Ser139 to form γ-H2AX upon treatment with DNA 
alkylating agent methylnitronitrosoguanidine (MNNG) is reported to be 
important for H2AX’s interaction with the C-terminal domain of AIF, which 
renders the complete assembly of the AIF-CypA-H2AX DNA degradation 
complex. Indeed, in the absence of CypA or H2AX, AIF-dependent DNA 
fragmentation has been reported to become compromised (Artus et al., 2010, 
Cande et al., 2004a). A summary of AIF-mediated apoptosis is illustrated in 
Fig. 1.5.  
 
Figure 1.5 AIF-mediated apoptosis. Precursor-AIF (p-AIF) translocates into the 
mitochondria, gets cleaved to mature-AIF (m-AIF) and resides in the mitochondrial 
inter-membrane space. Upon apoptosis induction, m-AIF is cleaved to form 
truncated-AIF (t-AIF). Lowering of the mitochondrial outer membrane 
permeabilization (MOMP) releases t-AIF into the cytosol, followed by AIF 




fragmentation with the help of H2AX and CypA. HSP70 binds and restricts the 
nuclear translocation of t-AIF.  
 
1.3.3 Oxidative stress and apoptosis 
Oxidative stress is the condition where balance between oxidants (ROS) and 
antioxidants become perturbed, where antioxidant systems are overwhelmed 
by excessive oxidants. In recent years, studies have reported that excessive 
ROS generation can lead to apoptotic and/or necrotic cell death (Mates and 
Sanchez-Jimenez, 2000). Exposure of oxidizing agents such as H2O2, 
hypochlorous acid (HOCl) and diamide are largely known to induce apoptosis 
in various ways (Clément et al., 1998, Vissers et al., 1999, Marchetti et al., 
1997). However, oxidative stress attenuated by treatment with antioxidants 
such as vitamin C, vitamin E, N-acetylcysteine (NAC) or overexpression of 
antioxidant enzyme such as MnSOD, has been reported to inhibit or delay 
apoptosis induction in various cell lines (Mayer and Noble, 1994).   
A) Oxidative stress inducers in apoptosis induction:  
In addition to ROS produced in the mitochondria, various other 
endogenous and exogenous factors/stimuli are known to induce 
oxidative stress that culminates in apoptosis induction. These 
factors/stimuli include death receptor ligands, bacterial endotoxins, 
ionizing radiation, anticancer drugs, withdrawal of growth factors, etc. 
Apart from their classical way of apoptosis induction, death receptor 
ligands such as FasL, TNF-α and TRAIL have been observed to induce 
ROS production and ROS-mediated apoptosis induction (Wang et al., 
2008, Kim et al., 2010b). Bacterial endotoxin lipopolysaccharide (LPS) 
is a strong inducer of inflammatory reactions; it is also reported to 
induce ROS-mediated apoptosis induction (Sanlioglu et al., 2001, de 
Souza et al., 2007). Serum withdrawal and exposure to ionizing 
radiation are also known to induce apoptosis through causing an 
increase in ROS generation (Lee et al., 2010, Yamamori et al., 2012). 
In addition, prototypical apoptosis inducer staurosporine (STS) and 




actinomycin D are also reported to induce apoptosis through ROS 
generation (Gil et al., 2003a, Brodska and Holoubek, 2011).  
 
B) Mechanisms of oxidative stress-induced apoptosis: 
Apoptosis induction caused by ROS acting as stimulus can occur 
through both mitochondria-dependent and mitochondria-independent 
pathways. The Mitochondrion is most susceptible to oxidative 
damages, since it is the power house that generates significant levels of 
ROS as a by-product of metabolic respiration. ROS in the 
mitochondria causes damage to the mitochondrial DNA (mtDNA), 
membrane lipids and vital proteins, resulting in mitochondrial 
dysfunctioning and activation of the intrinsic cell death pathway 
(Tsujimoto and Shimizu, 2007). Increased ROS affects components of 
the mitochondrial permeability transition pore such as the voltage-
dependent anion channel (VDAC), adenine nucleotide translocase 
(ANT) and cyclophilin D (CypD) through causing oxidative 
modifications and disturbing mitochondrial anion fluxes. The 
hyperpolarized mitochondrial membrane causes collapse of the 
mitochondrial membrane potential (MMP), release of cytochrome C 
and mitochondrial translocation of Bax and Bad, leading to activation 
of the intrinsic cell death pathway (reviewed by (Circu and Aw, 2010). 
The damaged mtDNA affects the expression of respiratory chain 
complex proteins and therefore compromises ATP production 
(Clayton, 1984). This which further leads to increased ROS production 
and the vicious cycle of ROS-mediated damage to mtDNA and other 
macromolecules ensues (Lenaz et al., 2002, Van Houten et al., 2006).  
Cytochrome C is known to bind tightly to the outer leaflet of the inner 
mitochondrial membrane in association with a phospholipid cardiolipin 
(Ott et al., 2002). In the presence of increased ROS levels, the 
exaggerated peroxidase activity of cytochrome C oxidizes cardiolipin, 
leading to detachment of cytochrome C from the inner mitochondrial 
membrane (Kagan et al., 2005, Kagan et al., 2004, Dejean et al., 




proteolysis of inactive caspases to active caspases (Salvesen and 
Abrams, 2004, Katoh et al., 2004). In addition, oxidative stress-
induced protein phosphorylation, another type of post-translational 
modification in proteins caused by various kinases, is also known to be 
involved in the activation of apoptotic processes. For example, 
oxidative stress promotes ASK1 oligomerization and phosphorylation 
that leads to activation of JNK signaling, which in turn triggers the 
intrinsic and extrinsic cell death pathways (Dhanasekaran and Reddy, 
2008, Saitoh et al., 1998a, Fujino et al., 2007). The activated JNK 
signaling is reported to promote AP-1-mediated apoptosis induction by 
upregulating the expression of pro-apoptotic proteins such as TNF-α, 
FasL and Bak (Fan et al., 2001) and causing release of cytochrome C 
from the mitochondria (Kharbanda et al., 2000). In addition, numerous 
apoptotic, pro-apoptotic and anti-apoptotic proteins, as well as 
transcription factors can undergo post-translational oxidative 
modifications such as S-nitrosylation, S-glutathionylation and disulfide 
bond formation, which would instigate the activation of apoptotic 
cascades. Some examples shall be discussed in the following Section 
1.3.4.   
1.3.4 Redox regulation of apoptosis 
Apoptosis, a programmed cell death mechanism, is an important cellular event 
in maintaining tissue homeostasis, host defense reactions, etc. Hence, this 
process is tightly regulated by various mechanisms depending on the 
pathophysiological conditions. Redox-dependent signaling is reported to 
regulate apoptotic pathways so as to maintain the balance between cell 
survival and cell death. At redox equilibrium state, the reversible oxidative 
modifications in proteins are crucial in suppressing apoptosis to allow cell 
repair and survival. On the other hand, during oxidative stress, the 
uncontrolled oxidative modifications in vital proteins lead to exaggerated 
apoptosis in normal cells, which results in the development of pathological 





1.3.4.1 Thiol oxidative modifications in proteins and redox regulation of 
apoptosis 
Reversible thiol oxidative modifications such as S-nitrosylation, S-
glutathionylation and disulfide bond formation are widely known for their role 
in the regulation of apoptosis. In general, thiol oxidative modifications can 
induce or inhibit apoptotic pathways. Thiol redox systems Trx and GSH 
systems protect cells from accidentally induced apoptosis, or if the damage is 
too severe in old and damaged cells they can promote apoptosis through 
oxidative modifications in cellular proteins (Biswas et al., 2006b).  
Redox-mediated S-nitrosylation of proteins by nitric oxide (NO) is regarded as 
one of the important modulator in thiol-mediated apoptosis regulation. Under 
physiological conditions, basal levels of NO act as a modulator in several 
essential cell signaling through their ability to S-nitrosylate several proteins 
and transcription factors. S-nitrosylation of proteins can lead to either 
induction or inhibition of apoptosis depending on the origin, strength and 
distribution of NO. For example, during FasL- and TNF-α-stimulated 
apoptosis induction, some proteins become S-nitrosylated while some other 
proteins such as caspase-3 and -9 get de-nitrosylated. Moreover, S-
nitrosylation of Trx1, Ras, ASK1, c-Jun-N-terminal kinase (JNK), caspase-3 
and -9 are reported to promote cell survival, whereas the same modification 
made to peroxiredoxin 2 (Prx2), glyceraldehydes-3 phosphate dehydrogenase 
(GAPDH), matrix metalloproteinase-9 (MMP-9), IKKβ and parkin brings 
about apoptosis [reviewed by (Nakamura et al., 2013)]. Recently, S-
nitrosylation of extracellular signal-regulating kinase (ERK) has been 
proposed to induce apoptosis through inhibiting ERK phosphorylation (Feng 
et al., 2013). Of note, the thiol-dependent Trx system is involved in the de-
nitrosylation of S-nitrosylated proteins. For instance, the de-nitrosylation of S-
nitrosylated caspase-3 by reduced Trx1 has been reported to increase caspase-
3 activity and its apoptogenic potential (Benhar et al., 2008).       
Growing evidence suggests the critical role of S-glutathionylation in redox-
based regulation of apoptosis. A number of proteins including caspase-3, Fas, 




glutathionylation, which is important in the regulation of their cellular 
functions. Caspase-3 been reported to undergo S-glutathionylation, which 
inhibits its activation and hence apoptotic activity. S-glutathionylation of death 
receptor Fas has been reported to increase its potential for binding with FasL 
and therefore cell death signaling is promoted [reviewed by (Anathy et al., 
2012)]. In a recent study, human carbonic anhydrase VІІ, an enzyme with 
carbon dioxide hydration activity has been revealed to undergo S-
glutathionylation, which results in the inhibition of oxidative stress-induced 
apoptosis (Del Giudice et al., 2013). Furthermore, S-glutathionylation of IκB 
(inhibitor of NF-κB) and p65 (a component of transcription factor NF-κB) has 
been found to modulate apoptosis during inflammatory reaction (Liao et al., 
2010, Qanungo et al., 2007). Besides participating in S-glutathionylation, the 
GSH system is also involved in de-glutathionylation of S-glutathionylated 
proteins through the catalytic action of Grx. In summary, oxidative 
modification rendered to cysteine residues of cellular proteins through S-
nitrosylation and/or S-glutathionylation contribute towards regulation of 
cellular signaling pathways. Depending on the specific protein involved in the 
modification, and the extent of oxidative modification, the cellular 
consequence can vary from cell survival to cell death. The next section 
(Section 1.3.4.2) shall discuss the direct and indirect role(s) of the Trx system 
in the regulation of apoptosis.   
1.3.4.2 Trx-dependent thiol-mediated redox regulation of apoptosis  
Trx is known for its role in the inhibition of apoptosis, which is mediated 
likely through its catalytic cysteine residues. On line of evidence that lends 
support is based on the observation that redox-inactive Trx (mutant 
Trx1C32SC35S) promotes cell death in WEHI7.2 cells (Freemerman and 
Powis, 2000). Besides the catalytic cysteines being involved in apoptosis 
inhibition, the non-catalytic structural cysteines in mammalian Trx1 are also 
proposed to be involved in the regulation of apoptosis. S-nitrosylation of 
Cys69 in hTrx1 is reported to inhibit apoptosis induction through yet unknown 
mechanism (Haendeler et al., 2002). In addition, oxidative stress-induced 




and Cys73 of hTrx1 respectively are reported to inhibit Trx1’s catalytic 
activity (Hashemy and Holmgren, 2008), which is proposed to lead to 
compromised cellular functions that promote apoptosis. Indeed, the redox 
regulatory role of catalytic cysteines in Trx is essential for maintaining redox 
homeostasis through its indirect ROS scavenging activity executed through 
Prx, as well as participating in reversing oxidative modifications rendered to 
proteins based on its disulfide reduction and denitrosylation activity. 
Moreover, Trx is also known to regulate cellular signaling by physically 
interacting with various cellular proteins including apoptotic proteins and 
transcription factors, so as to bring about redox control of cellular processes 
(Hirota et al., 1999, Lu and Holmgren, 2012).  
The free radical scavenging activity of Trx mediated through Prx plays an 
antioxidant role to combat oxidative stress, thereby attenuating oxidative 
stress-induced apoptosis (Dubuisson et al., 2004). Indeed, mitochondrial Trx2 
and Prx3 has been reported to control mitochondrial ROS levels and ROS-
mediated apoptosis induction (Tanaka et al., 2002). As mentioned above, the 
S-denitrosylation activity of Trx is important in regulating apoptosis induced 
or inhibited by various S-nitrosylated proteins (Benhar et al., 2008). The 
transcriptional activities of redox-active transcription factors are known to be 
regulated by Trx1 in a redox-dependent manner and the consequences of such 
regulation are related to cell growth or survival. For instance, oxidative stress 
induced by myrisate acetate (PMA) has been found to induce the nuclear 
translocation of Trx1. Cys32 in hTrx1 then associates with redox factor 1 
(Ref-1), which results in modulation of the DNA binding ability of AP-1. It is 
also reported that the DNA binding ability of NF-κB enhanced upon reduction 
by reduced Trx1 (Hirota et al., 1997, Hirota et al., 1999). Furthermore, nuclear 
Trx1 is reported to regulate p53-mediated p21 activation, which contributes 
towards inhibition of oxidative stress-induced apoptosis (Ueno et al., 1999). A 
change in the cytoskeleton is one key feature that occurs during oxidative 
stress-induced apoptosis. Actin, a cytoskeleton protein, is a redox-sensitive 
protein and plays an important role in redox proteomics under nitric oxide- 




through a proposed intermolecular disulfide bond formation, and protects it 
from harmful effects of oxidative stress (Wang et al., 2010). 
Inhibition of ASK1-mediated apoptosis by Trx is a well studied example of 
Trx-dependent redox regulation of apoptosis induction. Trx1 and Trx2, both in 
their reduced forms, interact with ASK1 in the cytosol and mitochondria 
respectively and inhibit ASK1-mediated apoptosis. However, under oxidative 
stress, oxidized Trx lose the ability to interact with ASK1. Dissociation of 
oxidized Trx from ASK1 allows ASK1 to undergo oligomerization to form the 
ASK1 signalosome by recruiting TRAF2/6. This in turn promotes ASK1 auto-
phosphorylation, which activates the downstream JNK signaling, leading to 
apoptosis induction (Saitoh et al., 1998b). A schematic presentation of the 
cellular events in relation to Trx-dependent regulation of ASK1-mediated 
apoptosis is depicted in Fig. 1.6. 
 
Figure 1.6 Trx-dependent regulation of ASK1-mediated apoptosis. At 
physiological conditions, reduced Trx binds to ASK1 and renders it inactive by 
inhibiting its oligomerization and phosphorylation. When exposed to oxidative stress, 
increased ROS levels cause Trx oxidation. Oxidized Trx dissociates from the Trx-
ASK1 complex, with Trx-free ASK1 undergoing oligomerization and auto-
phosphorylation to form active ASK1 that activates JNK signaling. As a result, 





1.4 Cytoprotective and immune/inflammatory responses 
ROS plays a pivotal role in the activation and regulation of a cytoprotective 
and immune/inflammatory response. The cytoprotective response has involved 
the Nrf2-Keap1 signaling pathway that is important in maintaining redox 
equilibrium by inducing the expression of phase ІІ detoxifying and antioxidant 
enzymes (Itoh et al., 1997, Itoh et al., 1999). Similarly, the NF-κB signaling 
pathway is important in regulating immune and inflammatory reactions 
through regulating the expression of growth factors, anti-apoptotic proteins, as 
well as pro-inflammatory mediators such as cytokines, cyclooxygenase 2 
(COX-2) and inducible nitric oxide synthetase (iNOS) (Pahl, 1999, Wang et 
al., 2002, Kabe et al., 2005).   
1.4.1 Nrf2-ARE signaling 
Nrf2 is a Cap ‘n’ Collar (CNC) basic leucine zipper redox-sensitive 
transcriptional factor involved in the induction of battery of phase ІІ 
detoxifying and antioxidant enzymes through activation of  ARE, a promoter 
binding sequence for genes expressing these enzymes (Motohashi et al., 2002, 
Venugopal and Jaiswal, 1996, Itoh et al., 1997). Upon exposure to oxidative 
stress and/or electrophiles, Nrf-2 translocates into the nucleus, heterodimerizes 
with a small bZIP protein, also called small Maf protein and together, they 
bind to the ARE promoter region to activate the expression of downstream 
genes such as GSTs, γ-GCL, GPx2, HO-1, NAD(P)H:quinone oxidoreductase 
(NQO1), TrxRs, UDP glucuronosyltransferase (UGT) (Hayes and McMahon, 
2001, Itoh et al., 1997). Actin-associated Kelch-like ECH-associated protein 1 
(Keap1) regulates Nrf2 steady state levels by acting as a substrate adaptor 
protein to link Nrf2 to the ubiquitin E3 ligase Cullin3 (Cul3)-Rbx1 complex 
and leads to proteasomal degradation of Nrf2. When oxidative/electrophilic 
stress is introduced, Keap1 loses its ability to repress Nrf2 and steady state 
levels of Nrf2 are enhanced to bring about upregulation of ARE-dependent 
transactivation of Nrf2 target genes (Kobayashi et al., 2004, Dinkova-Kostova 
et al., 2005, Kobayashi and Yamamoto, 2006).  Recently, the direct interaction 




oxidative stress, p21 levels are increased and compete with Keap1 to bind to 
Nrf2 (Chen et al., 2009). 
1.4.2 NF-κB signaling 
The NF-κB signaling pathway is involved in a number of cellular events such 
as inflammatory responses, cell growth and development. NF-κB is a 
transcriptional factor containing five structurally related subunits that include 
the DNA binding subunit NF-κB1 (p50/p105), NF-κB2 (p52/p100), and 
transcriptional activators p65 (RelA), RelB and c-Rel. Upon binding to the 
NF-κB promoter sequence found in the promoter region of NF-κB target 
genes, NF-κB brings about the transactivation and expression of these genes 
(Pahl, 1999). During injury or infection, the release of cytokines, bacterial 
endotoxins or viral oncogenes activates NF-κB signaling in a classical or non-
classical way (Brasier, 2006). The classical way of NF-κB signaling involves 
activation of cell surface receptors such as the TNF receptor (TNFR) and 
Toll/IL-1 receptor, which leads to phosphorylation of inhibitor of κB kinase β 
(IKKβ) in the IKKα/β complex. The phosphorylated IKKβ further 
phosphorylates inhibitor of κB (IκB) and promotes their proteasomal 
degradation. IκB sequesters NF-κB p50/p65 through physical binding and thus 
inhibits the nuclear translocation of p50 and p65. Phosphorylated IκB is 
targeted for ubiquitin proteasomal degradation. This allows p50 and p65 to 
translocate into the nucleus and activate the specific promoter region of NF-
κB target genes. In the non-classical pathway, activation of the B-cell 
activating factor receptor (BAFR) on B-cells stimulates phosphorylation of 
IKKα by NF-κB-inducing kinase (NIK), which leads to phosphorylation and 
subsequent proteasomal degradation of IκBα, the inhibitors of NF-κB 
p52/RelB.  When IκB levels decrease, NF-κB p52/RelB translocates into the 
nucleus and activates the promoter region of NF-κB target genes. In recent 
reports, Keap1 has also been found to downregulate NF-κB signaling by 
promoting proteasomal degradation of IKKβ (Hayden and Ghosh, 2004, 





1.4.3 Kelch-like ECH-associated protein 1 (Keap1) 
Keap1 is a cysteine-rich redox sensor protein discovered as a negative 
regulator of Nrf2, which plays an essential role in the regulation of Nrf2-ARE 
signaling. Keap1 is comprised of five conserved structural domains: an N-
terminal region (NTR), the bric-a-brac tram-track broad complex (BTB) 
domain, a central intervening region (IVR), a double glycine repeat (DGR) or 
Kelch domain and a small C-terminal domain (CTR) (Itoh et al., 2010). The 
BTB domain of Keap1 is involved in its homodimerization through Ser104, 
which acts as a substrate adapter for Cul3 E3 ligase-dependent ubiquitination 
and proteasomal degradation of proteins (Zipper and Mulcahy, 2002). Under 
physiological conditions, Keap1 interact with E3 based ligase Cul3 through 
the BTB domain and targets Nrf2 for proteasomal degradation (McMahon et 
al., 2003, Kobayashi et al., 2004, Kobayashi and Yamamoto, 2006). In this 
mechanistic way, under physiological conditions, Keap1 binds and inhibits 
nuclear translocation of Nrf2 and promotes its proteasome-dependent 
degradation. However, under oxidative stress conditions or xenobiotic insults, 
Keap1 has been observed to dissociate from Nrf2, leading to Nrf2 
upregulation and hence ARE activation.  
 
Figure 1.7 A pictorial diagram of human Keap1 indicating its structural 
domains and cysteine amino acids. Highlighted cysteines 151, 273 and 288 are the 
most reactive cysteines towards electrophilic attack.  
 
Human Keap1 contains 27 cysteine residues, which render it redox-sensitive 
(Holland and Fishbein, 2010). Among them, Cys151, Cys273 and Cys288 are 




proteins (Zhang and Hannink, 2003, Zhang et al., 2004). Cys151 is the most 
reactive cysteine towards electrophilic attack by various electrophiles such as 
sulforaphane (SF), t-butyl hydroquinone (tBHQ), resveratrol and curcumin. 
Basic amino acids (His129, Lys131, Arg135, Lys150 and His154) are adjacent 
to Cys151 which decrease its pKa value through coulombic interaction. In 
doing so, Cys151 is ionized and exists as thiolate anion at physiological pH 
(McMahon et al., 2010, Snyder et al., 1981). SF and tBHQ are reported to 
adduct Cys151 in Keap1, which leads to disturbance of the Keap1-Nrf2 
interaction and therefore inhibit Nrf2 degradation. Keap1 knock-out MEFs 
expressing Cys151 mutant of Keap1 are unable to upregulate Nrf2 levels upon 
treatment with SF and tBHQ (McMahon et al., 2010). This indicates that 
Cys151 in Keap1 is required for Nrf2 induction by electrophiles. However, 
Cys151 does not possess Nrf2 repressor activity, as Keap1 bearing mutation at 
Cys151 is still able to repress Nrf2 by promoting its proteasomal degradation. 
On the other hand, cysteine-to-alanine mutation of Cys273 and Cys288 leads 
to abolishment of Keap1’s Nrf2 repressor activity (McMahon et al., 2010). A 
study conducted by (Yamamoto et al., 2008), had also reported the 
involvement of Cys273 and Cys288 in Keap1 for Nrf2 repression. These 
experimental findings have agreed with earlier observations made by Zhang 
and Hannink (2003), and strongly suggest that Cys273 and Cys288 are 
important for binding to Nrf2 and/or are involved in facilitating the 
proteasome-dependent degradation of Nrf2. In summary, findings reported by 
published studies to date have indicated that under constitutive conditions, 
Cys151 in Keap1 does not possess a role in the interaction of Nrf2 with 
Keap1, but is important in disturbing the Keap1-Nrf2 interaction under 
oxidative/electrophilic stress conditions. On the other hand, Cys273 and 
Cys288 are necessary for Keap1-dependent ubiquitination of Nrf2 (i.e. 
Keap1’s Nrf2 repressor activity).   
  
The interaction between Keap1 and Nrf2 has been reported to follow a “hinge-
and-latch” model, where the DGR (Kelch) domain in each Keap1monomer 
(Keap1 exists as a homodimer) establishes two points of interaction with the 
Neh2 domain of Nrf2: it binds loosely with the DLG motif in Nrf2 as a latch 




et al., 2006). The binding of Nrf2 with Keap1 through its DLG and ETGF 
motif in a hinge-and-latch manner is reported to be important for its Keap1-
mediated ubiquitination and proteasomal degradation. Under electrophilic 
attack, the interaction between the DLG motif of Nrf2 and the DGR domain of 
Keap1 is proposed to be perturbed, leading to inhibition of ubiquitination of 
Nrf2. The hinge-and-latch model proposed for the Keap1-Nrf2 interaction is 
as illustrated in Fig. 1.8. 
 
 
Figure 1.8 Hinge-and-latch model for Keap1-Nrf2 interaction. (A) The DGR 
(Kelch) domains of the Keap1 homodimer interact with the ETGF and DLG motif in 
the Neh2 domain of Nrf2 with high and low affinity respectively. (B) When 
electrophiles such as sulforaphane forms adducts with Cys151 in the BTB domain of 
Keap1, the latch opens up and Nrf2-Keap1 interaction is disrupted. Modified from 
(Tong et al., 2007). 
 
Cysteines in Keap1 are also reported to undergo oxidative modifications such 
as intra- and inter-molecular disulfide bond formation and S-nitrosylation 
(Fourquet et al., 2010). Under oxidative stress, Cys226 and Cys613 are 
involved in intermolecular disulfide formation and Cys151 also participates in 
intermolecular disulfide formation that results in homodimerization of Keap1. 
In addition, Cys151 is also reported to undergo S-nitrosylation under 
nitrosative stress. These oxidative modifications are reversible depending on 
the redox state of the cell. At redox equilibrium state, the Trx and GSH 
systems are involved in reversing the disulfides formed in Keap1. It has 
reported that oxidative modifications in Keap1 are leads to upregulation of 
Nrf2 levels, but the mechanism of this Nrf2 induction is not well studied. Cul3 




E3 ubiquitin ligase complex that mediates Keap1-guided Nrf2 ubiquitination, 
which subsequently leads to proteasomal degradation of Nrf2 (Kaspar and 
Jaiswal, 2010). In addition to the disrupted Keap1-Nrf2 interaction, a 
perturbed Keap1-Cul3 interaction is also proposed as one mechanism that 
abolishes ubiquitination of Nrf2 and its proteasomal degradation. Hence, it 
remains plausible that alkylation by RES or oxidative modifications by ROS 
and RNS of Cys151, Cys273 and Cys288, serves to modulate the interaction 
between Keap1 and Cul3 so as to bring about Nrf2 upregulation.   
Keap1 has also been found to be involved in the regulation of NF-κB signaling 
by maintaining the levels of IKKβ. Keap1 downregulates NF-κB signaling by 
targeting proteasomal degradation of IKKβ (Lee et al., 2009), as well as by 
inducing autophagic degradation of IKKβ and inhibition of its phosphorylation 
(Kim et al., 2010a). It is also reported that p65 interacts with Keap1 and 
promotes ubiquitination of Nrf2 (Yu et al., 2011). Moreover, during oxidative 
stress, Keap1 itself gets targeted for ubiquitination, followed by proteasome-
independent degradation. The BTB-Kelch substrate adaptor protein for Cul3, 
targets Keap1 for degradation by a proteasome-independent pathway (Zhang 
et al., 2005), while sequestosome (p62) is also involved in the autophagic 
degradation of Keap1 (Copple et al., 2010, Jain et al., 2010, Komatsu et al., 
2010). In recent reports, Keap1 is found to be involved in the direct regulation 
of apoptosis by targeting the anti-apoptotic proteins Bcl-2 and Bcl-XL for 
proteasomal degradation (Niture and Jaiswal, 2011b, Niture and Jaiswal, 
2011a, Taguchi et al., 2012). The findings have suggested the direct 
involvement of Keap1 in the regulation of apoptosis.  
1.4.4 Cross-talk between Nrf2-ARE and NF-κB signaling 
Activation of Nrf2-ARE signaling is reported to inhibit NF-κB signaling (Li et 
al., 2008). It is logical that the redox homeostasis maintained through Nrf2-
ARE signaling inhibits the activation of NF-κB signaling, as increased ROS is 
known to activate NF-κB signaling by activation of various kinases. In 
addition, recent evidence suggests the potential cross-talk between these two 
signaling pathways occurring through Keap1. As mentioned in earlier 




signaling by targeting Nrf2 and IKKβ in the respective pathways for 
proteasomal degradation. This suggests that at physiological conditions, 
Keap1 is continuously involved in the negative regulation of Nrf2 and IKKβ. 
In the presence of low levels of ROS, it is proposed that Keap1 loses ability to 
interact with Nrf2, possibly leaving Keap1 free to target IKKβ instead for 
proteasomal degradation and leads to inhibition of NF-κB signaling. It is likely 
that known Nrf2 inducers, which mainly induce electrophilic stress, bring 
about similar effects on Nrf2-ARE and NF-κB signaling. Indeed, under 
electrophilic attack by known Nrf2 inducers, Nrf2-ARE signaling is activated, 
while NF-κB signaling is usually reported to be downregulated. For instance, 
SF treatment causes activation of Nrf2-ARE signaling (Prochaska and Talalay, 
1988, Zhang et al., 1992) and downregulation of NF-κB signaling (Heiss et al., 
2001). Similar to SF, Nrf2 inducer N-acetyl-p-benzoquinineimine (NAPQI) 
and dinitrochlorobenzene (DNCB) are also reported to activate Nrf2-ARE and 
downregulate NF-κB signaling (Chia et al., 2010). On the other hand, it has 
been reported that the oxidative stress induced by depletion of GSH and by 
treatment with H2O2 leads to the activation of NF-κB signaling (Haddad, 
2000, Haddad, 2001, Zhang et al., 2001) and activation of Nrf2-ARE signaling 
(Zhang et al., 2010, Rushmore et al., 1991). For those observations, it is 
suggested that during moderate to high oxidative stress, Keap1 loses ability to 
bind to both Nrf2 and IKKβ, and itself gets degraded through a proteasome-
independent manner. This eventually leads to activation of both Nrf2-ARE 
and NF-κB signaling.  Given the contradictory findings reported by published 
studies to date, it remains unclear how the Nrf2-Keap1 and NF-κB signaling 
pathway cross-talk and whether such cross-talk(s) varies with types and 
intensity of oxidative/electrophilic stresses. Nevertheless, a better 







1.5 Aims and objectives of PhD study 
In cells, a number of antioxidant systems are in place to counteract the daily 
production of ROS and RNS. Under different biological conditions, there are 
times when cells encounter transient or permanent episodes of mild, moderate 
or severe levels of ROS and RNS generation from endogenous or exogenous 
sources. Under such circumstances, cellular proteins undergo oxidative 
modifications, particularly at their redox-sensitive cysteine residues. In this 
PhD study, we were interested to gain a better understanding of the redox 
sensitivities of cellular proteins and how their redox states could be regulated 
by cellular thiol redox systems such as the GSH and Trx systems.  
As part of a preliminary effort to identify novel cellular proteins that could be 
associated with and under redox regulation by thiol redox systems, we had 
arrived at the discovery of a novel interaction between redox protein Trx and 
AIF. An abnormally increased ROS is known to induce AIF-mediated 
apoptosis. However, the redox sensitivity and redox regulation of AIF-
mediated apoptosis remain largely unknown. AIF had therefore hypothesized 
to be a redox sensitive protein under redox regulation of thiol redox systems. 
On the other hand, Keap1, a protein containing an exceptional high number of 
cysteine residues, is also known to be redox-sensitive. Under low to moderate 
oxidative stress, Keap1 is known to loss its ability to repress Nrf2, which 
would lead to activation of Nrf2-ARE signaling and maintains redox 
homeostasis. However, thiol oxidative modifications in Keap1 and their role in 
Nrf2-ARE activation are still unknown. Therefore, we had focused on 
investigating the redox sensitivities of these two cysteine-containing proteins 
to thiol oxidative modifications. The specific objectives of this PhD study are 
as follows: 
1. To characterize the AIF-Trx interaction. 
2. To elucidate the role of Trx1 in the regulation of AIF-mediated 
apoptosis in response to various apoptotic stimuli such as oxidative 
stress. 





4. To characterize the oxidation profiles of Keap1 caused various types of 
stress induced by oxidants and electrophilic compounds. 
5. To examine whether Keap1 was the molecular link between Nrf2-ARE 
and NF-κB signalling.   
 
The results of investigations undertaken to achieve Aim 1, 2 and 3 are 
discussed in Chapters 2, 3 and 4 respectively, and results obtained pertaining 











Investigation and characterization of a novel 
interaction between AIF and Trx 
 













Oxidative stress is known to activate apoptotic cell death through various 
pathways in a caspase-dependent and/or caspase-independent manner. 
Apoptosis induction mediated by oxidative stress during ageing, metabolic 
disorders, disease conditions or xenobiotic insults has led to many 
pathological conditions such as neurodegeneration, muscular apathy, cardiac 
dysfunctionings, etc (Mattson, 2000, Primeau et al., 2002, Serdaroglu et al., 
2002). ROS is continuously generated in mitochondria through processes 
involved in metabolic respiration such as oxidative phosphorylation. Redox 
homeostasis is maintained under normal physiological conditions where 
excessive ROS is scavenged by several cellular redox defense systems 
(Davies, 2000). These redox defense systems are also involved in the 
regulation of apoptosis by inhibiting activation of apoptotic proteins at a 
proteomic and/or genetic level (Saitoh et al., 1998a, Nordberg and Arner, 
2001, Haendeler et al., 2002, Anathy et al., 2012, Lu and Holmgren, 2012, 
Hirota et al., 1997). AIF is a mitochondrial caspase-independent programmed 
cell death effector. Upon application of an apoptotic stimulus, AIF translocates 
into the nucleus and causes chromatin condensation and large scale DNA 
fragmentation (Susin et al., 1999). Apoptotic stimuli caused by oxidative 
stress have also been reported to activate AIF-dependent apoptosis induction. 
For example, oxidative stress induced by H2O2 has caused nuclear 
translocation of AIF followed by DNA damage (Fonfria et al., 2002, Son et 
al., 2009, Colo et al., 2008). However, the mechanisms underlying the redox 
regulation of AIF-dependent apoptosis induction, as well as cellular 
consequences of such regulation have remained largely unknown. 
Given that redox homeostasis is crucial in maintaining cell survival, it was 
proposed that many cellular proteins susceptible to oxidative stress could be 
regulated by redox proteins. Trx is one redox protein known to perform 
several biological functions through interacting with a number of cellular 
proteins [reviewed by (Lu and Holmgren, 2012)]. Hence, it was postulated that 
there were novel proteins that could be associated with and under redox 




between AIF and Trx1 was reported. Initially, Trx immunoprecipitation 
experiments were performed to investigate the novel proteins that could 
interact with Trx. Further to this, experimental work to characterize this 






















2.2 Materials and methods 
2.2.1 Materials 
Reagents  
Dulbecco’s modified eagle medium (DMEM), hypochloric acid (HOCl), 
diamide, N-acetylcysteine (NAC), iodoacetamide (IAA), lipopolysachharide 
(LPS) and tissue necrosis factor-α (TNF-α) were purchased from Sigma-
Aldrich (St Louis, MO, USA). Hydrogen peroxide (H2O2) was purchased from 
Calbiochem (La Jolla, CA, USA). Protease inhibitor cocktail was purchased 
from Roche (Mannheim, Germany). Protein G sepharose beads were from GE 
Healthcare (Uppsala, Sweden). Coomassie brilliant blue R-250 and β-
mercaptoethanol (β-ME) were from Bio-Rad laboratories (CA, USA).  
Antibodies  
Mouse anti-AIF, mouse anti-β-actin and goat anti-TrxR1 primary antibodies, 
and goat anti-mouse IgG-HRP, goat anti-rabbit IgG-HRP, mouse anti-goat 
IgG-HRP and goat anti-rat IgG-HRP secondary antibodies were purchased 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Goat anti-Trx1 
antibody was from IMCO Corporation (Stockholm, Sweden). Mouse Anti-
FLAG M2 antibody was purchased from Sigma-Aldrich (St. Louis, CA, 
USA). Mouse anti-V5 antibody was purchased from Serotec Inc. (Kidlington, 
Oxford, UK) and rat anti-HA antibody was from Roche diagnostics (Lewes, 
East Sussex, UK). 
Plasmids 
The plasmids used in the experiments and listed below had been previously 
constructed by Dr. Chew Eng Hui (Department of pharmacy, National 
University of Singapore) and available in the laboratory.  
1) pcDNA3.1/mAIF(101-612)-FLAG [mAIF101-FLAG] 
2) pcDNA3.1/mAIF(101-612)C255SC316SC440S-FLAG  
[mAIF101-FLAGallcysmt] 




4) pcDNA3.1/hAIF(121-612)-FLAG [hAIF121-FLAG] 
5) pcDNA3.1/FLAG-Trx1 (FLAG-Trx1) 
6) pcDNA3.1/Trx1-V5 (Trx1-V5) 
7) pcDNA3.1/Trx2-V5 (Trx2-V5) 
8) pcDNA3.1/Trx2(∆MLS)-V5 [Trx2(∆MLS)-V5] 
9) pcDNA3.1/V5-Trx1 (V5-Trx1) 
10) pcDNA3.1/V5-Trx1C32S (V5-Trx1C32S) 
11) pcDNA3.1/V5-Trx1C35S (V5-Trx1C35S) 
12) pcDNA3.1/V5-Trx1C32SC35S (V5-Trx1C32SC35S) 
13) pcDNA3.1/V5-Trx1C62SC69SC73S (V5-Trx1C62SC69SC73S) 
14) pcDNA3.1/Txnip-HA (Txnip-HA) 
15) pET4I/6XHis-hAIF(121-612) [6XHis-hAIF121] 
16) pET4I/6XHis-hAIF(121-612)C256SC316SC441S 
[6XHis-hAIF121-allcysmt]   
The plasmids listed below were obtained from Dr. Chung C H (School of 
biological sciences, Seoul National University). 
1) pcDNA3.1/ratAIF(102-612)-V5-6XHis [ratAIF(102-612)-V5-His] 
2) pcDNA3.1/ratAIF(102-363)-V5-6XHis [ratAIF(102-363)-V5-His] 
3) pcDNA3.1/ratAIF(342-612)-V5-6XHis [ratAIF(342-612)-V5-His] 
4) pcDNA3.1/ratAIF(102-341/364-612)-V5-6XHis [ratAIF(102-341/364-
612)-V5-His] 
5) pcDNA3.1/ratAIF(221-363)-V5-6XHis [ratAIF(221-363)-V5-His] 




Recombinant hAIF121 and hAIF121C256SC317SC441S proteins tagged with 
6X-His at the N-terminus were expressed and purified in our laboratory. 
(Preparation and purification procedures were as described in Section 2.2.6). 
Recombinant human Trx1 (rhTrx) was obtained from IMCO Corporation 




2.2.2 Cell culture, transfection and treatment 
Human embryonic kidney HEK293 and human cervical carcinoma Hela cells 
were cultured in a high glucose DMEM growth medium supplemented with 
10% FBS, 100 U/ml penicillin-streptomycin and 1 mM of sodium pyruvate at 
37˚C in a 5% CO2 humidified incubator. Human breast carcinoma MCF-7 and 
colorectal carcinoma HCT116 cells were cultured in a RPMI 1640 growth 
medium supplemented with 10% FBS and 100 U/ml penicillin and 
streptomycin under similar cell culture incubation conditions. The respective 
cell lines were transfected or co-transfected with one or more of the 
mammalian expression plasmids as listed in Section 2.2.1 using GeneJuice® 
(Novagen, MA, USA) as a transfection reagent in a 1 µg : 2.5 µl 
(DNA:GeneJuice®) ratio for 24-48 h. Growth medium in the transfected plates 
were changed with fresh medium after 12 h of transfection. Finally, the 
transfected and/or the untransfected cells were treated with indicated reagents 
at various concentrations and timepoints as specified in each of the following 
Sections in this Chapter.  
2.2.3 SDS-PAGE and western blot analysis  
For each experiment, unless otherwise stated, the cells were harvested by 
washing with ice cold PBS and lysed in an ice cold triton-X lysis buffer (25 
mM Tris-HCl pH 7.5, 100 mM NaCl, 2.5 mM EGTA, 2.5 mM EDTA, 20 mM 
NaF, 1 mM Na3VO4, 10 mM sodium pyrophosphate, 20 mM sodium β-
glycerophosphate, 0.5% triton-X 100) supplemented with freshly added 
protease inhibitor cocktail. The lysates were centrifuged at 13,000 rpm, 4˚C 
for 10 min to obtain whole cell lysates precleared of cell debris. The whole 
cell lysates were estimated for total protein content using Bradford reagent 
following manufacturer’s instructions. Volumes of lysates containing equal 
amount of proteins (10-100 µg) were subjected to SDS-PAGE. For reducing 
SDS-PAGE, the lysates were mixed with equal volume of 2x Laemmli’s 
sample buffer (62.5 mM Tris-HCl, 25% glycerol, 2% SDS, and 0.02% 
bromophenol, pH 6.8) containing 5% w/v of β-mercaptoethanol (β-ME), and 
boiled for 10 min. The samples were then loaded on a 12-15% SDS-




SDS-PAGE running buffer (25 mM Tris-HCl, 192 mM glycine and 0.1% 
SDS). The separated proteins on the gel were transferred onto a nitrocellulose 
membrane by overnight transfer at 25 V in a transfer buffer (25 mM Tris-HCl, 
192 mM glycine and 20% v/v methanol). On the next day, the membrane was 
blocked in 10% fat-free milk in TBS-T buffer (25 mM Tris-HCl pH 7.4, 137 
mM NaCl, 3 mM KCl, containing 0.05% v/v Tween 20) for 1 h at room 
temperature. The blocked membrane was incubated with an appropriate 
primary antibody in TBS-T containing 0.05% sodium azide as anti-microbial 
agent for 2 h to overnight at 4˚C. After incubation with the primary antibody, 
the membrane was washed with TBS-T for 3 x 5 min and subsequently 
incubated with an appropriate secondary antibody conjugated to horse radish 
peroxidase (HRP) for 1 h in TBS-T for 1 h. The membrane was next washed 
with TBS-T for 3 x 5 min, incubated with enhanced chemi-luminescence 
(ECL) reagent (Pierce and Perkin Elmer) for 1-2 min and the protein bands 
were developed on X-ray film using X-ray film developing instrument 
(Konica) or captured using the digital Luminescent Image Analyzer 
(LAS3000, Fujifilm).                           
2.2.4 Co-immunoprecipitation 
Whole cell lysates were collected in either triton-X lysis buffer or IP buffer 
(50 mM HEPES pH 7.4, 1 mM EGTA, 100 mM NaCl, 0.1% NP-40, 
containing freshly added protease inhibitor cocktail) and the protein content 
for each lysates sample was determined using Bradford reagent as described 
above. The calculated volume of lysates containing equal amount of proteins 
(0.5-1 mg) were mixed with 20 µl of PBS-washed Protein G Sepharose beads 
and 1-2 µl of antibody against the protein that was to be immunoprecipitated. 
These mixtures were adjusted to a final volume of 1 ml using either triton-X 
lysis buffer or IP buffer and incubated for 2-3 h at 4˚C with gentle shaking. 
Following the incubation, the above samples were centrifuged at 2500 rpm for 
1 min to separate the Protein G Sepharose beads from lysates. These beads 
were washed with ice cold washing buffer (50 mM Tris-HCl pH 7.4, 100 mM 
and 1 mM EGTA) or IP buffer to remove/reduce proteins non-specifically 




Laemmli’s sample buffer containing 5% w/v of β-ME and boiled for 5-10 min 
followed by high speed centrifugation at 13,000 rpm to separate the beads 
from the eluted immunoprecipitates. The immunoprecipitates were subjected 
to SDS-PAGE and the co-immunoprecipitated proteins were detected by 
western blot analysis as described above.               
2.2.5 Coomassie blue staining of protein gels  
Proteins separated on a SDS-polyacrylamide gel were coomassie-stained by 
incubating the gel with 0.5% Coomassie Brilliant blue in 50% methanol and 
10% glacial acetic acid (GAA) for 2 h to overnight with gentle agitation. The 
stained gel was next destained in destaining solution (40% methanol and 10% 
GAA) with gentle agitation, and occasional changing of fresh volumes of 
destaining solution, until the protein-free parts of the gel became fully 
destained. Images of these gels were captured on a gel documentation machine 
(Biorad).      
2.2.6 Expression and purification of recombinant His-hAIF121 and His-
hAIF121C256SC317SC441S protein 
Competent E. coli cells (BL21 strain) were transformed with pET4I/6XHis-
hAIF121 or pET4I/6XHis-hAIF121C256SC317SC441S and successfully 
transformed cells were cultured in 50 ml of LB broth containing 50 μg/ml of 
kanamycin in the shaking incubator (200 rpm) at 37°C. The overnight culture 
was transferred into 1000 ml LB broth containing 50 μg/ml of kanamycin and 
incubated in the shaking incubator (200 rpm) at 37°C until the OD of the 
culture at 600 nm had reached 0.6. At this point, IPTG was added to a final 
concentration of 0.5 mM and the culture was incubated overnight in the 
shaking incubator (200 rpm) at 16°C. The overnight culture was then 
centrifuged at 8000 rpm for 30 min at 4°C to obtain the bacterial pellet. The 
bacterial pellet was washed once with ice cold PBS and the suspended cells 
were pelleted by centrifugation. The PBS-washed bacterial pellet was 
resuspended in Ni-NTA His-tagged protein purification Buffer A (20 mM 
imidazole, 50 mM sodium phosphate, 500 mM NaCl, pH 8.0a) and the 




intermittent shaking. The lysates were cleared by centrifugation at 22,000 rpm 
for 1 h at 4°C. The supernatant was with Ni-NTA sepharose beads (Qiagen) 
and incubated for 30 min with gentle shaking followed by washing of the 
beads with Buffer A and B to elute proteins non-specifically bound to the 
beads. His-hAIF121 or His-hAIF121C256SC317SC441S recombinant 
proteins bound to Ni-NTA sepharose beads were then eluted with Buffer C 
(250 mM imidazole, 50 mM sodium phosphate, 500 mm NaCl, pH 8.0) in 
various fractions. Aliquots of these fractions were subjected to SDS-PAGE 
followed by coomassie blue staining to visualize which fraction(s) contained 
the highest proportion of the protein of interest to non-specific proteins. The 
identified fractions were pooled and subjected to ultrafiltration using 
Amicon®-30k (Millipore) ultra filter units. The high molecular weight protein 
impurities were removed by gel filtration chromatography on Superdex®-75 
columns using AKTA prime plus (GE) instrument. The purified recombinant 
proteins were quantified for protein content and stored with 10% of glycerol at 
-80°C.              
2.2.7 Pull-down assay involving recombinant His-hAIF121 and hTrx1 
Recombinant protein His-hAIF121 and rhTrx1 were mixed to a final 
concentration of 5 and 10 µM respectively in a volume of up to 1 ml of Buffer 
D (50 mM sodium phosphate, 500 mM NaCl, pH 8.0) and 20 µl of PBS-
washed Protein G Sepharose beads. The protein mixture was incubated with 
anti-AIF or anti-Trx antibody (1 μg/ml) for 1-2 h at 4˚C with continuous 
gentle shaking. After incubation, the beads were washed with Buffer D for 3 x 
5 min to wash off the proteins non-specifically bound to the beads, followed 
by the elution of specifically bound proteins in the 2x sample buffer 
containing 5% w/v of β-ME. The pulled-down proteins were detected by 
western blot analysis as mentioned under Section 2.2.3.  
2.2.8 Molecular modeling of the AIF-Trx interaction 
Protein data bank (pdb) files of AIF (1GV4) and reduced Trx1 (1ERT) were 
obtained from the RCSB Protein Data Bank website. The crystal structures of 




rigid docking program on ClusPro, an online protein-protein docking server 
(Comeau et al., 2004, Kozakov et al., 2006). The protein-protein docking 
models obtained from this server were ranked according to the cluster size 
during the clustering and minimization process. The docking results obtained 
in pdb format were analyzed for various protein-protein interaction parameters 
using Pymol and Swiss-PdbViewer. The possible electrostatic interactions and 
hydrogen bondings between the amino acid residues of AIF and Trx in the 
predicted molecular models were obtained using Swiss-PdbViewer. Similarly, 
the surface areas between the binding interfaces of AIF and Trx in the 
predicted molecular models were estimated using Pymol.     
2.2.9 Determination of redox states of Trx 
The whole cell lysates were collected in a similar manner as mentioned in 
Section 2.2.3. These lysates were subjected to non-reducing native-PAGE, 
where the lysates were mixed with equal amount of native Laemmli’s sample 
buffer in the absence β-ME and were resolved on an 8% native 
polyacrylamide gel at 100 V for 1-1-5 h using native PAGE running buffer (25 
mM Tris-HCl and 192 mM glycine). The resolved proteins were transferred 
from the gel onto a nitrocellulose membrane and detected by western blot 
analysis as described in Section 2.2.3.  
2.2.10 siRNA-mediated gene silencing of TrxR1  
HEK293 cells were plated in 6-well plates and incubated to 40-50% of 
confluency before being transfected with 30 nM of targeting TrxR1 siRNA 
[ON-TARGETplus siRNA (Catalogue number: J-008236-06, J-008236-07, J-
008236-08, J-008236-09), Thermo Scientific Dharmacon®] and non-targeting 
control siRNA [siGENOME® (Catalogue number: D-001210-02-05) Thermo 
Scientific Dharmacon®] using Dharmafect® as the transfection reagent. The 
transfection procedure was carried out according to manufacturer’s 
instructions. Following 12 h of siRNA transfection, the culture medium was 
changed to fresh medium and the cells were further cultured for 48-72 h prior 
to use.  




2.3 Results    
2.3.1 Determination of the interaction between Trx and AIF 
In an initial attempt to identify novel proteins that could be under redox 
regulation by redox proteins such as redox thiol protein Trx, lysates of a MCF-
7 cell line stably expressing FLAG-Trx1 previously generated in the 
laboratory were subjected to immunoprecipitation reaction with FLAG 
antibody. On a coomassie blue-stained SDS-PAGE gel containing separated 
immunoprecipitates, a protein band in the region of the 65 kDa marker was 
observed exclusively in the FLAG-Trx1 lane (Fig. 2.1). MALDI-TOF mass 
spectrometric analysis identified the protein as programmed cell death 8 
isoform 2 (accession number NP_665811) (mass spectrometric work 
performed at Protein Analysis Laboratory, Cancer Research Center, London, 
UK, personal communication by Dr Chew Eng Hui), which corresponded to 
the amino acid sequence of AIF. The interaction of endogenous Trx and AIF 
was also found to be present in other human-derived cell lines such as 
HEK293, HCT116 and Hela cells (Fig. 2.2A). To further investigate whether 
there was a direct association between AIF and Trx, pull-down experiment 
was performed using recombinant His-hAIF121 (rHis-hAIF121) and hTrx1 
(rhTrx1) proteins. As depicted in Fig. 2.2C, rHis-hAIF121 and rhTrx1 were 
found to be able to interact. Taken together, based on immunoprecipitation 
reactions involving lysates either containing endogenous proteins or 
transfected proteins, as well as pull-down assays involving recombinant 
proteins, experimental evidence had demonstrated the existence of interaction 





Figure 2.1 Interaction between FLAG-Trx1 and endogenous AIF in MCF-7 cells 
stably expressing FLAG-Trx1. MCF-7 cells stably expressing FLAG-Trx1 were 
generated. Lysates of untransfected and FLAG-Trx1 expressing MCF-7 cells were 
subjected to FLAG immunoprecipitation. The immunoprecipitated proteins were 
eluted from anti-FLAG M2 agarose beads and were resolved on a 15% SDS-





Figure 2.2 Determination of AIF-Trx interaction by immunoprecipitation and 
pull-down assay.  (A) Endogenous Trx in HEK293, HCT116 and HeLa cell lysates 
were immunoprecipitated using anti-Trx antibody and the co-immunoprecipitated 
proteins were detected by western blot analysis. (B) Lysates of HEK293 expressing 
hAIF121–FLAG were subjected to FLAG immunoprecipitation and the 
immunoprecipitates and lysates were resolved by SDS-PAGE and analyzed by 
western blotting. (C) Recombinant His-hAIF121 and hTrx1 were mixed in a volume 
of Buffer D to a final concentration of 5 and 10 µM respectively and subjected to 
pull-down using anti-AIF or anti-Trx antibody. Eluted proteins were resolved by 
SDS-PAGE and analyzed by western blotting.     
The interaction of Trx with the full-length [inclusive of mitochondrial 
localization sequence (MLS)] and cytosolic forms of AIF was next 
investigated using immunoprecipitation experiments. Both full-length AIF 
[mAIF(FL)-FLAG] and cytosolic forms of AIF (mAIF101 and hAIF121) were 
found to interact with Trx1. In contrast, heat shock protein 60 (HSP60), a 




(Deocaris et al., 2006), did not interact with Trx1 (Fig. 2.3A). In an earlier 
study, DmTrx2 has been reported to interact with DmAIF and promote AIF-
mediated apoptosis induction in the neuronal cells of Drosophila 
melanogaster (Joza et al., 2008). It had prompted us to investigate whether 
AIF interacted with either or both cytosolic Trx1 and mitochondrial Trx2. 
Apparently, mitochondrial Trx2 showed weaker interaction with hAIF121-
FLAG as compared to cytosolic Trx1 (Fig. 2.4). Taken together, the obtained 
results as presented in Fig. 2.3 and 2.4 had demonstrated that under 
physiological conditions, both mitochondrial and cytosolic AIF could interact 
with Trx1, whereas Trx2 displayed weaker interaction.  
 
Figure 2.3 Interaction of Trx with full-length and cytosolic forms of AIF. (A) 
HEK293 cells were transiently transfected and expressing the indicated FLAG-tagged 
proteins. The freshly collected lysates were subjected to Trx immunoprecipitation, 
with the eluted immunoprecipitates separated by SDS-PAGE and analyzed by 
western blotting using the indicated antibodies. (B) A pictorial outline of the start and 






Figure 2.4 Interaction of AIF with Trx1 and Trx2. HEK293 cells were co-
transfected with hAIF121-FLAG and with Trx1-V5, Trx2-V5 or Trx-2(∆MLS)-V5. 
Transfected Trx2-V5 was a full-length Trx2 protein inclusive of the MLS while Trx2 
(∆MLS) was a Trx2 protein lacking the MLS. The freshly collected lysates were 
analyzed for AIF-Trx interaction by immunoprecipitation of Trx1-V5 using anti-V5 
antibody and western blotting using anti-V5 and anti-FLAG antibody.   
 
2.3.2 Characterization of AIF-Trx interaction by deletion mapping and 
molecular modeling studies  
In an attempt to characterize the binding domains and amino acids involved in 
the AIF-Trx interaction, deletions of cytosolic AIF(∆1-∆6) tagged with V5-
His to their C-termini were obtained from Dr. Chung CH (School of 
Biological sciences, Seoul National University) (Fig. 2.5A) and used in 
immunoprecipitation assays. HEK293 cells were transfected with DNA 
constructs carrying deletions of cytosolic AIF and the collected lysates were 
subjected to co-immunoprecipitation with anti-Trx antibody. As shown in Fig. 
2.5B, ∆1, ∆2 and ∆3 cytosolic AIF deletions retained their ability to bind with 
Trx, whereas the ∆4 and ∆5 deletions did not interact with Trx. These results 
suggested the involvement of stretch of amino acids 102-220 and 493-612 in 
AIF that likely interacted with Trx. Moreover, the interaction between the ∆6 
cytosolic AIF deletion and Trx further supported the notion that the 102-220 
amino acid sequence in the N-terminal FAD binding domain and 493-612 
amino acid sequence in the C-terminal domain of AIF were involved in the 





Figure 2.5 Interaction of Trx with deletions of cytosolic AIF. (A) The various 
deletions of cytosolic AIF used in deletion mapping study are presented. (B) The 
deletions of cytosolic AIF were transiently expressed in HEK293 cells and the lysates 
were subjected to Trx immunoprecipitation using anti-Trx antibody. These deletion 
proteins in the immunoprecipitates and cell lysates were detected by western blotting 
using anti-V5 and anti-Trx antibody.  
Subsequently, molecular modeling studies were carried out in order to 
investigate in detail the interaction between AIF and Trx1 at the molecular 
level. Molecular models for this interaction were obtained by using Cluspro, 
an online server for protein-protein docking. The predicted molecular models 
were analyzed by Swiss PDB-viewer and Pymol. Among the various 
molecular models of AIF-Trx interaction obtained from Cluspro protein-
protein docking, the most favored model of balanced electrostatic and 
hydrophobic interactions that was ranked higher according to cluster size (Fig. 
2.6A) was selected for further characterization of this protein-protein 
interaction. This molecular model showed around 820 Å of molecular 




molecular interaction between two proteins under physiological conditions 
(Fig. 2.6B). As observed in Fig. 2.6A, Trx1 appeared to be in close proximity 
with the stretch of amino acids in the N-terminus (aa 145-155 and aa 198-205) 
and C-terminus (aa 520-538) of AIF, where it had fitted inside the grove 
formed between these two domains of AIF. In addition, the closer view of this 
model showed the close association between positively charged surface amino 
acids in AIF with Trx1 (Fig. 2.7). The positively charged side chains of 
Arg147, Arg152 and Arg200 in AIF formed hydrogen bonding with Thr30, 
Asp50, Asp61, Asp64 and Trp31 of Trx1.  In addition, Ser535 contained in the 
C-terminal domain of AIF was involved in hydrogen bonding with Glu70 in 
Trx1. Furthermore, the interaction involving Arg147 and Arg152 in AIF 
revealed the possibility of salt bridges formation with Trx1 (Fig. 2.7). In 
summary, based on the deletion mapping and molecular modeling studies, it 
was found that the AIF-Trx interaction was likely to occur through 140-210 
and 520-540 amino acid sequences of AIF. AIF possesses two nuclear 
localization sequences (NLS), namely NLS1 (aa 277 to 301) and NLS2 (aa 
445 to 451) (Sevrioukova, 2011). As such, it was likely that Trx1 had 






Figure 2.6 Molecular modeling of AIF-Trx interaction. (A) A global view of the 
docking model of AIF-Trx interaction showing molecular binding between AIF 
(Yellow ribbon) and reduced Trx1 (Cyano ribbon). (B) A predicted molecular model 
of AIF-Trx interaction showing their estimated molecular-binding interfaces involved 

































































































































































































2.3.3 Investigation of the involvement of Trx1’s catalytic and non-
catalytic cysteine residues in its interaction with AIF 
Trx is a redox sensitive protein involved in the regulation of many 
fundamental cellular biological activities such as proliferation and survival. 
Many of the biological activities of Trx are mediated through its redox 
regulatory functions. Trx possesses a highly conserved redox catalytic site 
CXXC that through dithiol/disulfide exchange reactions catalyzes reduction of 
disulfide bonds. In addition, mammalian cytosolic and nuclear Trx1 possesses 
three non-catalytic structural cysteine residues that are absent in mitochondrial 
Trx2 and prokaryotic Trxs (Fig. 2.8).  
 
Figure 2.8: Cysteine residues in human Trxs and E. coli Trx. Unlike hTrx2 and E. 
coli Trx, hTrx1 possesses structural cysteines (Cys62, Cys69 and Cys73) in the non-
catalytic site in addition to cysteines in the catalytic site. 
In line with our initial objective to identify novel proteins that could be under 
redox regulation by a redox protein such as Trx, we hypothesized that the 
cysteine residues in Trx1 were involved in the interaction with AIF. To test 
this hypothesis, cysteine-to-serine site-directed mutagenesis was conducted to 
generate DNA constructs carrying Trx cysteine mutants tagged with V5 at the 
C-termini. Lysates of the transfected HEK293 cells co-expressing hAIF121-
FLAG and wild-type or cysteine mutants of Trx1 were immunoprecipitated 
and immunoprecipitates were analyzed for co-immunoprecipitating cytosolic 
AIF(121-612). As depicted in Fig. 2.9A, interaction was abolished by single 
mutation of Trx1 at Cys32, in redox-inactive Trx1C32SC35S, as well as in 
redox-active Trx1 devoid of structural cysteines.  On the contrary, single 




interaction. It is well established that Cys32 in Trx has a lower pKa [6.7 for E. 
coli Trx (Kallis and Holmgren, 1980); 6.3 for human Trx (Forman-Kay et al., 
1992)] value than that of Cys35, and thus serves as the attacking nucleophile 
in a disulfide reduction reaction. Our results were therefore in agreement with 
the biochemistry of the Trx1 active site where Trx1C32S failed to bind due to 
the loss of an attacking Cys32. A redox-active hTrx1 lacking structural 
cysteine residues was unable to interact with AIF. The results had seemingly 
agreed with the poor interaction between AIF and mitochondrial Trx2, an 
isoform that lacks the structural cysteines residues. While it remained unclear 
what contributed to the poor interaction, the results taken together had 
suggested that the structural cysteines did play a role in facilitating the AIF-
Trx interaction. The likely reason currently proposed could be that the 
structural cysteines rendered certain stability of the structure of Trx1 that 
probably favored the AIF-Trx1 interaction.  
 
Figure 2.9 Determination of involvement of the indicated cysteine residues in 
Trx for its interaction with AIF. (A) HEK293 cells were co-transfected and co-
expressing cysteine mutants of V5-Trx1 and hAIF121-FLAG. The collected lysates 




transfected with hAIF121-FLAG were either co-transfected with Txnip-HA for more 
than 24 h or treated with 1 mM IAA for 2 h. Lysates were subjected to 
immunoprecipitation with anti-Trx antibody. Co-immunoprecipitated hAIF121-
FLAG in experiment (A) and (B) was analyzed by western blotting.     
In another experiment, it was found that overexpression of thioredoxin 
interacting protein 2 (Txnip), an endogenous inhibitor of Trx or treatment of 
cysteine alkylating agent IAA, had brought about a reduced AIF-Trx 
interaction (Fig. 2.9B). Txnip is known to bind to Trx1 by forming a potential 
mixed disulfide bond between Cys247 of Txnip and Cys32 of Trx1 (Spindel et 
al., 2012) and IAA is a known cysteine alkylating agent; the above results 
shed light on the likely involvement of cysteine residues in Trx1 for its 
interaction with AIF.  
Surprisingly, the cysteine residues in AIF were found to be not involved in the 
AIF-Trx interaction, as cysteine-to-serine mutation to all the three cysteines in 
AIF did not impede its interaction with Trx1 (Fig. 2.10). Based on the crystal 
structure of AIF (Susin et al., 1999), it could be observed that the cysteines in 
AIF were buried deep within its structure; the cysteines might not be easily 
accessible for direct interaction with other macromolecules. This ruled out the 
possibility of AIF-Trx interaction occurring through intermolecular disulfide 
bond formation. Nonetheless, based on the experimental results, both catalytic 
and non-catalytic cysteines in Trx had been found to be crucial for its 
interaction with AIF.     
 
Figure 2.10 Redundancy of cysteines in AIF for AIF-Trx interaction. HEK293 
cells were co-transfected and co-expressing Trx1-V5 and mAIF101-FLAG or 




immunoprecipitation using anti-V5 antibody and the immunoprecipitates were 
analyzed by western blotting.  
 
2.3.4 Abrogation of AIF-Trx interaction under oxidative stress conditions 
Having found that the cysteines in Trx were important for AIF-Trx interaction, 
we were interested to investigate how oxidative stress induced by various 
sources would affect the AIF-Trx interaction. Initially, in a fortuitous 
experiment involving cell lysates that had been frozen for more than 24 h, 
AIF-Trx interaction was observed to be abolished (Fig. 2.11A). Given that 
freezing conditions were generally oxidizing, it was deduced that oxidizing 
conditions favored disruption of the protein-protein interaction. The effect of 
oxidative stress caused by endogenous oxidizing agents such as H2O2 and 
HOCl on the AIF-Trx interaction was next examined. As shown in Fig. 2.11B, 
a short duration of 2 h treatment with these oxidizing agents at a high dose that 
could induce apoptosis had caused apparent disturbances in the AIF-Trx 
interaction. In another experiment where HEK293 expressing mAIF101-
FLAG were treated with pro-apoptotic concentrations of H2O2 (1 mM and 3 
mM) for 2 h, similar reduction in AIF-Trx interaction was observed (Fig. 
2.11C). In a time-chase study that involved treatment of mAIF101-FLAG-
transfected HEK293 cells with 2 mM H2O2 for 1, 3, 5 or 8 h, it was found that 
the disturbed AIF-Trx interaction was not recovered even by 8 h (Fig. 2.11D). 
Microscopic observations made of the treated cells revealed that they looked 
morphologically stressed and shrunken at the early time points of 1 and 3 h. At 
the later time points of 5 and 8 h, the shrunken cells had detached from the 
culture plates and appeared dying. At lower H2O2 dose of 1 mM that was 
found in our preliminary experiments to be insufficient to produce significant 
cell death, the disrupted AIF-Trx interaction was observed to be reversible. As 
shown in Fig. 2.12A, over a period of 30 min following treatment with 1 mM 
H2O2, the disrupted AIF-Trx interaction recovered progressively. The recovery 
of disturbed AIF-Trx interaction suggested that redox defense systems might 
be in place to facilitate the reversal of oxidative stress-mediated modifications 




supported by an experiment where the concurrent addition of antioxidant NAC 
abrogated the H2O2-mediated disruption of AIF-Trx interaction (Fig. 2.12B). 
 
Figure 2.11 Disruption of AIF-Trx interaction under oxidative stress conditions. 
(A) HEK293 cell lysates frozen at -20°C for more than 24 h, as well as fresh lysates 
were subjected to immunoprecipitation using anti-Trx antibody, followed by western 
blot analysis of AIF and Trx. (B) HEK293 cells co-transfected with mAIF101-FLAG 
and Trx1-V5 were treated with H2O2 (2 mM) and HOCl (2 mM) for 2 h, and the 
lysates were subjected to immunoprecipitation using anti-V5 antibody and 
immunoprecipitates were resolved by SDS-PAGE and analyzed by western blotting. 
(C) HEK293 cells transfected with mAIF101-FLAG were treated with 1 and 3 mM 
H2O2 for 2 h, and the lysates were subjected to Trx immunoprecipitation, followed by 
western blot analysis. (D) HEK293 cells co-transfected and co-expressing mAIF101-
FLAG and Trx1-V5 were treated with 2 mM H2O2. Lysates were collected at 
different timepoints (1, 3, 5 and 8 h), and subjected to immunoprecipitation reaction, 








Figure 2.12 Disruption of AIF-Trx interaction mediated by oxidative stress. (A) 
HEK293 cells treated with 1 mM H2O2 for 1 h were subjected to oxidative stress 
recovery by changing the medium with fresh medium and cultured further for 
different timepoints.  The lysates of H2O2-treated cells with or without oxidative 
stress recovery were collected and examined for the AIF-Trx interaction by V5 
immunoprecipitation and western blot analysis. (B) HEK293 cells treated with 2 mM 
H2O2 for 2 h in the presence or absence of 5 mM NAC and the recovery of AIF-Trx 
interaction was examined by V5 immunoprecipitation and western blot analysis.    
In another experiment, AIF-Trx interaction was studied under oxidative stress 
conditions achieved by silencing of TrxR1, the NADPH-dependent enzyme 
that reduces oxidized Trx1. As depicted in Fig. 2.13, siRNA-mediated TrxR1 
silencing, which would lead to Trx oxidation, had caused disruption of the 
AIF-Trx interaction, which was reversed by the treatment of reducing agent β-
ME. LPS and TNF-α are stimulants known to activate various cell signaling 
pathways and cause ROS generation in the activation process (Wang et al., 
2004, Woo et al., 2000). Hence, we also examined the effect of LPS and TNF-
α on the AIF-Trx interaction. As shown in Fig. 2.14, treatment of LPS or 
TNF-α caused significant disruption in the AIF-Trx interaction, which was got 
reversed upon concurrent treatment with NAC. In general, oxidizing insults 
mediated by direct treatment with oxidizing agents or by treatment with 
stimulants such as LPS and TNF-α had led to the abrogation of AIF-Trx 
interaction, which was recovered upon oxidative stress recovery or by the 
treatment with an antioxidant such as NAC. These findings had therefore 
suggested the possibility of oxidative thiol modification in either or both of 





Figure 2.13 Disruption of AIF-Trx interaction mediated by oxidative stress 
induced by TrxR1 silencing.  HEK293 cells were co-transfected with hAIF121-
FLAG and Trx1-V5. Following 12 h of transfection, the culture medium was changed 
to fresh medium and the cells were further transfected with 30 nM of control siRNA 
or TrxR1 siRNA #1 for 72 h. The collected lysates were untreated or treated with 5 
mM β-ME for 10 min, and subjected to V5 immunoprecipitation reactions. The 
lysates and immunoprecipitates were then resolved by SDS-PAGE, followed by 




Figure 2.14 Abrogation of AIF-Trx interaction by LPS or TNF-α. HEK293 cells 
co-transfected with hAIF121-FLAG and Trx-V5 were treated with 1 µg/ml LPS or 
0.5 µg/ml TNF-α for 12 h with or without concurrent treatment of 5 mM NAC. The 
collected cell lysates were subjected to V5 immunoprecipitation and the 






2.3.5 Investigation of the involvement of Trx’s redox state in its 
interaction with AIF 
As discussed in Section 2.3.3, it was found that the cysteine residues in the 
active site of Trx1 were involved in interacting with AIF. Furthermore, we had 
also found that the AIF-Trx interaction was disrupted under oxidative stress 
conditions. Therefore we postulated that the disruption was attributed to 
oxidative thiol modifications in Trx, in similar way as that of disruption of 
ASK1-Trx interaction (Saitoh et al., 1998b). Trx is known to be susceptible to 
oxidative stress where Cys32 and Cys35 at the active site undergo oxidation to 
form an intramolecular disulfide bond. Hence, we examined the association 
between thiol-dependent oxidation of Trx and concurrent disturbances in the 
AIF-Trx interaction. In the experiment, diamide, a thiol oxidant was used to 
induce oxidative stress by forming intra- and/or inter-molecular disulfide 
linkages in cellular proteins. The redox status of Trx was examined by 
subjecting the cell lysates to non-reducing native PAGE where the oxidized 
Trx species would run faster than the reduced Trx species.  
Immunoprecipitation reactions revealed that HEK293 cells expressing 
mAIF101-FLAG produced a disrupted interaction between mAIF101-FLAG 
and Trx1-V5 after being treated with 1 mM diamide for 5 min (Fig. 2.15A). 
Lysates run alongside in an 8% native PAGE gel indeed showed an 
accumulation of oxidized Trx (Fig. 2.15B). The reversibility of the AIF-Trx 
interaction upon removal of 1 mM diamide treatment for 5 min was further 
investigated. To this end, medium containing diamide was removed and 
replaced by fresh culture medium. At timepoints of 0, 5 and 10 min following 
replacement of fresh medium, which would be indicative of the removal of an 
oxidant to allow cells to recover from an oxidative stress insult, 
immunoprecipitation reactions had found that the disrupted AIF-Trx 
interaction was regained as soon as within 5 min of oxidative stress recovery 
(Fig. 2.15C). In agreement, the oxidized state of Trx1 was also time-
dependently reversed towards the reduced state (Fig. 2.15D). In another 
experiment, disrupted AIF-Trx interaction in cell lysates that had been frozen 




β-ME in a dose-dependent manner (Fig. 2.16A). Examination of the lysates by 
native PAGE revealed the oxidized and reduced state of Trx1 in frozen lysates 
in the absence or presence of β-ME respectively (Fig. 2.16B).   
 
Figure 2.15 Disruption of AIF-Trx interaction by diamide-induced thiol 
oxidation. (A) HEK293 cells expressing mAIF101-FLAG were transfected with 
Trx1-V5 and treated with 0.5 and 1 mM diamide for 5 min. The cells were harvested 
in triton-X lysis buffer and the freshly collected lysates were subjected to V5 
immunoprecipitation, followed by reducing SDS-PAGE. (B) The same freshly 
collected lysates were simultaneously subjected to non-reducing native PAGE. 
HEK293 cells as described in experiment (A) were treated with 1 mM diamide for 5 
min, followed by recovery of diamide treatment by changing the medium with fresh 
medium and cultured further for different timepoints. (C) The cells were harvested in 
triton-X lysis buffer and the freshly collected lysates were subjected to V5 
immunoprecipitation, followed by reducing SDS-PAGE. (D) The same freshly 





Figure 2.16 Reversal of AIF-Trx interaction by reducing agent β-
mercaptoethanol. HEK293 expressing mAIF101-FLAG were harvested in triton-X 
lysis buffer and the cell lysates were frozen at -20˚C for more than 24 h. The frozen 
lysates were treated with indicated concentrations of β-ME and the freshly collected 
lysates were subjected to (A) immunoprecipitation reaction using anti-Trx antibody, 
followed by reducing SDS-PAGE. (B) The same freshly collected lysates were 















The objective of the project was to identify novel proteins that could be under 
redox regulation by cellular redox defense systems. Trx, a redox protein 
component of the thiol redox Trx system, has been reported to be involved in 
protein-protein interaction with several cellular proteins, including those 
involved in apoptosis (Nordberg and Arner, 2001, Lu and Holmgren, 2012). 
Therefore, we hypothesized that there were novel proteins that could be 
associated with and under the redox regulation by Trx. Therefore, in the initial 
stage, a MCF-7 cell line stably expressing FLAG-Trx1 was generated and 
collected lysates were subjected to immunoprecipitation reactions. As a result, 
AIF was identified to interact with Trx, and the interaction was specifically 
found to be with Trx1, not Trx2. Trx1 and Trx2 are structural isoforms with 
87% similarity (Zhang et al., 2008). Trx1 and Trx2 differ mainly in their 
localization in the cytosol/nucleus and mitochondria respectively, and that 
Trx1 possesses three non-catalytic structural cysteines in addition to the 
cysteines in the active site. These structural cysteines that are absent in Trx2 
have been recently reported to be involved in apoptosis regulation (Haendeler 
et al., 2002). Using a series of Trx1 cysteine-to-serine mutants, 
immunoprecipitation reactions demonstrated that the non-catalytic structural 
cysteines in Trx1 were essential for its interaction with AIF. This had 
suggested that the absence of non-catalytic structural cysteines in Trx2 could 
be the reason for its lower affinity than Trx1 to interact with AIF. As far as our 
experimental findings had indicated, we had ruled out the possibility of an 
AIF-Trx2 interaction occurring in a mitochondrial compartment because the 
whole cell lysates used in the immunoprecipitation reactions would contain 
mitochondrial proteins. Nevertheless, immunoprecipitation reactions using 
mitochondrial extracts could be planned in the future work to affirm whether 
an AIF-Trx2 interaction existed in mitochondria.   
Despite their conserved presence among cytosolic Trx1 in mammalian cells, 
the functional significance of the non-catalytic structural cysteines has yet to 
be studied extensively. Over the past decade, the regulatory roles of these 




Cys69 is reported to undergo S-nitrosylation and the S-nitrosylated hTrx1 is 
found to inhibit apoptosis (Haendeler et al., 2002). While it was revealed in 
our study that the structural cysteines in Trx1 were essential for the AIF-Trx 
interaction, experiments investigating the possible involvement of S-
nitrosylated cysteines in the protein-protein interaction had not been pursued. 
Nevertheless, the involvement of non-catalytic cysteine residues in Trx1 for its 
interaction with AIF had further underpinned their functional significance. In 
addition, the attacking catalytic Cys32 in Trx1 was found to be important for 
the AIF-Trx interaction. Interestingly, cysteine-null AIF was found to be able 
to interact with Trx1, which ruled out the possibility of the AIF-Trx 
interaction occurring through disulfide linkage.   
AIF is a mitochondrial flavoprotein, which under normal physiological 
condition, localizes within the mitochondria and under application of an 
apoptotic stimulus, translocates through the cytosol into the nucleus (Susin et 
al., 1999). Trx1 is mainly present in the cytosol and can translocate into the 
nucleus upon application of various stress stimuli (Hirota et al., 1997, Hirota 
et al., 1999). On the other hand, Trx2 resides only in the mitochondrial 
compartment. Based on the findings obtained in this Chapter, it was proposed 
that AIF, once translocated into the cytosol, would interact with cytosolic 
Trx1.  
The AIF-Trx interaction was found to be abrogated under oxidative stress 
conditions achieved by several approaches, including (1) the administration of 
endogenous oxidants H2O2 and HOCl, (2) the siRNA-mediated TrxR1 
silencing that would lead to Trx oxidation, as well as (3) the administration of 
indirect pro-oxidants LPS and TNF-α. Such abrogation of protein-protein 
interaction under oxidative stress conditions reconciled with the findings that 
accumulation of oxidized Trx occurred under oxidizing conditions. 
Interestingly, the disturbed AIF-Trx interaction was observed to recover 
significantly when the oxidative stress was attenuated by either concurrent 
treatment of thiol antioxidant NAC or the addition of reducing agent β-ME. In 
addition, the disturbed AIF-Trx interaction was found to recover upon 




redox defense mechanism(s) in preserving the AIF-Trx interaction. Hence, 
based on the results obtained, we postulated the following cellular events: 
when AIF was released into the cytosol, it interacted with Trx1 in a redox-
dependent manner. Under oxidizing conditions, Trx1 became oxidized and the 
AIF-Trx complex dissociated. Once oxidative stress was alleviated upon 
antioxidant treatment or by oxidative stress recovery, reduced Trx1 was 
regenerated and interacted with AIF again.  
In summary, in this Chapter, a novel interaction between AIF and Trx1 was 
reported.  In general, reduced Trx is viewed upon as an anti-apoptotic protein 
and oxidized Trx is devoid of this activity. For example, reduced Trx1 is 
reported to inhibit ASK-1-mediated apoptosis induction. (Saitoh et al., 1998b) 
Therefore, based on the experimental findings presented in this Chapter that 
the AIF-Trx interaction was abolished under pro-apoptotic oxidative stress 
conditions, we postulated that the Trx redox system, through a physical 
association between Trx1 and AIF, would regulate AIF-dependent apoptosis 













Investigation of the possible functional significance of 















In Chapter 2, a novel interaction between AIF and Trx1 was reported. The 
AIF-Trx interaction was found to be redox-dependent; under pro-apoptotic 
oxidative stress conditions, the protein-protein interaction was abolished. It 
was therefore deduced that the physical association between AIF and Trx1 
would regulate AIF’s pro-apoptotic function.  
In this chapter, experiments were focused on elucidating the functional 
significance of the AIF-Trx interaction. Given that an earlier study had 
reported that HSP70 was involved in interacting with AIF in the cytosol so as 
to prevent nuclear translocation of AIF (Gurbuxani et al., 2003), it was 
postulated that Trx1 could play a similar role as HSP70. This hypothesis was 
therefore investigated. Secondly, given that Trx1 does translocate into the 
nucleus under oxidizing conditions (Hirota et al., 1999), it was hypothesized 
that nuclear Trx1 would play a role in modulating AIF-mediated DNA 















3.2 Materials and methods 
3.2.1 Materials 
Reagents  
Dulbecco’s modified eagle medium (DMEM), curcumin, diamide, 
dithiothreitol (DTT), methylnitronitrosoguanidine (MNNG), N-acetylcysteine 
(NAC), poly-L-lysine and propidium iodide (PI) were purchased from Sigma-
Aldrich (St Louis, MO, USA). Hydrogen peroxide (H2O2) and staurosporine 
(STS) was purchased from Calbiochem (La Jolla, CA, USA). Protease 
inhibitor cocktail was purchased from Roche (Mannheim, Germany). 
Ribonuclease A (RNase) was from MP biomedicals (Illkirch, France). Protein 
G sepharose beads were from GE Healthcare (Uppsala, Sweden). β-
mercaptoethanol (β-ME) was from Biorad laboratories (CA, USA). Z-VAD-
FMK was obtained from RD systems (Minneapolis, USA). SYBR Safe® was 
obtained from Invitrogen (Oregon, USA). 
Antibodies  
Mouse anti-AIF, mouse anti-HSP70, mouse anti-β-actin and goat anti-TrxR 
primary antibodies, and goat anti-mouse IgG-HRP, goat anti-rabbit IgG-HRP, 
mouse anti-goat IgG-HRP and goat anti-rat IgG-HRP secondary antibodies 
were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
Goat anti-Trx1 antibody was from IMCO Corporation (Stockholm, Sweden). 
Mouse Anti-FLAG M2 and mouse anti-α-tubulin antibodies were purchased 
from Sigma-Aldrich (St. Louis, CA, USA). Mouse anti-V5 antibody was 
purchased from Serotec Inc. (Kidlington, Oxford, UK). Rabbit anti-lamin A 
antibody was obtained from Cell Signaling Technology (Danvers, MA, USA). 
Mouse anti-cyclophilin A antibody (CypA) was purchased from Abcam 
(Cambridge, UK). Rabbit anti-H2AX antibody was from Novus Biological 
(Littleton, CO, USA). Goat anti-mouse IgG conjugated with Alexa Fluor®488 






The following mammalian expression plasmids constructed by Dr. Chew Eng 
Hui (Department of Pharmacy, National University of Singapore) were used 
for stable or transient transfections in experiments performed in this chapter. 
1) pcDNA3.1/hAIF(121-612)-FLAG [hAIF121-FLAG] 
2) pcDNA3.1/V5-Trx1 (V5-Trx1) 
3) pcDNA3.1/V5-Trx1C62SC69SC73S (V5-Trx1C62SC69SC73S) 
Recombinant proteins 
Recombinant His-hAIF121 (rHis-hAIF121) was expressed and purified in our 
laboratory as described in Section 2.2.6. Recombinant hTrx1 (rhTrx1) was 
obtained from IMCO Corporation (Stockholm, Sweden).  
3.2.2 Cell culture, transfection and treatment 
HEK293 and Hela cells were cultured as described in Section 2.2.2. Hela cells 
stably expressing hAIF121-FLAG were prepared and sub-cultured as 
mentioned in the following Section 3.2.3. HEK293 cells were seeded and upon 
reaching 40-50% confluency, they were transfected with one or more of the 
above mentioned mammalian expression plasmids for approximately 36 to 48 
h, followed by treatment with oxidizing agents as specified in the respective 
experiment. Hela cells stably expressing hAIF121-FLAG were seeded and 
upon reaching 40-50% confluency, they were transfected with one or more 
above mentioned mammalian expression plasmids for approximately 36 to 48 
h, followed by treatment with oxidants as indicated in the respective 
experiments.   
3.2.3 Stable expression of hAIF121-FLAG using Sleeping Beauty (SB)      
transposon system 
A DNA sequence coding for hAIF121-FLAG was sub-cloned into an entry 
vector pE1A (Invitrogen) from pcDNA3.1-hAIF121-FLAG using Kpn1 and 
Xba1 restriction sites. The ligation product was transformed into competent 




hAIF121-FLAG were selected on kanamycin LB agar plates. The hAIF121-
FLAG region in pE1A-hAIF121-FLAG flanked by recombination sites AttL1 
and AttL2 was shuttled into the expression vector (ITR-CAG-DEST-IRES-
Puromycin-ITR) at the DEST region flanked by restriction sites AttR1 and 
AttR2 through the LR gateway recombination reaction (Invitrogen). The 
recombination product was transformed into DH5α competent cells and the 
positive colonies containing recombined expression vector that possessed the 
expression cassette (CAG-DEST/GOI-IRES-Puromycin) were selected on 
ampicillin LB agar plates. The Sleeping Beauty SB100 expression vector is 
flanked by inverted terminal repeats (ITR) that mediates the retro transpose-
catalyzed stable integration of the desired gene into the genome. The 
expression vector and the Sleeping Beauty SB100 vector were co-transfected 
into Hela cells. After 48 h of transfection, the cells were allowed to grow in 
media containing puromycin (2.5 µg/ml) for 4-5 days. The surviving cells in 
media containing puromycin were collected and sub-cultured and the 
expression of stably transfected hAIF121-FLAG in Hela cells was confirmed 
by western blot analysis.          
3.2.4 SDS-PAGE and western blot analysis 
Whole cell lysates and immunoprecipitates were collected and subjected to 
SDS-PAGE and western blot analysis as described previously in Section 2.2.3. 
3.2.5 Co-immunoprecipitation 
The experimental procedure was performed as described previously in Section 
2.2.4.   
3.2.6 Nuclei isolation and extraction of nuclear proteins 
HEK293 or Hela cells cultured in 60-mm culture plates were harvested by 
trypsinization. The trypsinized cells were collected in ice cold PBS and 
pelleted by centrifugation at 1000 rpm, for 5 min a 4˚C. The cell pellets were 
suspended and incubated in 0.8 ml of nuclei isolation buffer A (10 mM 
HEPES pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 1 mM EGTA) containing freshly 




incubation with buffer A, the suspended cells were treated with the non-ionic 
detergent NP-40 (final concentration = 0.5%) and further incubated for 5-10 
min on ice bath with occasional shaking. The mixtures were centrifuged at 
1000 rpm for 1 min at 4˚C to sediment the unlysed cells and cell debris. The 
supernatant was centrifuged at 0.7 g for 10 min at 4˚C to pellet the suspended 
nuclei. The supernatant was collected as cytosolic extract, while the nuclear 
pellet was washed with 0.5 ml of nuclei isolation buffer A and finally 
suspended in 50-100 µl of nuclei isolation buffer B (25 mM HEPES pH 7.5, 
500 mM NaCl, 10 mM NaF, 5 mM MgCl2, 10% glycerol, 0.2% NP-40 and 1 
mM DTT), containing freshly added protease inhibitor cocktail. For the 
nuclear assay, the isolated nuclei were suspended in CFS buffer (220 mM 
mannitol, 68 mM sucrose, 2 mM NaCl, 2.5 mM KH2PO4, 0.5 mM EGTA, 2 
mM MgCl2, 5 mM pyruvate and 10 mM HEPES pH 7.2). To obtain nuclear 
extracts, the isolated nuclei were lysed in triton-X lysis buffer with 4-5 
pulsating sonication cycles. Nuclear lysates were prepared at 13000 rpm for 10 
min at 4˚C and the supernatant was used in protein content determination 
followed by western blot analysis. 
3.2.7 Immunocytochemistry 
Hela cells stably expressing hAIF121-FLAG were cultured on cover slips 
coated with poly-L-lysine in 6-well culture plates until 40-50% confluency, 
followed by being transfected with 2 µg of plasmid pcDNA3.1/V5-Trx1 per 
well. Transfected cells were allowed to grow until 80-90%, then treated or 
untreated with an appropriate reagent or compound as indicated in the 
respective experiments. Cells were washed with PBS, and fixed with 4% para-
formaldehyde in PBS for 15 min at room temperature. Fixed cells were 
washed with PBS containing 0.05% Tween (PBS-T) and permeabilized by 
treatment of 0.5% triton-X in PBS for 15-20 min, followed by blocking with 
5% horse serum in PBS-T for 1 h at 4˚C. These cells were incubated with the 
primary antibody against the protein of interest in PBS-T containing 1% horse 
serum for 2-3 h at 4˚C. The cells were then washed with PBS-T for 3 x 5 min 
and further incubated with secondary antibody conjugated to Alexa Fluor®488 




were mounted on glass slides using Vectashield mounting medium containing 
4’,6-diamidino-2-phenylindole (DAPI). Edges of cover slips were sealed to 
glass slides using nail paint enamel as transparent sealant. Microscopic images 
were obtained at 100X magnification using a Nikon Eclipse Ti-S 
epifluorescence microscope connected to a Nikon DS-Ril camera (Einst 
Technologies).  
In another experimental set up, an aliquot of a mixture of nuclei isolated from 
Hela cells was mounted onto a glass slide using Vectashield. The slides were 
visualized at 100X magnification using a Nikon Eclipse Ti-S epifluorescence 
microscope. To quantify nuclei with damaged nuclear morphology, results 
were expressed as a percentage of nuclei with damaged nuclear morphology 
over a total of 50 nuclei stained with DAPI in a number of spots taken 
randomly from the coverslips.      
 3.2.8 Agarose gel electrophoresis 
Solutions containing 2.5 µg of plasmid pcDNA3.1/Trx1-V5 were incubated in 
the presence or absence of rHis-hAIF121 (0.5 µM) and/or reduced or oxidized 
rhTrx1 (2.5 µM) at 37˚c for 1 h. The mixtures were mixed with 6x DNA 
loading dye and loaded onto a 1% agarose gel prepared with SYBR® Safe in 
TAE buffer. The contents were electrophoresed at 50-100 V for 1-2 h at room 
temperature. DNA bands resolved on the agarose gel were visualized by UV 
trans-illumination and gel images were captured on the Gel-Doc® instrument 
(Biorad).  
3.2.9 Flow cytometric analysis of DNA content 
Isolated Hela cells nuclei were analyzed for DNA content using flow 
cytometry. Isolated nuclei were obtained as described under Section 3.2.6 and 
suspended in CFS buffer. The nuclei were preincubated in the presence or 
absence of reduced or oxidized rhTrx1 (5 µM) for 30 min at 37˚C, followed by 
the addition of rHis-hAIF121 (final concentration 1 µM) for further incubation 
of 2 h at 37˚C. Following the incubation, the nuclei were then incubated with 
propidium iodide (50 µg/ml) for 30 min in the dark at 4°C. This nuclei 




flow cytometer. The results obtained from flow cytometer were analyzed 























3.3.1 Determination of the role of Trx in the nuclear translocation of AIF 
In an earlier finding, HSP70, a cytosolic protein was reported to interact and 
prevent the nuclear translocation of AIF (Gurbuxani et al., 2003). In this study, 
we hypothesized a similar role of Trx1 in antagonizing the nuclear 
translocation of AIF. To investigate this hypothesis, Hela cells stably 
expressing cytosolic hAIF121-FLAG were employed. Western blot and 
immunocytochemical analysis revealed that in addition to a large fraction of 
overexpressed cytosolic hAIF121-FLAG being retained within a cytosolic 
compartment, a substantial amount of overexpressed hAIF121-FLAG was 
observed to have translocated into the nucleus (Fig. 3.1A and 3.1B). The 
observations had therefore demonstrated that overexpressed cytosolic AIF 
could translocate into the nucleus under physiological conditions. As such, we 
had adopted these hAIF121-FLAG-overexpressing cells as a cell model that 
mimicked the circumstances of AIF nuclear translocation when a cell was 
undergoing apoptosis induced by an apoptotic stimulus. As depicted in Fig. 
3.2, the nuclear translocation of hAIF121-FLAG was inhibited by the co-
expression of redox active V5-Trx1. Furthermore, in an in vitro experiment 
involving co-incubation of freshly isolated nuclei from Hela cells with His-
hAIF121 and hTrx1 recombinant proteins, it was observed that reduced Trx 
was able to restrict the uptake of rHis-hAIF121 into the isolated nuclei while 
oxidized Trx failed to do so (Fig. 3.3). Taken together, the results had 
suggested that redox active Trx possibly played the role of antagonizing 





Figure 3.1 Cytosolic and nuclear localization of hAIF121-FLAG in Hela cells 
stably expressing hAIF121-FLAG under physiological conditions. (A) Hela cells 
stably expressing hAIF121-FLAG were harvested and the cytosolic and nuclear 
extracts were prepared. The collected cytosolic and nuclear extracts were subjected to 
SDS-PAGE and western blot analysis for hAIF121-FLAG, α-tubulin (cytosol marker) 
and lamin A (nuclei marker). (B) Hela cells stably expressing hAIF121-FLAG were 
analyzed for cytosolic and nuclear localization of hAIF121-FLAG by 







Figure 3.2 Impeded nuclear translocation of cytosolic hAIF121-FLAG in Hela 
cells overexpressing V5-Trx1. Hela cells stably expressing hAIF121-FLAG were 
transiently co-transfected with V5-Trx1 plasmid. The transfected cells were then 
subjected to (A) western blot analysis of the cytosolic and nuclear extracts and (B) 
immunocytochemical analysis.  
 
  
Figure 3.3 Impeded uptake of recombinant His-hAIF121 protein into isolated 
nuclei of Hela cells by reduced form of recombinant hTrx1. Nuclei freshly 
isolated from Hela cells were suspended in CFS buffer containing 1 µM of rHis-
hAIF121 and 5 µM of rhTrx1, with or without 5 mM DTT and the mixture was 
incubated at 37˚C for 15 min. The nuclei were collected by centrifugation, lysed in 
lysis buffer and the nuclear lysates were subjected to SDS-PAGE and western blot 




3.3.2 Investigation of a redox-dependent nuclear translocation of AIF and 
its regulation by Trx redox system 
Based on the results presented in Section 3.3.1, where it was observed that 
redox-active Trx1 could impede the nuclear translocation of hAIF121-FLAG, 
we further proposed that the regulation of nuclear translocation of AIF was 
dependent on the cellular redox conditions. In Chapter 2, it was found that the 
AIF-Trx interaction was dependent on the redox status of Trx1 and was 
abrogated under oxidative stress conditions. Here we were interested to study 
how oxidative stress conditions would affect the cytosolic-nuclear 
translocation of AIF in relation to the AIF-Trx interaction. Hela cells stably 
expressing hAIF121-FLAG were treated with oxidants H2O2 (2 mM) or 
diamide (1 mM) in the presence or absence of antioxidant NAC (5 mM). As 
shown in Fig. 3.4A, the AIF-Trx interaction in the cells was disrupted upon 
H2O2 or diamide treatment, which was reversed by the concurrent addition of 
antioxidant NAC. Western blot analysis of the nuclear extracts (Fig. 3.4B), as 
well as immunocytochemical analysis of the treated cells (Fig. 3.4C) revealed 
that nuclear translocation of hAIF121-FLAG coincided with disrupted AIF-
Trx interaction. On the other hand, reversal of AIF-Trx interaction achieved 
by NAC-mediated alleviation of oxidative stress brought about undisrupted 
AIF-Trx interaction that corresponded to dominant cytosolic localization of 
AIF (Fig. 3.4B and C). In another experiment, instead of using oxidants to 
induce oxidative stress that would lead to Trx oxidation, compounds such as 
curcumin and cinnamaldehyde analogue 2-benzoyloxycinnamldehyde (BCA; 
structure as shown in Appendix І) that were previously found to inhibit TrxR 
(Fang et al., 2005, Chew et al., 2010), which would supposedly lead to Trx 
oxidation, were used. Interestingly, the disrupted AIF-Trx interaction caused 
by curcumin (40 µM) or BCA (40 µM) treatment was not reversed by the 
concurrent addition of NAC (Fig. 3.5A). Immunocytochemical analysis of the 
treated cells indeed showed that NAC treatment failed to block nuclear 
translocation of AIF (Fig. 3.5B). The possible reason for the difference in the 
effects produced by NAC in the former and latter experiment could lie in the 
different nature of the agents employed to disrupt the AIF-Trx interaction. In 




neutralizing H2O2 and diamide, while for the latter experiment, NAC not able 
to alleviate Trx oxidation caused by specific inhibition of the enzyme TrxR 
that reduces Trx. Nonetheless, both experiments had revealed that nuclear 
translocation of AIF appeared to be dependent on the AIF-Trx interaction; 
when AIF was bound to Trx1, it was retained in the cytosol whereas when the 
protein-protein interaction was disrupted, AIF nuclear localization happened.   
 
Figure 3.4 Disruption of AIF-Trx interaction and nuclear translocation of AIF 
under oxidative stress conditions. Hela cells co-expressing hAIF121-FLAG and 
Trx1-V5 were treated with 2 mM H2O2 or 1 mM diamide in the presence or absence 
of 5 mM NAC for 8 h. They were next subjected to (A) immunoprecipitation reaction 
to determine the AIF-Trx interaction, (B) western blot analysis of the nuclear extract 





Figure 3.5 Disruption of AIF-Trx interaction and nuclear translocation of AIF 
mediated by TrxR inhibitors curcumin and BCA. Hela cells co-expressing 
hAIF121-FLAG and Trx1-V5 were treated with 40 µM curcumin or BCA in the 
presence or absence of 5 mM NAC for 12 h. They were next subjected to (A) 
immunoprecipitation reaction to determine the AIF-Trx interaction and (B) 
immunocytochemical analysis.    
 
3.3.3 Investigation of a possible role of nuclear Trx in perturbing AIF-
dependent DNA-degradosome formation and preventing AIF-mediated 
DNA damage  
Under the influence of abnormal physiological conditions, Trx1 translocates 
from cytosol to nucleus where it is reported to impart cytoprotective effects 
through its disulfide reductase activity or by interactions with other proteins 
(Hirota et al., 1997, Okamoto et al., 1998, Hirota et al., 1999). In agreement 




AIF and Trx1 were observed to translocate to the nucleus in untransfected 
HEK293 cells subjected to oxidative stress upon treatment with diamide (1 
and 3 mM) for 1h (Fig. 3.6). As we had learnt from experimental findings 
presented in Section 2.3.4, Chapter 2, that the AIF-Trx interaction was 
disrupted under oxidative stress conditions, we further hypothesized here that 
nuclear Trx1 could modulate AIF-mediated DNA damaging effects. To 
investigate this hypothesis, several experimental approaches were conducted. 
Firstly, based on earlier studies by Cande et al. (2004) and Artus et al. (2010) 
that reported the association of AIF with CypA and H2AX in the nucleus to 
form the DNA degradosome complex, which would bind to nuclear DNA and 
induce chromatin condensation and large scale DNA fragmentation in 
apoptotic cells, nuclear Trx1 was proposed to hinder the binding of CypA and 
H2AX with AIF. In the experiment, 2 mM H2O2 treatment for 2 h was 
employed to induce oxidative stress and apoptosis. As shown in Fig. 3.7, in 
HEK293 cells untreated with H2O2, AIF-Trx interaction was detected while 
there was little and no co-immunoprecipitated CypA and H2AX respectively. 
In contrast, upon treatment with H2O2, CypA and H2AX were found to be co-
immunoprecipitated along with hAIF121-FLAG, but AIF-Trx interaction was 
abrogated. The results therefore suggested that Trx1 possibly played a role in 
blocking the interaction between AIF and CypA and H2AX, which in turn 
would hinder the interaction of the AIF-CypA-H2AX DNA degradosome 
complex with DNA. This led us to move on to investigate the possible effect 
Trx1 would have on the interaction between AIF and DNA. Initially, the 
interaction between recombinant His-hAIF121 and reduced or oxidized hTrx1 
proteins was investigated in a pull-down assay. As shown in Fig. 3.8A, rHis-
hAIF121 was found to interact with reduced rhTrx1, but no interaction 
between rHis-hAIF121 and oxidized rhTrx1 was observed. Furthermore, in an 
in vitro experiment, rHis-hAIF121 protein (0.5 µM) and circular plasmid 
DNA pcDNA3.1/Trx1-V5 (2.5 µg) were allowed to interact in the presence or 
absence of reduced or oxidized rhTrx1 (2.5 µM) and the mobility of the DNA 
was examined using agarose gel electrophoresis. As depicted in Fig. 3.8B, co-
incubation with recombinant His-hAIF121 alone brought about retarded DNA 
mobility that was partially alleviated in the presence of reduced hTrx1 




reversal effect on retardation of DNA mobility caused by AIF (Fig. 3.8B). The 
results had therefore suggested that the reduced form of Trx1 had prevented 
the interaction between AIF and DNA that had possibly led to the partial 
reversal of AIF-mediated retardation of DNA mobility.    
 
Figure 3.6 Nuclear translocation of AIF and Trx1 under oxidative stress 
conditions induced by diamide treatment. HEK293 cells were treated with 1 mM 
or 3 mM of diamide for 1 h. Cytosolic and nuclear extracts were obtained and 
subjected to SDS-PAGE, followed by western blot analysis. 
 
 
Figure 3.7 AIF-CypA and AIF-H2AX interactions under oxidative stress 
conditions. HEK2393 cells were co-transfected with hAIF121-FLAG and Trx1-V5 
for 48 h, followed by treatment of 2 mM H2O2 for 2 h. Whole cell lysates were 
collected and subjected to immunoprecipitation reactions using anti-FLAG M2 
antibody. The collected lysates and immunoprecipitates were further resolved by 






Figure 3.8 Modulating effect of Trx1 on retardation of rHis-hAIF121-mediated 
electrophoretic mobility of DNA. The oxidized hTrx1 recombinant protein was 
reduced by treatment with 10 mM DTT for 15 min and the reduced rhTrx1 was 
desalted by passing through NAP-5 column. (A) His-hAIF121 recombinant protein (1 
µM) and reduced or oxidized form of hTrx1 recombinant protein (5 µM) were co-
incubated in PBS buffer at 37˚C for 1 h followed by Trx1 pull-down using anti-Trx1 
antibody. The pulled-down proteins were resolved by SDS-PAGE and detected by 
western blot analysis. (B) Recombinant His-hAIF121 (1 µM) and reduced or oxidized 
rhTrx1 (5 µM) were incubated in PBS buffer at 37°C for 1 h. The mixtures and rHis-
hAIF121 (1 µM) only sample were further incubated with supercoiled circular DNA 
plasmid pcDNA3.1/Trx1-V5 (1 µg) at 37˚C for 1 h. All the samples were 




To further investigate the postulation that nuclear Trx1 could modulate AIF-
mediated DNA damaging effects, we moved on to examine whether Trx1 
could attenuate nuclear DNA damage induced by translocated AIF. To this 
end, the experiment was conducted in a cell-free system involving isolated 
nuclei from Hela cells preincubated with reduced or oxidized recombinant 
hTrx1 for 30 min to allow sufficient protein uptake, followed by addition of 
recombinant His-hAIF121. Damage conferred to isolated nuclei was 
determined by assessing the nuclear morphology of the DAPI-stained nuclei 
under fluorescence microscopy, as well as the extent of nuclei disintegration 
using flow cytometric analysis.  As shown in Fig. 3.9A, nuclei incubated with 
rHis-hAIF121 displayed distorted morphology; the nuclei looked shrunken, 
lacked a clearly defined nuclear membrane and DAPI-stained nucleic acid 
content appeared condensed and fragmented. Pre-treatment of nuclei with 
reduced rhTrx1, but not oxidized rhTrx1, was able to reverse the distorted 
nuclear morphology brought about by rHis-hAIF121 (Fig. 3.9A). 
Quantification of nuclei with distorted morphology in each treatment group 
indeed revealed a statistically significant reduction in the amount of AIF-
mediated damaged nuclei in the group receiving pre-treatment of reduced 
rhTrx1 (Fig. 3.9B). When the DNA content in these nuclei was analyzed by 
flow cytometry, it was found that nuclei incubated with rHis-hAIF121 
contained around 47% of DNA content in the sub-G1 phase (Fig. 3.10A and 
B). Apparently, the percentage of nuclei in sub-G1 phase was reduced 
significantly upon pre-incubating the nuclei with reduced rhTrx1 (Fig. 3.10A 
and B). Taken together, results obtained from fluorescence microscopic 
observations and flow cytometry had indicated that Trx1 in its reduced form 






Figure 3.9 Effect of recombinant His-hAIF121 on the nuclear morphology of 
isolated nuclei pre-treated with reduced or oxidized form of recombinant hTrx1. 
Nuclei isolated from Hela cells were pre-incubated with 5 µM of rhTrx1 (reduced or 
oxidized) in CFS buffer for 30 min; followed by addition of rHis-hAIF121 to a final 
concentration of 1 µM. The mixture was incubated at 37°C for 2 h, after which an 
aliquot of the mixture was mounted onto a glass slide using Vectashield mounting 
medium containing DAPI. The slides were viewed immediately on the Eclipse Ti-
Nikon fluorescence microscope. (A) Representative fluorescence microscopic images 
depicting the nuclear morphology of nuclei in each treatment group were shown. (B) 
Bar graph showing percentage of number of damaged nuclei observed under 
microscope at various randomly selected spots on each coverslip. Data points are 
means ± SD (n = 3). * indicates p < 0.05 versus rHis-hAIF121 treatment group; ns 






Figure 3.10 Effect of recombinant His-hAIF121 on the extent of DNA damage 
rendered to isolated nuclei pre-treated with reduced or oxidized form of 
recombinant hTrx1. Nuclei isolated from Hela cells were pre-incubated with 5 µM 
of rhTrx1 (reduced or oxidized) in CFS buffer for 30 min, followed by addition of 
rHis-hAIF121 to a final concentration of 1 µM and the mixture was incubated at 37°C 
for 2 h. To the above incubated mixture, propidium iodide (final concentration 50 
µg/ml) was added and the mixture was further incubated for 30 min at 4°C in dark, 
followed by analysis of DNA content using flow cytometry. (A) Representative 
histograms showing percentage DNA content of nuclei in each treatment group in 
Sub-G1 phase were shown. (B) Bar graph showing percentage hyploploidy (% DNA 
content in Sub-G1 phase) of nuclei in each treatment group. Data points are means ± 
SD (n = 3). * indicates p < 0.05 versus rHis-hAIF121 treatment group; # indicates p < 





Apoptosis is a fundamental biological process in which old and damaged cells 
commit suicide under endogenous or exogenous apoptotic stimuli. Under 
physiological conditions, apoptosis is tightly regulated by various proteins in 
order to maintain cellular homeostasis (Sato et al., 1995, Tsujimoto and 
Shimizu, 2000, Ueda et al., 2002). AIF is a mitochondrial caspase-independent 
cell death activator; upon application of an appropriate stimulus, AIF 
translocates from the mitochondria through the cytosol into the nucleus and 
induces chromatin condensation and large scale DNA fragmentation (Susin et 
al., 1999). Although this apoptotic event is reported to occur under oxidative 
stress (Colo et al., 2008, Son et al., 2009), the redox regulation of this process 
has not been studied extensively and remains to be elucidated. Research work 
carried out in this chapter was therefore focused on elucidating the functional 
significance of the AIF-Trx interaction. On the basis that Trx is a known redox 
protein involved in redox homeostasis, the findings would provide better 
understanding of the molecular events involved in apoptosis induction caused 
by oxidative stress.   
To investigate the hypothesis that Trx1 could antagonize the nuclear 
translocation of AIF, a Hela cell line stably expressing cytosolic hAIF121-
FLAG was generated. This cell line, which had overexpressed hAIF121-
FLAG localized in both the cytosol and nucleus under physiological 
conditions, was employed as the main cell model in most of the experiments 
carried out in this chapter. The co-expression of Trx1-V5 was observed to 
antagonize nuclear localization of cytosolic AIF. However, the blocked 
nuclear translocation of hAIF121-FLAG by co-overexpression of Trx1-V5 
was reversed under oxidizing conditions, which occurred along with a 
disrupted AIF-Trx interaction. We had demonstrated in Chapter 2 that under 
oxidative stress, a large fraction of Trx1 was oxidized and the AIF-Trx1 
complex was dissociated. Therefore, the inhibition of nuclear translocation of 
AIF by reduced Trx1 had underpinned the significance of a redox-dependent 
interaction between AIF and Trx1 that would in turn bring about regulation of 




In times of oxidative stress, Trx1 has been reported to translocate into the 
nucleus, where depending on its thiol redox state, it modulates biological 
processes such as the transcriptional activity of AP-1 and NF-κB (Hirota et al., 
1997, Okamoto et al., 1998, Hirota et al., 1999). In agreement with the 
reported findings, we also observed the nuclear translocation of Trx1 in the 
experiments using oxidant diamide to induce oxidative stress. On the basis that 
both Trx1 and AIF were co-localized in the nucleus under such pro-apoptotic 
oxidizing conditions, we next investigated whether nuclear Trx1 could 
modulate AIF-mediated DNA damaging effects. AIF is devoid of 
endonuclease activity and hence is unable to induce significant DNA damage. 
Endonuclease CypA is reported to bind to AIF and induces DNA damage 
(Cande et al., 2004a). In addition to CypA, histone protein H2AX is also 
required for mediating AIF-dependent DNA damage. In the study, 
phosphorylated H2AX was found to bind with AIF at the point of DNA 
double strand break (DSB), after which DNA damage could take place (Artus 
et al., 2010). AIF, CypA and H2AX together therefore form the DNA-
degradosome complex (Baritaud et al., 2010). Our experimental findings had 
shown that under physiological conditions, the AIF-Trx interaction had existed 
while no interaction between AIF, CypA and H2AX was detected. However, 
under oxidizing conditions, the reverse was observed. The results, though not 
proving direct evidence, seemed to suggest that Trx1 might be involved in 
hindering the formation of the AIF-CypA-H2AX DNA degradosome complex. 
To ascertain whether nuclear Trx1 indeed participated in blocking the 
interaction between AIF and CypA and H2AX, co-immunoprecipitation 
reactions would need to be carried out using nuclear extracts instead of whole 
cell lysates. To the time this PhD thesis was prepared and submitted, 
experimental conditions to perform these reactions had yet to be optimized. As 
such, these experiments shall be pursued in the future work. To investigate 
whether Trx1 could play a possible role in hindering the interaction between 
the DNA degradosome complex with DNA, the effect of Trx1 on the 
interaction between AIF and DNA was examined in vitro. It was then found 
that reduced form of Trx1, but not oxidized Trx1 was able to alleviate AIF-
mediated retardation of electrophoretic mobility of DNA. In addition, 




recombinant cytosolic AIF (rHis-AIF121) protein taken up into isolated nuclei 
from Hela cells had revealed that reduced rhTrx1 was capable of attenuating 
DNA damage induced by AIF.  
In summary, experimental results presented in this chapter had provided 
evidence suggesting that cytosolic Trx1 in its reduced state brought about 
antagonism of the nuclear translocation of AIF. When localized in the nucleus, 
nuclear Trx1 in its reduced form was capable of attenuating AIF’s DNA 




























Redox sensitivity of AIF to oxidative stress and its 















As reviewed in Chapter 1, ROS are known to induce oxidative modifications 
in several redox-sensitive proteins. These proteins usually undergo thiol 
oxidative modifications such as S-nitrosylation, S-glutathionylation and 
disulfide bond formation, which can affect their cellular functions. On the 
other hand, thiol redox defense systems such as the GSH and Trx systems are 
involved in reversing the oxidative modification in cellular proteins so as to 
achieve redox homeostasis. In Chapter 3, the possible involvement of Trx1 in 
regulating AIF-mediated apoptosis induced by oxidative stress was 
investigated. However, being a protein that contains three cysteine residues 
and has been reported to possess oxidoreductase activity in the mitochondria 
(Daugas et al., 2000, Miramar et al., 2001), AIF might be susceptible to 
modifications in times of oxidative stress. However, the redox sensitivity of 
AIF had remained largely unknown.   
In this chapter, we investigated the redox sensitivity of AIF and the possible 
involvement of the thiol redox defense systems in regulating any oxidative 
modifications rendered to the AIF protein. It was hypothesized that under 
oxidative stress, AIF could undergo intra- and/or inter-molecular disulfide 
bond formation and the GSH and Trx systems were proposed to reverse such 
reactions. Initially, the susceptibility of AIF’s cysteines to oxidative reactions 
was confirmed by the use of a cysteine cross-linker, bis-maleimide hexane 
(BMH). Under oxidizing conditions, AIF was found to become oxidized with 
formation of an intramolecular disulfide bond between Cys255 and Cys440. 
Subsequent experiments performed then demonstrated that the GSH and Trx 








4.2 Materials and methods 
4.2.1 Materials 
Reagents 
Dulbecco’s modified eagle medium (DMEM), Bis-maleimide hexane (BMH), 
diamide, reduced glutathione (GSH), buthionine sulfoximine (BSO), 5,5'-
dithiobis-(2-nitrobenzoic acid) (DTNB), 5-sulfosalicylic acid, reduced 
nicotinamide adenine dinucleotide (NADH) and dithiothreitol (DTT) were 
purchased from Sigma-Aldrich  (St Louis, MO, USA). Nicotinamide adenine 
dinucleotide phosphate (NADPH) and H2O2 were obtained from Calbiochem 
(La Jolla, CA, USA). Flavin adenine dinucleotide (FAD) was purchased from 
Alfa Aesar (UK). β-mercaptoethanol (β-ME) was from Biorad laboratories 
(CA, USA). 
Antibodies  
Mouse anti-AIF, mouse anti-β-actin and goat anti-TrxR primary antibodies, 
and goat anti-mouse IgG-HRP, goat anti-rabbit IgG-HRP, mouse anti-goat 
IgG-HRP and goat anti-rat IgG-HRP secondary antibodies were purchased 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Mouse Anti-
FLAG M2 antibodies were purchased from Sigma-Aldrich (St. Louis, CA, 
USA). Mouse anti-V5 antibody was purchased from Serotec Inc. (Kidlington, 
Oxford, UK). Goat anti-mouse IgG conjugated with Alexa Fluor®488 was 
obtained from Invitrogen (Oregon, USA). 
Plasmids 
The following mammalian expression plasmids constructed by Dr. Chew Eng 
Hui (Department of Pharmacy, National University of Singapore) were used 
for transfections in experiments performed in this chapter. 
1) pcDNA3.1/mAIF(101-612)-FLAG [mAIF101-FLAG] 
2) pcDNA3.1/mAIF(101-612)C255S-FLAG [mAIF101C255S-FLAG] 
3) pcDNA3.1/mAIF(101-612)C316S-FLAG [mAIF101C316-FLAG] 










8) pcDNA3.1/mAIF(101-612)C255SC316SC440S-FLAG  
[mAIF101-FLAGallcysmt] 
9) pcDNA3.1/mAIF(FL)-V5 [mAIF(FL)-V5] 
10) pcDNA3.1/mAIF(FL)C255SC316SC440S-V5     
[mAIF(FL)-V5allcysmt] 
Recombinant proteins 
Recombinant hAIF121 and hAIF121C256SC317SC441S proteins tagged with 
6X-His at the N-terminus were expressed and purified in our laboratory. 
Details of preparation and purification procedures were as described in Section 
2.2.6. 
4.2.2 Cell culture, transfection and treatment 
HEK293 and COS-1 (African green monkey kidney fibroblast-like cells) cells 
were cultured in a high glucose DMEM supplemented with 10% FBS, 100 
U/ml penicillin-streptomycin and 1 mM of sodium pyruvate at 37˚C in a 5% 
CO2 humidified incubator. Cells were cultured to 40-50% of cell confluency 
and transfected with mammalian expression plasmids for 24-48 h. Transfected 
and untransfected cells were treated with oxidizing agents and/or other 
reagents as specified under respective experiments. 
4.2.3 Reducing and non-reducing SDS-PAGE 
The experimental procedure used for reducing SDS-PAGE was as described 
previously in Section 2.2.3. The experimental procedure used for non-reducing 
SDS-PAGE was similar in principle to that employed in reducing SDS-PAGE, 




4.2.4 Immunoprecipitation  
Immunoprecipitation reactions were performed as described previously in 
Section 2.2.4.   
4.2.5 Western blot analysis 
Following resolution of proteins in cell lysates by reducing or non-reducing 
SDS-PAGE, western blot analysis was performed. The procedure was as 
described in Section 2.2.3.  
4.2.6 GSH determination assay 
GSH determination assay was performed as described previously by Tietze, 
1969. Briefly, total GSH either extracted from cells or obtained commercially, 
along with GR and NADPH, was mixed with DTNB. In this mixture, the 
reduction of DTNB caused by reduced GSH was registered as the absorbance 
at 412 nm. The increase in absorbance at 412 nm was taken to be directly 
proportional to the amount of GSH present in the mixture. HEK293 cells were 
cultured in 60-mm culture plates until 90-100% of cell confluency. Following 
drug treatment as specified in the respective experiments, cells were harvested 
and pelleted by centrifugation at 1000 rpm for 5 min. The cell pellets were 
treated with 500 µl of 3% 5-sulfosalicylic acid in PBS to precipitate proteins. 
The mixtures were centrifuged at 13,000 rpm for 10 min and the protein-free 
supernatant was collected and used for the GSH determination assay. Initially, 
a standard curve of GSH (0-10 µM) versus increase in absorbance at 412 nm 
caused by reduction of DTNB was prepared. Appropriate volumes of 
supernatants extracted from HEK293 cells were mixed with DTNB (final 
concentration 0.6 µM), yeastGR (final concentration 10 µg/ml) and NADPH 
(final concentration 200 µM) and the absorbance at 412 nm was measured for 
10 min at room temperature. The unknown concentration of GSH in the 






 4.2.7 NADH oxidase assay 
NADH oxidase assay was performed for recombinant His-hAIF121 proteins. 
The purified rHis-hAIF121 (1-5 µM) were mixed with 500 µM NADH and 30 
µM FAD in 50 mM sodium phosphate buffer (pH 6.5 to 7.5), followed by 
measuring the decrease in absorbance of NADH at 340 nm for up to 30 min at 
room temperature.    
4.2.8 Immunocytochemistry 
COS-1 cells were used for immunocytochemical analysis of nuclear 
localization of transiently expressed mAIF(FL)-V5 proteins. The experimental 
procedure used for immunocytochemistry was previously described in Section 
3.2.7. 
4.2.9 Statistical analysis 
Student’s t-test was performed to analyze the significance(s) between groups 















4.3.1 Determination of thiol reactivity of cysteines in AIF  
The full length human and mouse AIF protein possesses three cysteine 
residues at position 256, 317 and 441, and 255, 316 and 440 respectively. 
Given that AIF has been reported to possess oxidoreductase activity in the 
mitochondria (Daugas et al., 2000, Miramar et al., 2001), it was postulated that 
AIF was sensitive to the cellular redox state and oxidative stress-induced thiol 
oxidative modification could occur to AIF. As an initial attempt to test the 
hypothesis, the susceptibility of the cysteines in AIF to be cross-linked by a 
cysteine cross-linker BMH was examined. Fresh cell lysates of HEK293 cells 
expressing mAIF101-FLAG were treated with BMH (200 µM) at room 
temperature, and FLAG immunoprecipitation reactions were performed. As 
shown in Fig. 4.1, on the coomassie blue-stained gel, two slow migrating 
bands of cross-linked proteins were observed in the immunoprecipitates 
obtained from the lysates treated with BMH. The presence of cross-linked 
proteins had therefore suggested that the cysteines in AIF were reactive and 
could participate in cross-linking reactions to form intramolecular disulfides, 
or intermolecular disulfides with either another AIF molecule or another thiol-
containing protein or molecule such as GSH.  
 
Figure 4.1 Susceptibility of cysteines in AIF for cross-linking by BMH. HEK293 
cells were transfected with plasmid expressing mAIF101-FLAG for 48 h and the 
lysates were collected in triton-X lysis buffer. Fresh lysates were treated with 200 µM 




immunoprecipitation reactions using anti-FLAG M2 antibody. Immunoprecipitates 
were collected and subjected to SDS-PAGE and coomassie blue staining.   
In view that there lied a possibility that cysteines within an AIF monomer 
were engaged in intramolecular disulfide formation, lysates of HEK293 cells 
were collected in triton-X lysis buffer with or without cysteine alkylating 
agent IAA. The lysates were next frozen at -20°C for at least 24 h, which 
would render oxidizing conditions that could promote oxidation of proteins. 
Upon thawing, the IAA-free lysates were treated or untreated with reducing 
agent β-ME. The samples were next resolved on a non-reducing SDS-
polyacrylamide gel, followed by western blot analysis. As depicted in Fig. 4.2, 
in the lane containing frozen lysates containing IAA (lane 1), AIF migrated as 
a single band, whereas in the lane containing frozen lysates without IAA (lane 
2), AIF migrated as two separate bands. The lower band of AIF appeared in 
the same position as the AIF band that appeared in lane 1, to which from now 
it would be referred to as “reduced AIF”. The upper AIF band that had 
appeared exclusively in lane 2 was likely an oxidized form of the protein, 
which from now would be referred as “oxidized AIF”. The results had 
indicated that the oxidized species of AIF were formed involving cysteines, 
thiol group blocker IAA was present in the lysates prior to freezing, oxidized 
AIF had not appeared. In addition, as evident from its absence in the lane 
containing IAA-free frozen lysates that were reduced by β-ME upon thawing, 
the upper slow migrating oxidized AIF likely contained an intra- or inter-
molecular disulfide bond (Fig. 4.2).   
 
Figure 4.2 Evidence of oxidized species of AIF formed by disulfide bond 
formation. HEK293 cell lysates were collected in triton-X lysis buffer with or 
without 20 mM IAA and stored at -20˚C for more than 24 h. A fraction of frozen 
lysates collected in lysis buffer without IAA were treated with 5% (v/v) β-ME for 10 





Besides natural oxidizing conditions (in the presence of molecular O2 in 
frozen lysates), AIF oxidation occurring through disulfide bond formation was 
observed to occur in HEK293 cells treated with oxidants H2O2 and diamide. 
Treatment of HEK293 cells with H2O2 and diamide (0.5 to 10 mM) for 10 min 
produced oxidative stress that led to formation of oxidized AIF (Fig. 4.3A and 
B). Similar to observations made in Fig. 4.2, the slower migrating oxidized 
AIF band disappeared upon treatment with β-ME (Fig. 4.3A and B). To 
further investigate whether the disulfide(s) in oxidized AIF was/were of intra- 
or inter-molecular in nature, we repeated the experiment using recombinant 
His-hAIF121 protein. Aliquots of purified rHis-hAIF121 (1 µM) protein were 
incubated with H2O2 (2 mM) or diamide (2 mM) for 5 min, and the protein 
samples were resolved by non-reducing or reducing SDS-PAGE, followed by 
coomassie blue staining of the gel. As shown in 4.3C, formation of the upper 
band of oxidized AIF was observed in protein aliquots treated with H2O2 or 
diamide, which again disappeared when reducing agent β-ME was present. 
Given that there were no other types of proteins in this in vitro experiment, 
and that the upper AIF band had appeared at around 70 kDa that would rule 
out the presence of AIF dimer (molecular weight would be ~110 kDa), it was 
therefore surmised that an intramolecular disulfide existed in oxidized AIF. In 
summary, the results demonstrated the redox sensitivity of the cysteines in 
AIF; under oxidizing conditions, an oxidized AIF species containing an 





Figure 4.3 Intramolecular disulfide bond formation in AIF under oxidative 
stress conditions caused by H2O2 and diamide. HEK293 cells were treated dose-
dependently with (A) H2O2 and (B) diamide for 10 min and the lysates were collected 
in triton-X lysis buffer containing 20 mM IAA. A fraction of lysates from cells 
treated with 10 mM H2O2 or diamide was treated with 5% (v/v) β-ME. Lysates were 
then subjected to non-reducing SDS-PAGE and western blot analysis. (C) Purified 
rHis-hAIF121 protein was first reduced by treatment with 10 mM DTT for 10 min 
and excess DTT was desalted using NAP-5 columns. The reduced purified rHis-
hAIF121 (1 µM) were treated with H2O2 (2 mM) or diamide (2 mM) for 5 min, 
followed by being resolved on reducing and non-reducing SDS-polyacrylamide gels 
and gels were subsequently stained by coomassie blue. 
 
4.3.2 Elucidation of cysteines involved in disulfide bond formation in AIF 
Having found that oxidizing conditions caused AIF oxidation with an 
intramolecular disulfide found within the AIF monomer, we moved on to 
identify the cysteines residues involved in disulfide bond formation. Single, 
double and triple cysteine mutants of cytosolic mouse AIF, mAIF101-FLAG 
were created and western blotting of frozen lysates of transfected HEK293 
cells ran under non-reducing conditions showed that mutation of Cys316 
resulted in increased formation of the oxidized AIF band at around 70 kDa 
while the other single cysteine mutants (C255S and C440S), as well as all 
double and triple cysteine mutants failed to give rise to this oxidized AIF 




with different cysteine mutants of mAIF101-FLAG were treated with 1 mM 
diamide and lysates collected were resolved by non-reducing SDS-PAGE, 
observations made were similar to those obtained for frozen lysates (Fig. 
4.4B). It was noteworthy that another slow migrating AIF band of around 60 
kDa observed for mAIF101-FLAG and mAIF101C255S-FLAG was not 
physiologically relevant since a similar band was not observed for endogenous 
AIF and rHis-hAIF121 (Fig. 4.4A and B). As such, the results obtained had 
indicated that the intramolecular disulfide was formed between Cys255 and 
Cys440 of mAIF101-FLAG.  
 
Figure 4.4 Determination of cysteines involved in intramolecular disulfide bond 
formation in AIF. HEK293 cells were transfected with 1.5 µg of plasmids 
expressing mAIF101-FLAG and its various cysteine mutants for 48 h. (A) Lysates 
were collected and frozen for more than 24 h, and thawed lysates were resolved by 
non-reducing SDS-PAGE, followed by western blot analysis. (B) Following 48 h of 
transfection, transfected cells were treated with 1 mM diamide for 10 min and lysates 
were collected in triton-X lysis buffer containing 20 mM IAA. The collected lysates 
were subjected to non-reducing SDS-PAGE, followed by western blot analysis to 





4.3.3 Time-chase study of AIF oxidation in times of acute oxidative stress  
To study the onset and changes in the redox state of AIF upon application of 
oxidizing conditions, a time-chase experiment that involved treatment of 
HEK293 cells with 1 mM diamide for 5, 15, 30, 60 and 120 min was carried 
out. At each timepoint, the cells were harvested and the lysates were collected 
in lysis buffer containing IAA. The lysates were subjected to non-reducing 
SDS-PAGE and western blot analysis. It was observed that oxidation of AIF 
occurred immediately within 5 min of diamide treatment. Oxidizing conditions 
at the start of the time-chase experiment was likely to be the strongest, as 
oxidized AIF had appeared as most intense at 5 min and gradually decreased 
in intensity along subsequent timepoints and disappeared by around 60-90 min 
(Fig. 4.5A). The results seemed to suggest that AIF oxidation could be 
reversed. In another experiment, HEK293 cells were treated with 1 mM 
diamide for 5 min, followed by replacement of medium containing diamide 
with fresh culture medium. Doing so would be indicative of the removal of an 
oxidant to allow cells to recover from an oxidative stress insult. Western blot 
analysis showed that AIF oxidation had completely recovered as soon as the 
presence of oxidant was removed. Taken together, the results had agreed with 
those obtained in Chapter 2, Section 2.3.4 (Fig. 2.12A); cellular redox defense 





Figure 4.5 Time-dependent changes in the redox state of AIF under oxidizing 
conditions and upon removal of oxidative stress. (A) HEK293 cells were treated 
with 1 mM diamide and the cells were harvested at indicated timepoints. Lysates 
were collected in triton-X lysis buffer containing 20 mM IAA and subjected to 
reducing and non-reducing SDS-PAGE. (B) HEK293 cells were treated with 1 mM 
diamide for 5 min, followed by recovery of diamide treatment by replacing the 
diamide-containing medium with fresh medium. Cells were further cultured for 
different timepoints and the lysates were collected in triton-X lysis buffer containing 
20 mM IAA, followed by being resolved using reducing and non-reducing SDS-
PAGE. 
 
4.3.4 Investigation of the regulation of AIF oxidation by thiol redox 
systems 
Experimental results obtained and presented in Fig. 4.5 had suggested the 
involvement of thiol redox systems in the regulation of oxidized AIF. 
Therefore, we moved on to examine whether the GSH system played a role in 
reducing the disulfide in AIF. To this end, HEK293 cells treated with diamide 
over a range of concentrations were harvested for measurement of total GSH 
content alongside the collection of lysates for separation by non-reducing 
SDS-PAGE and subsequent western blotting to probe for levels of reduced 




dependent accumulation of oxidized AIF, which was observed to be correlated 
to a concurrent decrease in the levels of total cellular GSH (Fig. 4.6B). The 
experiment was also conducted with cells treated with 1 mM diamide for 5 
min, followed by replacement of diamide-containing medium with fresh 
medium. The results obtained had agreed with those obtained in the former 
experiment, where the time-dependent gradual reduction in oxidized AIF was 
observed to occur along with the time-dependent recovery of total GSH 
content (Fig. 4.6C and D). These results had further underpinned a role that 
the GSH system would play in reducing oxidized AIF.       
 
Figure 4.6 Effect of diamide treatment on the redox state of AIF and levels of 
total cellular GSH. HEK293 cells were treated with diamide at indicated 
concentrations for 5 min (A and B) or cells were treated with 1 mM diamide for 5 
min, followed by recovery of diamide treatment by replacing the diamide-containing 
medium with fresh medium (C and D). Cells were harvested, with a fraction lysed in 
triton-X lysis buffer containing 20 mM IAA and subjected to non-reducing SDS-
PAGE and western blot analysis (B and D). The remaining cells were determined for 
total GSH content (A and C).   
Under an in vitro experimental set-up, effects of the Trx system on the levels 
of oxidized AIF were determined. HEK293 cell lysates that had been frozen 




oxidation) were thawed and divided into aliquots. Each aliquot of lysates was 
mixed with reduced or oxidized Trx alone, NADPH alone, or all three 
components of the Trx (recombinant hTrx1, recombinant rat TrxR and 
NADPH) systems for 30 min at room temperature. As shown in Fig. 4.7, 
treatment with reduced Trx (2 and 20 µM) alone or oxidized Trx (20 µM) 
alone was not able to bring about reduction of the disulfide AIF species. 
Conversely, treatment with all three components of the Trx system (Trx, TrxR 
and NADPH), NADPH-reduced TrxR alone or NADPH alone could 
significantly reduce the disulfide form of AIF (Fig. 4.7). Addition of NADPH-
reduced TrxR in the presence of excessive NADPH, as well as addition of 
NADPH into frozen lysates would have reactivated those NADPH-dependent 
proteins that had been oxidized in the freezing process. Hence, it explained the 
ability of the reactivated redox systems to reduce the disulfide form of AIF.  
 
Figure 4.7 In vitro effects of the Trx system on levels of oxidized AIF. HEK293 
cell lysates were collected in triton-X lysis buffer and kept frozen for more than 24 h. 
Frozen lysates (containing 50 µg proteins in each reaction) were untreated or treated 
with one or all components of the Trx system as indicated for 30 min at room 
temperature. The untreated and treated lysates were subjected to non-reducing SDS-
PAGE, followed by western blot analysis using anti-AIF antibody.    
To examine the effects of thiol redox systems on regulation of oxidized AIF, 
loss-of-function cell-based studies were next carried out. For investigation of 
whether the GSH system played a role in preventing formation of oxidized 
AIF or reducing oxidized AIF, HEK293 cells were depleted of GSH through 
being treated with BSO, an inhibitor of γ-GCL that catalyzes a rate-limiting 
step in GSH biosynthesis (Fig. 4.8A). Cells treated or untreated with 30 µM 
BSO for 24 h were next treated with diamide over a range of concentrations 
for 10 min. As depicted in Fig. 4.8B, cells deficient in total GSH levels 




cells. This result had therefore indicated that the GSH system served two 
plausible functions. Firstly, it either antagonized the oxidizing effects of 
diamide such that the cellular milieu was not oxidizing enough to cause 
extensive AIF oxidation. The second plausible function of the GSH system 
was that it caused direct or indirect reduction of the disulfide in oxidized AIF.      
 
Figure 4.8 Levels of oxidized AIF formed in GSH-deficient HEK293 cells upon 
treatment with diamide. (A) HEK293 cells were treated with various concentrations 
of BSO (30, 50, 100 µM) for 24 h and the total GSH (reduced and oxidized) levels 
were detected following the experimental procedure given by (Tietze, 1969). (B) 
HEK293 cells were treated with 30 µM BSO for 24 h, followed by treatment with 
diamide at various concentrations for 10 min. Lysates were collected in triton-X lysis 
buffer containing 20 mM IAA, and the lysates were resolved by non-reducing SDS-
PAGE, followed by western blotting.  
For the same purpose of investigating whether the Trx system was involved in 
the modulation of oxidative stress-mediated AIF oxidation, the strategy of 
siRNA-mediated TrxR1 silencing to simulate a Trx-deficient cellular 
environment was employed. Having determined that among the four TrxR1 
siRNAs designed to silence TrxR1, TrxR1 siRNA #1 and #2 were found to 
produce the most significant knock-down of TrxR1 (Fig. 4.9A), TrxR1 siRNA 




down of TrxR1 in HEK293 cells led to an enhancement of formation of 
oxidized AIF under oxidizing conditions. Moreover, the combined effect of 
TrxR1 knock-down and GSH depletion also caused formation of oxidized AIF 
at lower concentrations of diamide (Fig. 4.9C).  Taken together, results 
obtained from the above mentioned experiments had revealed that both the 
GSH and Trx systems were involved in the regulation of the redox state of 
AIF under oxidative stress, which otherwise could adversely affect the normal 
functioning of a cell. 
 
Figure 4.9 Effect of TrxR1 silencing and/or GSH depletion on AIF oxidation in 
HEK293 cells. (A) Control siRNA (30 nM) and 30 nM of siRNAs (#1 to 4) targeted 
for TrxR1 were transfected in HEK293 cells for 72 h. Lysates were then collected in 
triton-X lysis buffer and the reduction in TrxR1 levels were detected by western blot 
analysis using anti-TrxR1 antibody. (B) HEK293 cells were transfected with control 
siRNA and TrxR1 siRNA#1 for 72 h, followed by treatment with diamide at 
indicated concentrations for 10 min. (C) Cells were transfected with control siRNA 
and TrxR1 siRNA#1. After 48 h of siRNA transfection, cells were treated with 30 
µM of BSO and further cultured for 24 h. Following siRNA and BSO treatment, cells 
were treated with diamide at indicated concentrations. Cells were harvested and the 
lysates were collected in triton-X lysis buffer containing 20 mM IAA, and the lysates 




4.3.5 Investigation of the possible dependence of AIF’s NADH oxidase 
activity and nuclear translocation on its cysteine residues and thiol redox 
state   
Having found that AIF was oxidized to a disulfide form under oxidative stress, 
we were next interested in investigating the biological significance of oxidized 
AIF. AIF is known to possess two biological properties. Under physiological 
conditions, AIF’s oxidoreductase activity is largely believed to be associated 
with its function to maintain mitochondrial integrity and normal functioning 
(Daugas et al., 2000, Klein et al., 2002). However, under apoptotic conditions, 
AIF is released from the mitochondria and translocated into the nucleus where 
it exerts DNA fragmentation activity (Susin et al., 1999). As a NADH-
dependent flavoprotein, AIF possesses NADH oxidase activity, which has 
been exploited in in vitro biochemical assays to access whether the AIF 
protein has been inactivated. Inactivation of AIF’s NADH oxidase activity is 
deduced to relate to a direct or indirect loss of AIF’s biological properties. 
Here, to assess whether oxidizing conditions could affect the NADH oxidase 
activity of AIF, recombinant His-hAIF121 protein was used in the in vitro 
NADH oxidase assay. Initially, the pH at which rHis-hAIF121 would possess 
maximum NADH oxidase activity was detected. NADH oxidase assay were 
carried out over a range of pH from 6.5 to 7.4 using rHis-hAIF121 (1 µM) in 
50 mM sodium phosphate buffer. As shown in Fig. 4.10A, rHis-hAIF121 
displayed optimal NADH oxidase activity at pH 6.8. Therefore, subsequent 
experiments were carried out at pH 6.8. It was observed that cysteine-null 
rHis-hAIF121 still possessed NADH oxidase activity, though the activity was 
significantly lower than the rate of NADH oxidation by wild-type rHis-
hAIF121 (Fig. 4.10B). This result had suggested that the cysteines in AIF 
were likely not directly involved in its NADH oxidase activity. However, it 
was noted that AIF oxidation caused by treatment with H2O2 (2 mM) and 







Figure 4.10 NADH oxidase activity of rHis-hAIF121 under oxidative stress 
conditions. Wild-type and cysteine-null (Cys-null) rHis-hAIF121 proteins were 
prepared and used for in vitro NADH oxidase assay. Prior to being used in the assay, 
the proteins were reduced with 10 mM DTT for 10 min and the excess of DTT was 
desalted by passing through NAP-5 columns. The change in NADH absorbance was 
measured at 340 nM for 10 min and the results were expressed as rate of change in 
NADH concentration i.e. ∆ [NADH] µM/min using extinction coefficient of NADH 
at 340 nM (ε = 6220 M−1 cm−1). (A) The change in ∆ [NADH] µM/min displayed by 
rHis-hAIF121 (1 µM) was determined in sodium phosphate buffer of different pHs 
(6.5 to 7.4). (B) The change in ∆ [NADH] µM/min displayed by wild-type and Cys-
null rHis-hAIF121 (1 µM) was determined at pH 6.8. Results were presented as 
means of ∆ [NADH] µM/min ± SD (n=3). Student’s t-test was performed for Cys-
null rHis-hAIF121 with BSA and wild-type rHis-hAIF121, where *** indicates p < 
0.001 as compared to BSA and ** indicates p < 0.05 as compared to wild-type rHis-
hAIF121. (C) Wild-type rHis-hAIF121 (1 µM) was treated with H2O2 (2 mM) and 
diamide (2 mM) for 5-10 min at room temperature, followed by removal of excess 
H2O2 and diamide by desalting the proteins using NAP-5 columns. The change in ∆ 
[NADH] µM/min displayed by H2O2 and diamide-treated rHis-hAIF121 was 
determined at pH 6.8. Results were presented as mean of ∆ [NADH] µM/min ± SD 
(n=3). Student’s t-test was performed for H2O2-treated and diamide-treated rHis-
hAIF121, where ns indicates p > 0.05 and *** indicates p < 0.001 as compared to 





To further examine whether the cysteine residues in AIF would play a role in 
determining AIF’s nuclear translocation upon application of oxidative stress 
and/or apoptotic stimuli, COS-1 cells transfected with wild-type or cysteine-
null mAIF(FL)-V5 were treated with H2O2 (2 mM), diamide (1 mM) or STS 
(0.5 µM) for 12 h and analyzed by immunocytochemical analysis. As shown 
in Fig. 4.11, both wild-type and cysteine-null mAIF(FL)-V5 could translocate 
into the nucleus under application of the oxidative stress and/or apoptotic 
stimuli. This result had revealed that nuclear translocation of mAIF(FL)-V5 
was independent of the presence of cysteines in AIF. Given that it was found 
earlier that Cys255 and Cys440 were involved in intramolecular disulfide 
bonding to form oxidized AIF, the nuclear translocation of cysteine-null AIF 
also implied that the event happened independent of the thiol redox state of 
AIF. 
 
Figure 4.11 Cysteine residues in AIF and their thiol oxidation are not required 
for its nuclear translocation. COS-1 cells were transiently transfected with plasmids 
expressing wild-type and cysteine-null (Cys-null) mAIF(FL)-V5. Following 24 h of 
post-transfection, cells were treated with H2O2 (2 mM), diamide (1 mM) or STS (0.5 
µM) for 12 h. Treated and untreated cells were fixed on cover slips, probed with 
mouse anti-V5 antibody and the nuclear localization of mAIF(FL)-V5 was detected 
by immunofluorescence imaging using anti-mouse antibody conjugated with Alexa 







Emerging evidence has suggested the susceptibility of AIF to oxidative stress, 
which is to lead to apoptosis induction through known and unknown 
mechanisms. AIF has been recently reported to undergo carbonylation under 
oxidative stress conditions, which leads to its calpain-mediated truncation and 
release from the mitochondria and finally apoptosis induction (Norberg et al., 
2008, Norberg et al., 2010). In the present study, we had focused on studying 
whether AIF would undergo thiol oxidative modification under oxidative 
stress and the possible regulation by redox defense systems. Oxidative stress-
induced disulfide bond formation in AIF was characterized. Under constitutive 
cellular conditions, AIF was found to be in its reduced form, whereas when 
subjected to strong oxidizing conditions induced by cytotoxic concentrations 
of H2O2 and diamide, AIF oxidation occurred. Oxidized AIF was found to be 
formed likely through formation of an intramolecular disulfide bond between 
Cys255 and Cys440 in mouse AIF.  
AIF oxidation was found to be reversible, suggesting that the thiol redox state 
of AIF was intricately regulated by cellular antioxidant systems. Indeed, the 
thiol redox defense systems, namely the GSH and Trx systems were found to 
be involved in maintaining the reduced state of AIF under physiological 
conditions. In face of insults from low to moderate oxidizing conditions, the 
spontaneous response from these redox defense systems provided the reducing 
equivalents to resist oxidative modifications or to reverse oxidized AIF back 
to its reduced form. However, it was observed that upon exposure to strong 
oxidative insults caused by pro-apoptotic concentrations of oxidants, the thiol 
redox systems probably lacked the capacity to cope with large amounts of 
oxidants, which therefore led to persistent AIF oxidation.            
Thiol reactive agent p-chloromercuryphenylsulfuric acid has been reported to 
inhibit DNA damaging effects of AIF in isolated nuclei (Susin et al., 1999). As 
Cys441 in hAIF lies next to the NLS2, Sevrivoukova (2011) had suggested 
that blockade of Cys441 by p-chloromercuryphenylsulfuric acid could result 
in retardation of the nuclear translocation of AIF. Drawing similar inferences, 




NLS2 respectively, it was hypothesized that the formation of an 
intramolecular disulfide bond between Cys256 and Cys441 in times of 
oxidative stress would affect the nuclear translocation of AIF. However, our 
experimental finding revealed that a cysteine-null AIF was still able to 
translocate into the nucleus upon exposure to oxidative stress, which would 
suggest that nuclear translocation of AIF was independent of its cysteine 
residues.   
Under normal physiological conditions, AIF resides in the mitochondria and is 
reported to be involved in cell survival functions such as maintenance of 
mitochondrial membrane integrity and free radical scavenging activity (Klein 
et al., 2002). It has also been reported to interact with NAD(P)H, where the 
redox state of AIF-bound NAD(P)H is proposed to affect its dimerization, 
calpain-mediated processing, as well as AIF-DNA interaction (Churbanova 
and Sevrioukova, 2008, Sevrioukova, 2009). Here, in our study, we had found 
that the NADH oxidase activity of AIF was independent of its cysteine 
residues. Besides, under oxidative stress, the NADH oxidase activity of AIF 
was hampered. However, further research work is needed to investigate 
whether the decrease in NADH oxidase activity of AIF is a result of the 
disturbed charge transfer complex following intramolecular disulfide bond 
formation within the AIF molecule.    
In summary, AIF was found to be redox-sensitive such that under oxidative 
stress, it was oxidized with the formation of an intramolecular disulfide bond 
between Cys255 and Cys440. However, the cysteines in AIF were found not 
to be required for oxidative stress-induced nuclear translocation of AIF. 
































To prevent the undesirable consequences of oxidative stress, cells possess 
endogenous defensive systems such as the redox antioxidant systems, as well 
as the Nrf2-Keap1 pathway. Keap1 is known to regulate Nrf2-ARE signaling 
by targeting Nrf2 for ubiquitination and proteasomal degradation in a redox-
dependent manner (McMahon et al., 2003, McMahon et al., 2004, Kobayashi 
et al., 2004, Kobayashi and Yamamoto, 2006). Under increased ROS levels, 
Keap1 losses its ability to ubiquitinate and repress Nrf2 leading to Nrf2-ARE 
activation. Keap1 contains 27 cysteine residues, among which site-directed 
mutagenesis studies have identified Cys151, Cys273 and Cys288 to be 
actively involved in regulating proteasomal degradation of Nrf2 (Yamamoto et 
al., 2008, McMahon et al., 2010). Although it is generally believed that 
induction of Nrf2 is a result of Keap1’s cysteines being targeted and modified 
by electrophilic compounds, the actual Keap1 oxidation profiles and whether 
these lead to loss of Keap1’s function in targeting Nrf2 for proteasomal 
degradation have remained largely unestablished.       
We hypothesized that under oxidative stress, Keap1 would undergo thiol 
oxidative modifications such as disulfide bond formation through their 
reactive cysteine residues, which would lead to loss, gain or switch in Keap1’s 
function as an adapter protein for targeting Nrf2 for Cul3-mediated 
ubiquitination and proteasomal degradation. As such, using non-cytotoxic 
concentrations of oxidants, we investigated the redox susceptibility of Keap1 
to undergo intra- and inter-molecular disulfide bond formation, as well as their 
redox regulation by GSH and Trx systems. Furthermore, the possible 
mechanisms underlying Nrf2 induction by known and novel Nrf2 inducers 
were proposed and investigated. Given that electrophilic Nrf2 inducers are 
also known to suppress NF-κB signaling, and that Keap1 has been reported to 
be involved in Cul3-mediated proteasomal degradation of IKKβ, a component 
of the NF-κB signaling cascade, the possible mechanism through which such 





5.2 Materials and methods 
5.2.1 Materials 
Reagents 
Dulbecco’s modified eagle medium (DMEM), iodoacetamide (IAA), 
buthionine sulfoximine (BSO), diamide, MG132, cycloheximide, DL-
sulforaphane (SF), ZnCl2 and trans-cinnamaldehyde (CA) were purchased 
from Sigma-Aldrich (St Louis, MO, USA). H2O2 was obtained from 
Calbiochem (La Jolla, CA, USA). t-butyl hydroquinone (tBHQ) was 
purchased from Fluka (USA). BCA and 6-shogaol synthesized by Dr. Geoffry 
Wells (Department of Pharmaceutical and Biological Chemistry, University 
College London, School of Pharmacy) and in our laboratory respectively. The 
structure of SF, tBHQ, CA, BCA and 6-shogaol are presented in Appendix І. 
Protease inhibitor cocktail was purchased from Roche (Mannheim, Germany). 
Protein G sepharose beads were from GE Healthcare (Uppsala, Sweden). β-
mercaptoethanol (β-ME) was from Biorad laboratories (CA, USA). Quick 
Change ІІ® site-directed mutagenesis kit was obtained from Stratagene (La 
Jolla, CA, USA) 
Antibodies  
Mouse anti-β-actin primary antibody and goat anti-mouse IgG-HRP, goat anti-
rabbit IgG-HRP and goat anti-rat IgG-HRP secondary antibodies were 
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
Mouse Anti-FLAG M2 antibodies were purchased from Sigma-Aldrich (St. 
Louis, CA, USA). Mouse anti-V5 antibody was purchased from Serotec Inc. 
(Kidlington, Oxford, UK). Rat anti-HA was purchased from Roche diagnostics 
(Lewes, East Sussex, UK). Rabbit anti-IKKβ and anti-p65 were obtained from 
Cell Signaling Technology (Danvers, MA, USA). 
Plasmids 
The following mammalian expression plasmids constructed by Dr. Chew Eng 




University of Singapore) were used for transfections in experiments performed 
in this chapter. 
1) pcDNA3.1/V5-Keap1 (V5-Keap1) 
2) pcDNA3.1/V5-Keap1C13S (V5-Keap1C13S) 
3) pcDNA3.1/V5-Keap1C14S (V5-Keap1C14S) 
4) pcDNA3.1/V5-Keap1C23S (V5-Keap1C23S) 
5) pcDNA3.1/V5-Keap1C38S (V5-Keap1C38S) 
6) pcDNA3.1/V5-Keap1C77S (V5-Keap1C77S) 
7) pcDNA3.1/V5-Keap1C151S (V5-Keap1C151S) 
8) pcDNA3.1/V5-Keap1C171S (V5-Keap1C171S) 
9) pcDNA3.1/V5-Keap1C196S (V5-Keap1C196S) 
10) pcDNA3.1/V5-Keap1C226S (V5-Keap1C226S) 
11) pcDNA3.1/V5-Keap1C241S (V5-Keap1C241S) 
12) pcDNA3.1/V5-Keap1C249S (V5-Keap1C249S) 
13) pcDNA3.1/V5-Keap1C257S (V5-Keap1C257) 
14) pcDNA3.1/V5-Keap1C273S (V5-Keap1C273S) 
15) pcDNA3.1/V5-Keap1C288S (V5-Keap1C288S) 
16) pcDNA3.1/V5-Keap1C297S (V5-Keap1C297S) 
17) pcDNA3.1/V5-Keap1C613S (V5-Keap1C613S) 
18) pcDNA3.1/V5-Keap1C622S (V5-Keap1C622S) 
19) pcDNA3.1/V5-Keap1C624S (V5-Keap1C624S) 
20) pcDNA3.1/V5-Keap1C622SC624S (V5-Keap1C622SC624S) 
21) pcDNA3.1/FLAG-Keap1 (FLAG-Keap1) 
22) pcDNA3.1/Cul3-FLAG (Cul3-FLAG) 
23) pcDNA3.1/Cul3-HA (Cul3-HA) 
24) pcDNA3.1/Nrf2-HA (Nrf2-HA) 
5.2.2 Cell culture, transfection and treatment 
HEK293 cells were cultured in a high glucose DMEM growth medium 
supplemented with 10% FBS, 100 U/ml penicillin-streptomycin and 1 mM of 
sodium pyruvate at 37˚C in a 5% CO2 humidified incubator. Cells were 
cultured to 40-50% of cell confluency and transfected with mammalian 




treated with oxidizing agents and/or other chemicals as specified under the 
respective experiments. 
5.2.3 Reducing and non-reducing SDS-PAGE 
The experimental procedure used for reducing SDS-PAGE was as described 
previously in Section 2.2.3. The experimental procedure used for non-reducing 
SDS-PAGE was similar in principle to that employed in reducing SDS-PAGE, 
except that β-ME was omitted in Laemmli’s sample buffer.  
5.2.4 Western blot analysis 
Following resolution of proteins in cell lysates by reducing or non-reducing 
SDS-PAGE, western blot analysis was performed. The procedure used was as 
described in Section 2.2.3. 
5.2.5 Co-immunoprecipitation 
The experimental procedure was performed as described previously in Section 
2.2.4.   
5.2.6 Site-directed mutagenesis 
Single and double cysteine-to-serine mutants of V5-Keap1 DNA constructs 
were obtained by site-directed mutagenesis using the Quik Change ІІ® site-
directed mutagenesis kit following manufacturer’s instructions. The PCR 
primers containing point mutations were obtained from 1st Base DNA 
Technology (Singapore). PCR reactions were carried out in Eppendorf 
Mastercycler Personal PCR machine. Following PCR reactions, the PCR 
products were digested with DpnІ restriction enzyme (Biolabs, UK) at 37˚C 
for 3-4 h. The DpnІ digested PCR products were transformed into the 
competent DH5α cells, followed by selection on ampicillin LB agar plates. A 
single bacterial colony growing on agar plate was selected and amplified in 
LB Broth in an overnight culture at 37˚C. Plasmids were extracted and 






5.3.1 Detection of oxidized forms of Keap1 
To investigate the existence of oxidized forms of Keap1 attributed to disulfide 
formation, HEK293 cells expressing V5-Keap1 were exposed to acute 
oxidizing conditions induced by 0.5 mM of H2O2 and diamide, and the 
collected lysates were subjected to reducing and non-reducing SDS-PAGE, 
and western blot analysis. At this point, we sought to clarify that within the 
context of this study, the experimental focus was to assess Keap1 oxidation in 
cells upon exposure to oxidative or electrophilic stress achieved by non-
cytotoxic doses of oxidants/electrophiles. In other words, while the 
experiments conducted in previous Chapters were cytotoxic doses of oxidants 
or electrophilic compounds were used as pro-apoptotic stimuli, the 
concentrations of these reagents used in this study were not strong enough to 
lead to cell death, but enough to cause oxidative changes in Keap1. These 
doses were therefore the doses likely to induce Nrf2. As depicted in Fig. 5.1, 
slow migrating species of oxidized V5-Keap1 were observed in the lysates of 
cells treated with H2O2 and diamide and resolved under non-reducing 
conditions. These oxidized forms of Keap1 were absent when similar lysates 
were resolved by SDS-PAGE under reducing conditions, thus suggesting that 
the slow migrating bands observed on the non-reducing gel were disulfide 
species of V5-Keap1. Treatment with oxidants H2O2 and diamide caused 
formation of two oxidized disulfide species of V5-Keap1: an oxidized species 
appearing close to reduced V5-Keap1 (~72 kDa) likely formed from 
intramolecular disulfide bond formation, as well as another oxidized species of 
higher molecular weight (~130 and 170 kDa) formed via intramolecular 
disulfide bond formation either between two V5-Keap1 monomers or between 
V5-Keap1 and one or more other cellular proteins molecules. The appearance 
of the intramolecular disulfide of V5-Keap1 species in untreated cells had 
suggested that the cells probably experienced certain extent of oxidative stress 





Figure 5.1 Oxidation status of V5-Keap1 under oxidative stress conditions 
induced by H2O2 and diamide. Transfected HEK293 cells expressing V5-Keap1 
were treated with 0.5 mM H2O2 or diamide for 5 min. Lysates were collected in 
triton-X lysis buffer containing 20 mM IAA and subjected to non-reducing and 
reducing SDS-PAGE and western blot analysis. 
The dose-dependent and time-dependent changes in oxidation state of V5-
Keap1 were next investigated. Cells expressing V5-Keap1 were exposed to 
different concentrations of H2O2 for 5 min. As shown in Fig. 5.2A, increasing 
concentrations of H2O2 led to increased oxidation of V5-Keap1 such that 
almost all reduced form of V5-Keap1 was oxidized upon cell treatment with 
cytotoxic doses of H2O2 (2 or 3 mM). Notably, it was observed that severe 
oxidizing conditions induced by these lethal concentrations appeared to favor 
formation of intermolecular disulfide forms of oxidized V5-Keap1 (Fig. 5.2A). 
In a time-chase experiment involving treatment of V5-Keap1 transfected 
HEK293 cells with 1 mM H2O2 for 5, 10, 15, 30 and 60 min, it was observed 
that by 5 min of cellular exposure to H2O2, oxidation of Keap1 to both intra- 
and inter-molecular disulfide forms occurred (Fig. 5.2B). This Keap1 
oxidation state persisted for 10 min of H2O2 exposure. Prolonged duration of 
H2O2 exposure (15 min and longer) on the contrary culminated in reduced 
levels of intermolecular disulfide forms of oxidized V5-Keap1 (Fig. 5.2B), 
which suggested the reversibility of oxidized Keap1 and redox regulation of 





Figure 5.2 Dose- and time-dependent changes in the oxidation status of V5-
Keap1 under oxidative stress conditions induced by H2O2. Transfected HEK293 
cells expressing V5-Keap1 were treated with (A) indicated concentrations of H2O2 for 
5 min or (B) 1 mM H2O2 for various timepoints as indicated. Following H2O2 
treatment, lysates were collected in triton-X lysis buffer containing 20 mM IAA and 
subjected to non-reducing SDS-PAGE and western blot analysis.  
 
5.3.2 Identification of cysteines involved in disulfide bond formation in 
Keap1   
To examine and identify the cysteine(s) involved in disulfide bond 
formation(s) in Keap1, site-directed mutagenesis was performed to obtain a set 
of DNA constructs with a single cysteine-to-serine mutation to each of 
Keap1’s cysteines apart from those in the DGR domain. Each of the DNA 
construct carrying the single cysteine mutants was listed in Section 5.2.1. 
HEK293 cells were transfected with these plasmids and exposed to 1 mM 
H2O2 for 5 min. A dose of 1 mM H2O2 had been pre-determined to be non-
toxic to HEK293 cells, but capable of inducing transient oxidative stress that 




(results not shown/revealed) that those expressing V5-Keap1C151S, V5-
Keap1C226S and V5-Keap1C613S displayed changes in the oxidation 
patterns of Keap1. As such, the concerned plasmids were used to transfect 
HEK293 cells and western blot analysis was presented in Fig. 5.3A. It was 
observed that under oxidizing conditions, mutation of Cys226 and Cys613 had 
led to formation of intermolecular disulfide forms of oxidized V5-Keap1; 
formation of intramolecular disulfide forms of oxidized V5-Keap1 was 
abolished (lane 4 and 5 in Fig. 5.3A). On the other hand, mutation of Cys151 
led to Keap1 oxidation that comprised mainly of intramolecular disulfide 
forms (lane 3 in Fig. 5.3A). The results had indicated that Cys226 and Cys613 
were involved in formation of intramolecular disulfide forms of oxidized 
Keap1, whereas Cys151 was mainly involved in formation of intermolecular 
disulfide forms of oxidized Keap1. The studies were extended to investigating 
whether Cys273 and Cys288, the cysteines that have been reported to be 
important in Keap1-dependent repression of Nrf2 (Yamamoto et al., 2008), 
gave rise to a distinctly different Keap1 oxidation profile. As shown in Fig. 
5.3B, mutation of Cys273 or Cys288 had abolished neither intra- nor inter-
molecular disulfide forms of oxidized Keap1, suggesting that these cysteines 
were either both involved in forming intra- and inter-molecular disulfide forms 
of oxidized Keap1, or both played no crucial role in producing the different 





Figure 5.3 Involvement of specific cysteine residues in giving rise to different 
Keap1 oxidation profiles under oxidative stress conditions by H2O2. Transfected 
HEK293 cells expressing V5-Keap1, V5-Keap1C151S, V5-Keap1C226S, V5-
Keap1C613S, V5-Keap1C273S or V5-Keap1C288S were treated with 1 mM H2O2 
for 5 min (A and B). Lysates were collected in triton-X lysis buffer containing 20 
mM IAA and subjected to non-reducing SDS-PAGE and western blot analysis.  
 
5.3.3 Examination of self disulfide-reductive activity of C-terminal CXC 
motif in Keap1 
Keap1 possesses a CXC motif (Cys622-X-Cys624 in human Keap1) at its C-
terminus. This CXC motif resembles the typical CXXC active site motif in 




we were interested to investigate whether the CXC motif in Keap1 could 
impart self disulfide-reductive ability by reducing the intra- and inter-
molecular disulfide bond(s) formed in oxidized Keap1. To investigate this 
potential activity, Cys622 and Cys624 were mutated to serine in V5-Keap1 
and were used to examine the change in H2O2-induced thiol oxidation of V5-
Keap1 in a time-chase experiment. Briefly, HEK293 cells were transfected 
with wild-type V5-Keap1 or V5-Keap1C622SC624S and exposed to non-
cytotoxic oxidative stress brought about by addition of 0.5 mM H2O2 for 5, 15, 
30 and 60 min. It was postulated that in the event that as compared to cells 
expressing wild-type Keap1, those expressing V5-Keap1C622SC624S 
possessed no or reduced ability to reduce the disulfide forms of oxidized 
mutant Keap1 over time, it would suggest that the CXC motif in Keap1 
possessed self disulfide-reductive activity. However, experimental results 
showed that both wild-type and C622SC624S mutant of V5-Keap1 underwent 
maximal oxidation within 5 min of H2O2 treatment, followed by a comparable 
extent of progressive reduction of oxidized Keap1 over duration of 60 min 
(Fig. 5.4). The results had therefore ruled out the possibility that the CXC 
motif in Keap1 possessed self disulfide-reductive activity.            
 
Figure 5.4 Investigation of the possible self disulfide-reductive activity of the 
Cys622-X-Cys624 motif at the C-terminus of Keap1. Transfected HEK293 cells 
expressing V5-Keap1 or V5-Keap1C622SC624S were treated with 0.5 mM H2O2 for 
5, 15. 30 and 60 min. Lysates were collected in triton-X lysis buffer containing 20 
mM IAA. The collected lysates were subjected to non-reducing SDS-PAGE and 






5.3.4 Investigation of the regulation of Keap1 oxidation by thiol redox 
systems  
In the previous section, the hypothesis that the C-terminal CXC motif in 
Keap1 possessed self disulfide-reductive activity had been demonstrated to be 
incorrect. We next hypothesized that the GSH and Trx systems were involved 
in the regulation of the oxidation state of Keap1 under oxidizing conditions. In 
the experimental setup, cellular levels of GSH and TrxR1 were depleted by 
treatment of the cells with BSO and TrxR1 siRNA respectively so as to 
investigate the possible changes in the pattern of Keap1’s oxidation profile. 
Briefly, HEK293 cells expressing V5-Keap1 were treated with 30 µM BSO 
for 24 h or transfected with 30 nM TrxR1 siRNA#1 for 72 h, followed by 
treatment with 0.5 mM H2O2 for various timepoints up to 60 min. As shown in 
Fig. 5.5A, cells deficient in total GSH levels displayed as delayed response to 
bring about progressive reduction of intra- and inter-molecular disulfide forms 
of oxidized Keap1 over time. Similarly, TrxR1 silencing caused the cells to be 
less efficient than unsilenced cells in reducing oxidized Keap1, particularly 
intermolecular disulfide species of oxidized Keap1 (Fig. 5.5B). The obtained 
results had agreed with those obtained in experimental investigating the 
involvement of thiol redox systems in regulating thiol redox status of AIF 
under oxidative stress conditions (Section 4.4); both GSH and Trx systems 






Figure 5.5 Effects of GSH depletion or TrxR1 silencing on Keap1 oxidation in 
HEK293 cells. Transfected HEK293 cells expressing V5-Keap1 were treated with 30 
µM BSO for 24 h (A) or 30 nM TrxR1 siRNA#1 for 72 h (B). Following BSO and 
siRNA treatment, cells were further treated with 0.5 mM H2O2 for 5, 15, 30 and 60 
min. Lysates were collected in triton-X lysis buffer containing 20 mM IAA, and 
resolved by non-reducing SDS-PAGE, followed by western blotting. 
 
5.3.5 Investigation of the effect of oxidative stress on Keap1 dimerization 
and its interaction with Cul3 and Nrf2 
Under physiological conditions, Keap1 exists as a homodimer through 
interaction between the BTB domain of each Keap1 monomer. The 
homodimerization is important for Keap1 to act as an adapter protein for 
binding and targeting proteins such as Nrf2 and IKKβ for Cul3-mediated 
ubiquitination and proteasomal degradation (Zipper and Mulcahy, 2002, Kim 
et al., 2010a). As oxidative stress is known to cause Nrf2 upregulation through 
inhibition of its ubiquitination and proteasomal degradation (Kobayashi et al., 
2004), we were curious to investigate whether oxidative stress could affect 




with V5-Keap1 and FLAG-Keap1 and the collected lysates were either used 
fresh or frozen at -20°C for 24 h, then thawed for use. The freshly collected 
and frozen lysates were subjected to immunoprecipitation reactions using anti-
FLAG antibody. Lysates and immunoprecipitates were further resolved by 
reducing SDS-PAGE and western blot analysis. As depicted in Fig. 5.6A, 
interaction between V5-Keap1 and FLAG-Keap1 had remained the same in 
both fresh and frozen lysates, suggesting that Keap1 homodimerization was 
not disrupted when oxidizing conditions (through freezing) were applied. 
There lied a possibility that oxidizing conditions would induce dimerization 
through formation of intermolecular disulfides through Cys151 in V5-Keap1 
or FLAG-Keap1. To investigate this possibility, HEK293 cells were co-
transfected with FLAG-Keap1 and V5-Keap1 or V5-Keap1C151S. Results of 
the immunoprecipitation reactions performed revealed that both wild-type V5-
Keap1 and V5-Keap1C151S in the frozen and thawed lysates were able to co-
immunoprecipitate FLAG-Keap1 to the same extent (Fig. 5.6B). Taken 
together, these results had revealed that Keap1 dimerization had remained 
unaffected under oxidizing conditions irrespective of their thiol oxidative 





Figure 5.6 Dimerization of Keap1 and its Cys151 mutant under oxidative stress. 
HEK293 cells were co-transfected with (A) FLAG-Keap1 and V5-Keap1, or (B) 
FLAG-Keap1 and V5-Keap1 or V5-Keap1C151S. (A) Lysates were collected in 
triton-X lysis buffer frozen for 24 h. Fresh lysates and/or thawed frozen lysates were 
subjected to immunoprecipitation reactions using anti-FLAG antibody. Lysates and 
immunoprecipitates were resolved by reducing SDS-PAGE and analyzed by western 
blotting.   
It was next hypothesized that oxidative stress could disturb Keap1-Cul3 or 
Keap1-Nrf2 interaction. HEK293 cells were co-transfected with V5-Keap1 
and Cul3-HA, followed by treatment with 1 mM H2O2 and diamide for 5 min. 
Of note, it was observed in our experiments that 1 mM H2O2 was non-
cytotoxic and induced enough oxidative stress to affect Keap1 oxidation. 
However, 1 mM diamide was observed to bring about stronger oxidative stress 
that led to certain extent of cytotoxicity upon longer duration of treatment (for 
example 1-2 h). Lysates were collected and subjected to V5 
immunoprecipitation reactions. Cell exposure to strong oxidative stress 
induced by 1 mM diamide caused a decrease in the amount of Cul3 co-
immunoprecipitated with V5-Keap1, while milder oxidative stress induced by 
1 mM H2O2 failed to diminish Keap1-Cul3 interaction (Fig. 5.7A). 
Furthermore, the Keap1-Nrf2 interaction under such oxidative stress 
conditions was examined. To this end, transfected HEK293 cells co-
expressing V5-Keap1 and Nrf2-HA were treated with 10 µM of MG132 for 5 
h. MG132 is a non-specific proteasome inhibitor, treatment of which 
upregulates cellular Nrf2 levels. Experimentally, we had added a low dose of 
MG132 to allow basal levels of cellular Nrf2 to be maintained as it was 
observed in previous experimental attempts that co-transfection involving 
overexpression of cellular Keap1 had caused levels of cellular Nrf2 to be 
reduced to levels lower than those under constitutive conditions. Following 
MG132 treatment, cells were subjected to 1 mM H2O2 and diamide treatment 
for 5 min, followed by subjecting the collected lysates to V5 
immunoprecipitation reactions. As depicted in Fig. 5.7B, both mild and strong 
oxidative stress-induced by 1 mM H2O2 and diamide respectively caused 
abrogation of Nrf2-Keap1 interaction. In summary, these findings had 
suggested that the Keap1-Cul3 interaction could remain intact in times of low 
to moderate oxidative stress, while it could be disrupted under strong oxidative 




be more susceptible to oxidative stress and would get disturbed even at low to 
moderate oxidative stress.  
     
Figure 5.7 Disturbances in interaction between Keap1 and Cul3 and Nrf2 under 
oxidative stress conditions. Transfected HEK293 cells co-expressing (A) V5-Keap1 
and Cul3-HA and (B) V5-Keap1 and Nrf2-HA were treated with 1 mM H2O2 and 
diamide for 5 min. For the experiment performed in (B) prior to H2O2 and diamide 
treatment, transfected cells were treated with 10 µM MG132 for 5 h. Lysates freshly 
collected in triton-X lysis buffer were subjected to immunoprecipitation reactions 
using anti-V5 antibody. Lysates and immunoprecipitates were resolved by reducing 
SDS-PAGE and analyzed by western blotting.  
 
5.3.6 Characterization of patterns of Keap1 oxidation by different 
electrophiles 
In the previous sections of this chapter, Keap1 oxidation to form intra- and 
inter-molecular disulfide forms under oxidizing conditions induced by H2O2 
and/or diamide was investigated. Electrophiles such as SF and tBHQ are 
known Nrf2 inducers through targeting Keap1. It was therefore hypothesized 
that electrophiles would cause Keap1 oxidation and the pattern of Keap1 




hypothesis, transfected HEK293 cells expressing V5-Keap1 were treated with 
non-cytotoxic concentrations of known Nrf2 inducers SF (10 µM), tBHQ (100 
µM) and ZnCl2 (500 µM), as well as 6-shogaol (10 µM), BCA (10 µM) and 
CA (10 µM), which were potential chemopreventers currently under 
investigation in the lab. As shown in Fig. 5.8, treatment of electrophilic 
compounds 6-shogaol, BCA, CA and SF at the non-cytotoxic concentration 
that would induce Nrf2 levels were able to form disulfide species of oxidized 
Keap1. However, it was note-worthy that these oxidized forms of Keap1 were 
formed at lower levels as compared to those formed upon treatment with 1 
mM H2O2. In contrast, Nrf2 inducers tBHQ and ZnCl2 were able to oxidize 
Keap1 significantly, as evident from the significant appearance of disulfide 
species of oxidized V5-Keap1 (lane 7 and 8 in Fig. 5.8).    
 
Figure 5.8 Oxidation profile of Keap1 in transfected HEK293 cells upon 
treatment with known Nrf2 inducers and electrophilic compounds. Transfected 
HEK293 cells expressing V5-Keap1 were treated with 0.5 mM H2O2, 10 µM of 6-
shogaol, BCA, CA and SF, 100 µM tBHQ or 500 µM ZnCl2 for 15 min. Lysates were 
collected in triton-X lysis buffer containing 20 mM IAA and subjected to non-
reducing SDS-PAGE and western blot analysis.  
SF is reported to alkylate Cys151 of Keap1, which leads to reduction of 
Keap1’s Nrf2 repressor activity and thus accumulation of steady state levels of 
Nrf2 (McMahon et al., 2010). If it could alkylate Cys151 in Keap1, oxidative 
stress-induced intermolecular disulfide bond formation through Cys151 in 
Keap1 would therefore be blocked. To test this possibility, HEK293 cells 
transfected with V5-Keap1 or V5-Keap1C151S plasmids were treated or 
untreated with 10 µM SF prior to a 5-min exposure to 0.5 mM H2O2. 
Endogenous oxidant H2O2, which had been found to cause intermolecular 




experiment to determine whether SF had indeed alkylated cysteine residues in 
Keap1 that would therefore not be available for intermolecular disulfide bond 
formation in times of oxidative stress induced by H2O2. Similar to previous 
observations, untreated cells contained an amount of oxidized Keap1 as a 
result of intramolecular disulfide bond formation (lane 1 in Fig. 5.9A). No 
oxidized Keap1 formed from intermolecular disulfide bond formation was 
observed, indicating that under constitutive conditions, a certain pool of 
oxidized cellular Keap1 relatively smaller to the pool of reduced Keap1 was 
present. Consistent with previous observations, H2O2 treatment brought about 
Keap1 oxidation where a large pool of intermolecular disulfide forms of 
oxidized V5-Keap1 was formed (lane 2 in Fig. 5.9A). In contrast, V5-
Keap1C151S was relatively resistant to H2O2-induced oxidation to form 
intermolecular disulfide species of Keap1 (lane 3 in Fig. 5.9A). Interestingly, 
V5-Keap1 pretreated with SF and subsequently exposed to H2O2 strongly lost 
the ability to form intermolecular disulfide species of oxidized Keap1. The 
results had suggested that alkylation of Cys151 by SF had blocked oxidative 
stress-induced intermolecular disulfide bond formation in Keap1. To 
investigate whether alkylation of Cys151 by SF was reversible or irreversible, 
a time-chase experiment involving pre-treatment of V5-Keap1 transfected 
HEK293 cells with 10 µM SF for various time exposures (1, 3, 7 and 10 h), 
followed by 5 min treatment of 0.5 mM H2O2 was carried out. As shown in 
Fig. 5.9B, SF produced relatively similar efficacies in preventing H2O2–
mediated Keap1 oxidation to form intermolecular disulfide forms for durations 
1 to 7 h. By 10 h of SF treatment, subsequent H2O2 treatment had therefore led 
to intense Keap1 oxidation, as indicated by the intense formation of 
intermolecular disulfide forms of Keap1 (Fig. 5.9B). Taken together, the 
results had suggested that the alkylation of Cys151 by SF could be 
irreversible, as observed from strong blockage of Cys151 by SF for up to 7 h. 
However, the reappearance of intermolecular disulfide of oxidized V5-Keap1 
after 10 h of SF treatment could have occurred as result of continuous 





Figure 5.9 Effects of adduction of Keap1’s cysteines including Cys151 by SF on 
the oxidation status of Keap1 under oxidative stress conditions. (A) HEK293 cells 
were transfected with V5-Keap1 or V5-Keap1C151S plasmid. Transfected cells were 
pre-treated with 10 µM SF for 1 h, followed by treatment with 0.5 mM H2O2 for 5 
min. (B) HEK293 cells transfected with V5-Keap1 plasmid were pre-treated with 10 
µM SF for 1, 3, 7 and 10 h, followed by treatment with 0.5 mM H2O2 for 5 min. 
Lysates were harvested in triton-X lysis buffer containing 20 mM IAA and subjected 
to non-reducing SDS-PAGE and western blot analysis.    
Preliminary data previously obtained in the laboratory had revealed the ARE-
inducing activities of naturally-occurring trans-cinnamaldehyde (CA) and its 
novel analogue BCA (Chew et al., 2010). In addition, tBHQ and ZnCl2 were 
also previously found to induce Nrf2 (McMahon et al., 2010). We therefore 
sought to examine the effects of those compounds on the redox status of 
Keap1. HEK293 cells expressing V5-Keap1 were treated with 5 and 10 µM of 
BCA and CA, 100 µM of tBHQ and 500 µM ZnCl2 for 30 min, followed by 
treatment with 0.5 mM H2O2 for 5 min. As a positive control, cells were also 
treated with 10 µM SF for 30 min before the 0.5 mM H2O2 treatment for 5 




as well as 5 and 10 µM CA had prevented H2O2-induced Keap1 oxidation to 
form intermolecular disulfide forms (lane 5 to 7 in Fig. 5.10A). However, 
BCA at 5 µM was not as effective in blocking intermolecular disulfide bond 
formation induced by H2O2 (lane 4 in Fig. 5.10A). On the other hand, 
pretreatment of tBHQ but not ZnCl2 was able to block H2O2-induced 
formation of intermolecular disulfides of V5-Keap1 (Fig. 5.10B). These 
results had therefore suggested that novel electrophilic drugs BCA and CA, as 
well as known Nrf2 inducer tBHQ could alkylate Cys151 or any other 
cysteine(s) in Keap1 that possibly take part in intermolecular disulfide 
bonding. This pattern of Keap1 oxidation could be a possible mechanism 
underlying induction of Nrf2. Treatment with ZnCl2 did not bring about a 
similar pattern of Keap1 oxidation, which might imply that ZnCl2 induced 







Figure 5.10 Effects of CA, BCA, tBHQ and ZnCl2 on the oxidation status of 
Keap1. (A) Transfected HEK293 cells expressing V5-Keap1 were pretreated with 
indicated concentrations of CA, BCA or SF for 30 min, followed by treatment with 
0.5 mM H2O2 for 5 min. (B) Transfected HEK293 cells expressing V5-Keap1 were 
pretreated with 100 µM tBHQ, 10 µM sulforaphane or 500 µM ZnCl2 for 30 min, 
followed by treatment with 0.5 mM H2O2 for 5 min. Freshly collected lysates were 
subjected to non-reducing SDS-PAGE and western blot analysis. 
 
5.3.7 Investigation of the role of Keap1-Cys151 adduction by electrophiles 
in targeting IKKβ and p65 for proteasomal degradation    
Keap1 is known for its function as an adapter protein in the Nrf2-Keap1-Cul3 
complex to mediate Cul3-dependent ubiquitination and proteasomal 
degradation of Nrf2. Recently, IKKβ is also found to undergo Keap1-
dependent ubiquitination and proteasomal degradation (Lee et al., 2009, Kim 
et al., 2010a). In addition, p65 is found to interact with Keap1 and modulate 




caused increased proteasomal degradation of IKKβ and p65, HEK293 cells 
transfected with FLAG-Keap1 plasmid were treated or untreated with 40 µM 
MG132 for 5 h. As shown in Fig. 5.11A, in the absence of proteasomal 
inhibitor, lysates of cells overexpressing FLAG-Keap1 showed decreased 
levels of IKKβ and p65. On the other hand, treatment of MG132 to FLAG-
Keap1 overexpressing cells did not produce a decrease in IKKβ and p65 levels 
(Fig. 5.11B). These results had therefore ascertained the role of Keap1 in 
promoting proteasomal degradation of IKKβ and suggested the potential role 
of Keap1 in promoting proteasomal degradation of p65. Untransfected 
HEK293 cells were next treated with protein synthesis inhibitor 
cycloheximide and SF over a range of concentrations (1-10 µM) for 5 h. One 
plate of cells were treated with cycloheximide and 10 µM SF in the presence 
of 10 µM MG132 for 5 h. With synthesis of new proteins being blocked, it 
was found that levels of IKKβ and p65 decreased progressively along with 
increasing concentration of SF, whereas co-treatment with MG132 abolished 
the decline in IKKβ and p65 levels (Fig. 5.11C). The findings had thus shed 
light on the potential role of Keap1 in down-regulating NF-κB signaling 






Figure 5.11 Effect of Keap1 overexpression and SF treatment on cellular levels 
of IKKβ and p65. HEK293 cells were transfected with 2 µg of FLAG-Keap1 
plasmid for 48 h and (A) kept untreated or (B) treated with 40 µM MG132 for 5 h. 
(C) HEK293 cells were treated with 40 µM cycloheximide for 1 h, followed by 
treatment with SF at indicated concentrations for 5 h. One group of cells were 
subjected to concurrent treatment with 10 µM MG132 for 5 h. Lysates were collected 
and subjected to SDS-PAGE and western blot analysis. 
It has been reported that electrophiles such as SF activate Nrf2-ARE signaling 
(Prochaska and Talalay, 1988, Zhang et al., 1992) and downregulate NF-κB 
signaling (Heiss et al., 2001). On these bases, we hypothesized that Cys151 in 
Keap1 could act as a switch, which when adducted by electrophiles would 
lead to disturbances of the interaction between Keap1 and Nrf2 and promotion 
of interaction between Keap1 and IKKβ and p65. Consequently, Nrf2 would 
be upregulated while IKKβ and p65 were down-regulated. This was proposed 
as one of the possible mechanisms through which electrophiles acted as 
activators and down-regulators of Nrf2-ARE and NF-κB signaling 
respectively. To investigate the hypothesis, we investigated whether 




interaction between Keap1 and Nrf2 to interaction between Keap1 and IKKβ 
or p65. HEK293 cells were co-transfected with FLAG-Keap1 and Nrf2-HA 
plasmids, followed by treatment with 10 µM MG132 for 5 h so as to stabilize 
constitutive levels of Nrf2-HA. The cells were next treated with 10 µM of SF, 
100 µM tBHQ or 500 µM ZnCl2 for 30 min. It was observed that the 
compounds indeed caused a decrease in the amount of Nrf2-HA co-
immunoprecipitated with FLAG-Keap1. This was accompanied by a 
corresponding increase in the amount of co-immunoprecipitated IKKβ and 
p65 (Fig. 5.12A). In another experiment, cells co-expressing wild-type V5-
Keap1 or V5-Keap1C151S and Nrf2-HA were pretreated with 10 µM MG132 
for 5 h, followed by treatment with 10 µM SF for 30 min. Results of 
immunoprecipitation reactions showed that while SF cause a decrease in 
Keap1-Nrf2 interaction that was accompanied by an increase in Keap1-IKKβ 
and Keap1-p65 interaction in cells expressing wild-type V5-Keap1, the 
converse was observed for SF treatment to cells expressing the V5-
Keap1C151S mutant. As shown in Fig. 5.12B, an increase in the amount of 
Nrf2-HA co-immunoprecipitated with V5-Keap1C151S was increased 
whereas the amount of co-immunoprecipitated IKKβ and p65 was totally 
abolished. These results had therefore revealed that under treatment of known 
Nrf2 inducers, the Keap1-Nrf2 interaction was disturbed and a switch towards 
enhanced Keap1-IKKβ and Keap1-p65 interaction took place. Moreover, 
experimental results had exposed Cys151 in Keap1 to be a critical residue that 
possibly facilitated the switching of interaction between Keap1 and Nrf2 to 





Figure 5.12 Effects of Nrf2 inducers on the Keap1-Nrf2, Keap1-IKKβ and 
Keap1-p65 interactions. (A) HEK293 cells were co-transfected with FLAG-Keap1 
and Nrf2-HA plasmids. Following 48 h of transfection, cells were treated with 10 µM 
MG132 for 5 h, followed by treatment with 10 µM SF, 100 µM tBHQ or 500 µM 
ZnCl2 for 30 min. Lysates were collected and subjected to immunoprecipitation using 
anti-FLAG antibody. Lysates and immunoprecipitates were resolved by reducing 
SDS-PAGE, and analyzed by western blotting. (B) HEK293 cells were co-transfected 
with V5-Keap1 or V5-Keap1C151S and Nrf2-HA plasmids for 48 h. Following 
transfection, cells were treated with 10 µM MG132 for 5 h, followed by treatment 
with 10 µM SF. The collected lysates were subjected to immunoprecipitation using 
anti-V5 antibody. Lysates and immunoprecipitates were resolved by reducing SDS-







Oxidative stress has been increasingly associated with the development and 
exacerbation of multiple diseases such as cancer (Ma and He, 2012). Efforts to 
lower risk of cancer have pointed towards the use of phytochemicals and 
related small molecules as potential chemopreventers (Surh, 2003). One of the 
most important cellular defense mechanisms against oxidative stress is the 
Nrf2-Keap1 pathway. To date, pro-oxidants/oxidants, as well as electrophilic 
compounds that may potentially be developed as chemopreventers are 
generally believed to induce Nrf2 through targeting the redox-sensitive 
cysteines in Keap1 (Yamamoto et al., 2008). However, the actual Keap1 
oxidation profile upon exposure to oxidant and/or electrophiles have yet to be 
well established. We had hypothesized that each pro-oxidative or electrophilic 
compound caused a different thiol oxidation profile for Keap1, which would 
be translated to a loss, gain or switch in Keap1’s cellular functions, thereby 
affecting steady levels of Nrf2. Keap1 was found to be sensitive to oxidative 
stress; upon treatment with low to moderate doses of H2O2 and diamide, 
Keap1 was oxidized to yield intra- and inter-molecular disulfide forms. 
Appearance of the disulfide species of oxidized Keap1 under constitutive 
conditions might be attributed to the redox-sensitive cysteines in Keap1 
succumbing to oxidation by endogenously generated ROS. Cys226 and 
Cys613 were found to be involved in forming intramolecular disulfide forms 
of oxidized Keap1, while Cys151 was involved in forming intermolecular 
disulfide species of oxidized Keap1. Cys273 and Cys288, which were known 
to be important in Nrf2 induction (Yamamoto et al., 2008), were found not to 
be playing crucial roles in producing intra- and inter-molecular disulfide forms 
of oxidized Keap1. As observed from the time-dependent recovery of disulfide 
species of Keap1, strong redox defense system(s) could be in place to reverse 
the formation of these disulfides so as to achieve redox homeostasis. Indeed, 
the GSH and Trx systems were found to regulate the thiol redox state of 
Keap1.  
The CXC motif of a tri-peptide CGC has been reported to possess disulfide 




disulfide isomerase (Woycechowsky and Raines, 2003). Therefore, the C-
terminal CXC motif of Keap1, which resembles the CXXC active site motif in 
Trx, was hypothesized to possess self disulfide-reductive activity. As observed 
from the results obtained from the experiments using V5-Keap1C622SC624S, 
the CXC motif in Keap1 was not found to possess self-disulfide reduction 
potential.       
According to the hinge-and-latch model (Tong et al., 2006), Keap1 
homodimerization is essential for Keap1’s biological functions, where it acts 
as an adaptor for targeting proteins such as Nrf2 and IKKβ for Cul3-mediated 
ubiquitination and proteasomal degradation (McMahon et al., 2003, Lee et al., 
2009). Homodimerization of Keap1 exists at physiological conditions and we 
had hypothesized that it would be disturbed during oxidative stress. In doing 
so, this could potentially lead to loss of Keap1’s function as an adaptor 
protein. As observed from the results obtained, Keap1 dimerization was found 
to be undisrupted in times of oxidative stress and it was also found to be 
independent of intermolecular disulfide bond formation between Keap1 
monomers through Cys151. These results had suggested that under oxidative 
stress, irrespective of Keap1’s thiol oxidation state, Keap1 homodimerization 
had remained unaffected and this would unlikely contribute towards the loss 
of Keap1’s Nrf2 repressor activity. Interestingly, under strong oxidative stress 
conditions induced by a higher dose of diamide (1 mM), Keap1-Cul3 
interaction was found to get disturbed, whereas low to moderate oxidative 
stress induced by low to moderate doses of H2O2 (0.5-1 mM) was not able to 
perturb this interaction. Nonetheless, Keap1-Nrf2 interaction was found to be 
susceptible under low to moderate oxidative stress. Taken together, these 
results had suggested that although Keap1 was oxidized to form intra- and 
inter-molecular disulfides when it was challenged with a low to moderate dose 
of oxidant, its homodimerization and interaction with Cul3 had remained 
unaffected. However, such low to moderate oxidative stress was enough to 
bring about perturbation of the interaction between Keap1 and Nrf2, which 
was therefore proposed to be one possible mechanism underlying Nrf2 
upregulation, which culminates in enhanced Nrf2-ARE activation to increase 




stress and maintains redox homeostasis. On the other hand, in times of strong 
oxidative stress, besides disturbing Keap1-Nrf2 interaction, Keap1-Cul3 
interaction was also disturbed, which was proposed to lead to abolishment of 
Cul3-mediated Keap1-dependent ubiquitination and proteasomal degradation 
of targeted proteins.          
Cys151 in Keap1 has been reported to be targeted by electrophilic Nrf2 
inducers such as SF to bring about Nrf2 upregulation and activation of Nrf2-
ARE signaling (McMahon et al., 2010). Besides, these Nrf2 inducers are also 
found to downregulate NF-κB signaling (Heiss et al., 2001). Given that IKKβ 
is also reported to be a target protein for Keap1-dependent proteasomal 
degradation (Lee et al., 2009), we had hypothesized a possible link between 
Nrf2-Keap1 and NF-κB signaling. In our findings, we observed that 
prototypical Nrf2 inducer SF caused a disruption and enhancement in the 
Keap1-Nrf2 and Keap1-IKKβ/Keap1-p65 interaction respectively. Given that 
such effects of SF were absent in cells expressing V5-Keap1C151S, it was 
deduced that targeting of Cys151 by SF accounted at least in part to the switch 
in Keap1-Nrf2 interaction towards Keap1-IKKβ/Keap1-p65 interaction.  
In summary, Keap1 was found to undergo oxidation to form intra- and inter-
molecular disulfides. Thiol redox systems, namely the GSH and Trx systems 
were found to attenuate such oxidative effects, which in turn implied the 
involvement of these redox systems in achieving redox homeostasis.  In 
addition, Cys151 was exposed to be one crucial residue that upon its adduction 
with electrophiles such as SF caused a switch from Keap1-Nrf2 interaction to 
Keap1-IKKβ and possibly Keap1-p65 interaction. In doing so, Keap1-
dependent Cul3-mediated ubiquitination and proteasomal degradation of Nrf2 
and IKKβ would be decreased and increased respectively. This would 
probably be one mechanism that partly explained the induction of Nrf2-ARE 























6.1 General conclusion  
The primary aim of this PhD thesis was to investigate the redox sensitivities of 
cysteine containing cellular proteins. Using a MCF-7 cell line that was stably 
expressing FLAG-Trx1, a novel interaction between thiol redox protein Trx 
and AIF was discovered. The interaction had led to the deduction that AIF was 
redox-sensitive. As such, we had focused on investigating the redox 
sensitivities of AIF, as well as Keap1, a cysteine-rich protein known to be 
susceptible to oxidative and electrophilic stress. The two proteins were found 
to be sensitive to oxidative stress, and their redox states were regulated by 
thiol redox systems, namely the GSH and Trx systems.   
6.1.1 Redox regulation of AIF-mediated apoptosis by cytosolic Trx1 
Characterization of the AIF-Trx interaction had led to the understanding of the 
possible effect of Trx1 would have on AIF-dependent apoptosis. Trx1 was 
found to interact with both full length and cytosolic form of AIF at 
physiological conditions. However, under oxidizing conditions, the AIF-Trx 
interaction was found to be abrogated, which was further observed to re-
establish during oxidative stress recovery or by concurrent treatment of thiol 
antioxidant NAC. Investigating further, the thiol redox status of Trx was found 
to be crucial in its interaction with AIF. Such redox-dependent interaction 
between ASK1 and Trx1 has been reported, where reduced Trx1 inhibits 
ASK1-mediated apoptosis induction through interacting with ASK1 (Saitoh et 
al., 1998b). Since AIF is also known to be involved in apoptosis that occurs in 
times of oxidative stress, the significance of the AIF-Trx interaction in 
regulating apoptosis involving AIF was investigated. The AIF-Trx interaction 
was found to regulate the nuclear translocation of AIF. Under physiological 
conditions, the interaction between AIF and Trx was observed to be associated 
with suppressed cytosol-to-nuclear shuttling of AIF, possibly by blocking the 
nuclear localization sequences in AIF. HSP70, a stress-induced cytosolic 
protein, is also reported to inhibit the nuclear translocation of AIF (Gurbuxani 
et al., 2003). Hence, it was suggested that Trx1 and HSP70, either in 
association with each other or independently, could modulate the nuclear 




DNA degradosome complex with DNA (AIF-CypA-H2AX-DNA) was 
investigated. Reduced Trx1, but not oxidized Trx1, partially disturbed the 
binding of AIF with DNA. On the other hand, preliminary findings in our 
study had revealed that Trx1 appeared to hamper the AIF-CypA and AIF-
H2AX interaction. Interestingly, reduced Trx1 was found to attenuate the 
DNA damaging effects of AIF in isolated nuclei, which was suggested to 
occur as a result of either inhibition of nuclear translocation of AIF or 
perturbation of AIF-DNA interaction by reduced Trx1. A summary of the 
proposed redox-dependent role of Trx in the regulation of AIF-dependent 
apoptosis is depicted in Fig. 6.1.  
 
Figure 6.1 Proposed sequence of events occurring in Trx-dependent regulation 
of AIF-mediated apoptosis. Based on experimental findings obtained in this study, it 
was proposed that under physiological conditions, reduced Trx1 interacted with AIF, 
leading to inhibition of nuclear translocation of AIF. However, under oxidative stress, 
Trx1 was oxidized, resulting in the dissociation of the AIF-Trx1 complex, leaving 
AIF free to translocate into the nucleus. Nuclear reduced Trx1 was proposed to 







6.1.2 Redox sensitivity of AIF and its regulation by the GSH and Trx 
systems 
Under constitutive conditions, AIF had remained in its reduced form. Upon 
application of strongly oxidizing conditions brought about by high doses of 
H2O2 and diamide that would induce cytotoxicities, the appearance of slow 
migrating band of AIF on a non-reducing SDS-PAGE gel that this form of 
AIF disappeared on a SDS-PAGE gel in the presence of reducing agent β-ME, 
had indicated that oxidation of AIF occurred through disulfide bond 
formation. Using a series of cysteine-to-serine AIF mutants, it was elucidated 
that among the three cysteine in AIF (Cys255, Cys316 and Cys440 in murine 
AIF), the disulfide bond was formed intramolecularly between Cys255 and 
Cys440. The two major thiol redox systems, namely the GSH and Trx 
systems, were found to be involved in the regulation of AIF oxidation. This 
likely explained why in times of low to moderate oxidative stress, AIF 
oxidation had not occurred, as under such mild oxidizing conditions, the redox 
systems possessed sufficient reducing capacities to oppose thiol oxidative 
modifications in susceptible proteins. A summary of AIF oxidation and its 
possible their thiol redox regulation is presented in Fig. 6.2.  
 
Figure 6.2 Scheme of AIF oxidation induced by oxidizing conditions and its 
regulation by the GSH and Trx systems. Under strongly oxidizing conditions, AIF 
underwent thiol oxidation through formation of intramolecular disulfide bond 




brought about reduction of the disulfide bond formed in oxidized AIF. Oxidized AIF 
was postulated to possess disrupted biological functions, which include its potential 
oxidoreductase role in the mitochondrial and apoptosis inducing potential upon its 
translocation into the nucleus.   
       
6.1.3 Thiol oxidative modifications in Keap1, its significance in Nrf2-ARE 
signaling and regulation by the GSH and Trx systems 
While it was observed that AIF remained in its reduced state under 
constitutive conditions, Keap1 was found to be more redox-sensitive. Firstly, 
under constitutive conditions, Keap1 was found to be partially oxidized. 
Secondly, a relatively lower dose of oxidants was able to cause Keap1 
oxidation than that required to cause AIF oxidation. These non-cytotoxic low 
doses of H2O2 and diamide were deemed as low to modulate doses that had led 
to formation of intra- and inter-molecular disulfide forms of oxidized Keap1. 
It was deduced that the high redox sensitivity of Keap1 to AIF was attributed 
to the larger number of cysteines in Keap1 (27 cysteines in human Keap1 
versus 3 cysteines in human AIF). The greater redox sensitivity of Keap1 had 
indeed aligned with the role of Keap1 as a sensor responsive to stress induced 
by a broad variety of mild to moderate doses of electrophilic compounds, pro-
oxidants and oxidants.  
Upon exposure to low to moderate doses of H2O2 and diamide, Keap1 had 
undergone oxidation to form intra- and inter-molecular disulfide forms. 
Among the cysteines in Keap1, Cys226 and Cys613 were observed to be 
involved in intramolecular disulfide bond formation and Cys151 was found to 
be involved in intermolecular disulfide bond formation. These oxidized 
disulfide species of Keap1 were found to be reduced in a time-dependent 
manner, which had suggested that redox defense systems were in place to 
alleviate the low to moderate level of oxidative and/or electrophilic stress so as 
to reverse the oxidation of Keap1. Indeed, like in the case of AIF oxidation, 
the GSH and Trx systems were found to be involved in maintaining the thiol 




Since oxidative stress is known to cause Nrf2 upregulation, the effect of 
oxidative modifications in Keap1 on its ability to target Nrf2 for Cul3-
mediated ubiquitination and proteasomal degradation was investigated. The 
homodimerization of Keap1, which is important for Keap1’s function as a 
substrate adaptor for Nrf2 and other proteins, was found to be unaffected 
under oxidizing conditions. On the other hand, the Keap1-Cul3 interaction was 
found to be disturbed under pro-apoptotic strongly oxidizing conditions, but 
had remained unchanged under low to moderate non-cytotoxic oxidizing 
conditions. Intriguingly, under these low to moderate oxidizing conditions, 
Nrf2 was observed to display reduced association with Keap1. Therefore, 
based on our experimental findings, it was postulated that upon exposure to 
low to moderate dose of oxidants, although Keap1 might be able to retain its 
ability to target proteins for Cul3-mediated ubiquitination and proteasomal 
degradation, the disturbed Keap1-Nrf2 interaction would lead to Nrf2 
upregulation. The results have thus emphasized the pivotal role of Keap1 in 
maintaining redox homeostasis. A schematic presentation of oxidative stress-
induced modulation of Keap1-Nrf2-ARE signaling is shown in Fig. 6.3.    
 
Figure 6.3 Scheme of redox-dependent Keap1-mediated regulation of Nrf2-ARE 
signaling. Under physiological conditions, Keap1 targets Nrf2 for Cul3-mediated 
ubiquitination and proteasomal degradation. However, under low to moderate 
oxidative stress, the perturbed Keap1-Nrf2 interaction, had led to nuclear 




In addition, in the attempt to investigate the role of Cys151 in Keap1 as a 
possible link between Nrf2-Keap1 and NF-κB signaling, prototypical Nrf2 
inducer SF, which is reported to possess anti-inflammatory activities through 
suppression of NF-κB signaling, was tested in our experimental set-up. The 
results obtained had revealed that Cys151 was indeed one crucial residue 
targeted by SF, which led to a switch from Keap1-Nrf2 interaction to Keap1-
IKKβ and possibly Keap1-p65 interaction. The resultant cellular outcomes 






















6.3 Future work 
6.3.1 Investigation of interaction between AIF and Trx2 in the isolated 
mitochondria and its biological significance 
Immunoprecipitation reactions carried out using whole cell lysates had 
revealed a weak interaction between AIF and Trx2. However, the interaction 
between AIF and Trx2 might be stronger in the mitochondria. Hence, the AIF-
Trx2 interaction can be investigated in immunoprecipitation reactions using 
lysates obtained from isolated mitochondria. Upon establishing that AIF-Trx2 
interaction indeed occurs in the mitochondria, its biological significances can 
next be examined.  
6.3.2 Evaluation of the role of non-catalytic cysteine residues present in 
Trx1 in regulating AIF-mediated apoptosis 
Experimental findings presented in Chapter 2 had suggested that non-catalytic 
cysteines were likely involved in the AIF-Trx1 interaction. Therefore, it is 
proposed that further work can be carried out to investigate the role of Trx1’s 
non-catalytic cysteines in the regulation of AIF-mediated apoptosis induction.   
6.4.3 Determination of functional activities of oxidized AIF 
AIF was found to become oxidized under oxidizing conditions. Although we 
had attempted to investigate whether the functions of AIF were affected upon 
its oxidation on the basis of assessment of AIF’s NADH oxidase activity in an 
in vitro assay using recombinant His-hAIF121 protein, we acknowledge the 
investigation was carried based on the assumption that the NADH oxidase 
activity was associated with its oxidoreductase activity in the mitochondria 
and apoptosis inducing activity upon translocation into the nucleus. Therefore, 
the future work may involve assessing whether oxidized AIF still possesses 
oxidoreductase and/or apoptosis inducing abilities using cell-based assays.  
6.5.4 Examination of the role of Keap1 in proteasomal degradation of p65 
Our experimental results had shown that overexpression of Keap1 was related 




MG132 treatment. Given that p65 has been reported to interact with Keap1, 
the possible role of Keap1 in the ubiquitination and proteasomal degradation 
of p65 can be examined.     
6.6.5 Investigation of Keap1’s ability to target IKKβ and p65 for Cul3-
mediated ubiquitination and proteasomal degradation under low 
oxidative stress 
The Keap1-Cul3 interaction had been found to remain undisturbed under low 
oxidative stress, which had suggested that Keap1 still retained the ability to 
target proteins for Cul3-mediated ubiquitination and proteasomal degradation. 
As we had investigated and presented the experimental findings in Chapter 5, 
upon treatment with prototypical Nrf2 inducer SF and in the presence of 
proteasome inhibitor MG132, interaction between Keap1 and IKKβ and p65 
was increased while that between Keap1 and Nrf2 had decreased. It remains to 
be investigated whether Keap1 is able to enhance proteasomal degradation of 
IKKβ and p65 through this increased interaction, which can be pursued in the 
future.   
6.7.6 Investigation of the role of Cys151 in the regulation of Nrf2-ARE 
and NF-κB signaling   
Adduction of Cys151 by SF was found to switch the interaction between 
Keap1-Nrf2 to Keap1-IKKβ or Keap1-p65. In addition, in the absence of 
proteasomal inhibitor MG132, the cellular levels of IKKβ and p65 were 
decreased under SF treatment. To confirm the role of Cys151 in the regulation 
of Nrf2-ARE and NF-κB signaling, further investigations can be pursued 
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Appendix І Structures of known and potential electrophilic Nrf2 inducers    
 























Figure 1 Structures of known (A) SF and (B) tBHQ and potential (C) CA 
(D) BCA and (E) 6-shogaol electrophilic Nrf2 inducers. 
 
